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General introduction




In clinical psychiatry it is common practice that the clinical effectiveness of a treatment is 
judged by the health care professionals and patients. Routine Outcome Monitoring (ROM) 
can provide exact and valuable additional information about this clinical effectiveness. 
ROM is a measurement and feedback system, facilitating the systematic evaluation of a 
psychiatric patient’s treatment response during the course of treatment in routine clinical 
practice. Measuring progress and providing feedback is beneficial to the treatment, both 
for the clinician and the patient. This feedback is facilitated by the application of reference 
values in combination with ROM scores. Reference values may quantify the patient progress 
in therapy and support decisions on continuing, altering or terminating treatment can be 
considered.
A case
A 64-year old female inpatient was diagnosed with a 7 year history of depression and anxiety. 
Her problems had started rather abrupt after marital problems that resulted in divorce. Her 
past medical history included agoraphobia and orthostatic hypotension. Several times she 
was treated for anxiety and depression with psychotherapy and several antidepressants, 
either as inpatient or outpatient. Because of severe depression with psychotic features and 
resistance to antidepressant treatment she was admitted to the Leiden University Medical 
Centre (LUMC). She was treated with Electroconvulsive Therapy (ECT) unilaterally and 
her depression went into remission. Depression severity was monitored during the treatment 
through clinical judgement and ROM. Depression symptom scores are depicted in the graph, 
showing a slow but steady decline of the symptom severity, assessed through the observer-
rated Montgomery-Äsberg Depression Rating Scale (MADRS), where a higher score means 
more psychopathology (see Figure 1.1).
 
Figure 1.1. ROM graph of MADRS scores of 12 consecutive assessments of an ECT treated patient 
diagnosed with major depressive disorder.
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The provided ROM scores in the above case need interpretation. The baseline MADRS 
score (week 0, first consultation or admission) matches a diagnosis of depression that was 
previously established by a clinical interview in combination with the Mini-International 
Neuropsychiatric Interview-Plus (MINI-Plus; [1]): a severe depression in this case. The 
consecutive scores (week 1 through 12) depict the course of the symptom severity, supporting 
the evaluation of the treatment effect (outcome): has the patient deteriorated, improved, not 
changed, or recovered? In this case a steady improvement can be seen. A key question for the 
therapist is: when is the patient sufficiently recovered to make the next step in the treatment? 
One approach that can support such a decision is that the ratings can be compared to those 
of a normal population. When scoring below a certain cut-off value, the patient is no longer 
dissimilar from the reference population, and it could be argued that it is legitimate to make 
a start shifting treatment towards interventions aimed at relapse prevention and ultimately 
to refer the patient back to her general practitioner (GP). Evidence based cut-off values for 
commonly used ROM questionnaires, such as the MADRS, can support clinical decisions. 
These cut-off values can be derived from the distributions of scores from the healthy general 
population and from patient populations. Cut-off values and additional measures of score 
distributions are referred to here as reference values.
 To provide empirical based reference values for ROM questionnaires, the 
NormQuest [i.e., quest for norms] study was initiated in 2008 by the LUMC and the regional 
mental health care provider Rivierduinen. This thesis aims to present these reference values 
that can be used to support clinical evaluations in the referral and treatment of patients with 
mood, anxiety, and somatoform (MAS) disorders. Reference values comprise cut-off values, 
marking the difference between the patient population (‘psychiatrically ill’) and the reference 
population (‘healthy’).
 Currently, it is common practice that the clinical effect of an individual treatment 
is judged qualitatively by the health care professionals and patients. The application of 
ROM in combination with reference values may facilitate decision making. Ideally, they 
provide standardized yard-sticks to assess whether the patient’s severity of symptoms has 
been reduced, whether the patient’s level of functioning has improved over time and whether 
therapy has moved someone outside the range of the patient population and within the range 
of the reference population.
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ROUTINE OUTCOME MONITORING (ROM)
ROM provides health care professionals and patients with information relevant to the 
patient’s progress [2]. Diagnosis, monitoring of treatment, and communication between 
clinician and patient can be improved by ROM [3]. A range of objective, standard outcome 
measures (self-report questionnaires and observational instruments) are an essential part of 
ROM. A practical ROM-strategy was implemented in the department of psychiatry of the 
Leiden University Medical Center (LUMC) and in the outpatient department of the regional 
mental health care provider Rivierduinen from 2002 onwards (see Box 1).
 ROM questionnaires should be clinically relevant, sensitive to change, and minimally 
burdensome to patient, staff and organization [4]. Therefore, the selection of questionnaires 
should be based on validity, reliability, availability of reference data, but also on costs. With 
test characteristics being equal, public domain questionnaires that are free of charge are 
preferred over copyrighted questionnaires that are commercially exploited. In the context of 
ROM, there can be serious economic obstacles to the required frequent assessments that are 
intended for all patients. So, there is an urgent need for the development of public domain 
questionnaires [5,6].
 Questionnaires for ROM comprise both generic and specific ones. Generic measures 
are used for the assessment of general psychopathology, distress, or general functioning. 
Since they are, in principle, applicable to all patients, they allow for comparison of treatment 
outcomes among all patients, irrespective of specific disorders. Generic questionnaires allow 
statements about the therapy effect regardless of the diagnosis and they are applicable for 
patients with more than one condition. Furthermore, they facilitate comparisons between 
different patient groups [7]. Disease-specific measures focus on particular symptoms relevant 
to a single disorder and are administered only to those patients meeting criteria for the disorder 
at hand. They are more sensitive to changes in outcome due to treatment as they assess the 
intensity of the symptoms that the patient suffers from and the specific treatment targets [4,8].
 In addition to clinical applications, treatment outcome data can also be relevant to 
researchers and managers. Research is constantly searching to develop new treatments and 
these treatments require clinical effectiveness research, which can be facilitated by outcome 
data. Additionally, researchers can use outcome data for basic research into factors impacting 
upon outcomes [9] and psychometric research [8,10-14]. For managers, data can provide 
insight in the quality level of the mental health care by comparing outcomes on differential 
effectiveness of various treatment programs, locations, departments or even therapists 
(benchmarking).
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BOX 1. ROM in the Leiden University Medical Center & Rivierduinen (courtesy M. van Noorden)BOX 1. ROM in the Leiden University Medical Center & Rivierduinen (courtesy M. van Noorden) 
 
 
In spring 2002, the Regional Mental Health Provider ‘Rivierduinen’ (an institute serving a region with more than 1 
million inhabitants) and the Department of Psychiatry of the Leiden University Medical Center (LUMC) started 
collaboration for routine assessment of the DSM-IV diagnosis as well as the symptom severity, well-being and 
health status at time of the first interview of outpatients referred to Rivierduinen.  
At the start, ROM was restricted to patients referred for treatment of mood, anxiety, and somatoform (MAS) 
disorders. These patients form a relatively homogenous group with substantial mutual comorbidity (Kessler et al., 
1996) and they mainly receive outpatient care. To be eligible, patients had to have sufficient mastery of the Dutch 
language and had to be able to complete self-report instruments. Patients who are considered (by their clinician) to 
be too ill to complete questionnaires or refuse to be assessed are excluded from ROM assessment.  
All patients are assessed by an independent psychiatric research nurse at the start, and during follow up at 
intervals of three to four months, at the beginning of a new treatment step and at the end of the treatment.  
 
During the first session, a standardised diagnostic interview is administered and observer- and self-reported 
ratings are determined. At baseline the Axis-I diagnosis according to the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV) is established using the Mini-International Neuropsychiatric Interview-plus (MINI-plus, 
Sheehan et al., 1998). The interviews are performed by psychiatric research nurses who have been extensively 
trained and supervised. The Dimensional Assessment of Personality Pathology (DAPP-SF) is administered to 
assess maladaptive personality traits (Livesley et al., 2006; van Kampen et al., 2008). Until now, in ROM no 
detailed treatment information is available.  
Subsequently, a number of symptom severity rating scales are administered at baseline and are also completed 
at each re-assessment to allow for the evaluation of treatment outcome. Together, these instruments cover change 
in three areas of functioning: symptom reduction, increased wellbeing, and improvement in general life functioning 
(Sperry et al., 1996). They are commonly used in treatment-outcome research and have good psychometric 
properties as evidenced by national and international publications (an overview of instruments used is available at 
http://www.lumc.nl/psychiatry/ROM-instruments). Outcome is assessed by patients’ self-report and by an 
independent assessor (observer-rated), and includes both generic and disorder-specific measures. Clinicians 
receive a report on the results of the baseline assessments as well as follow-up reporting on treatment outcome in 
the above mentioned domains. Results of the assessments are provided in detail by the research nurses as well 
as in a summarised form. The summaries facilitate clinicians to discuss the results with their patients and use them 
as a tool to evaluate the treatment. Results are also used, in an anonymous form, for scientific purposes. 
 
Since ROM-data are primarily being used by clinicians and patients to monitor treatment progress, no specific 
informed consent is needed. The use of anonymized data for research purposes has been approved by the 




MOOD, ANXIETY AND SOMATOFORM (MAS) DISORDERS
There are many different categories of psychiatric disorders for which ROM could be used to 
systematically evaluate a patient’s treatment. We focused on mood, anxiety, and somatoform 
(MAS) disorders. The majority of patients of the LUMC and a substantial number in 
Rivierduinen are treated for these disorders. Estimates of different prevalence proportions 
for mood and anxiety disorders are relatively high [15-19], as can be seen in Table 1.1. 
Unfortunately no data are available for somatoform disorders.
Table 1.1. Lifetime-, 12 month, and point prevalence rates of common mood and anxiety disorders* in the 
Netherlands in weighted percentages.
                                                    Prevalence rates
                                                                                                    Lifetime*           12-month*           Point            
Any mood disorder 19.6 6.9 4.1
- Major Depression 17.0 5.5 2.9
- Dysthymic Disorder 3.9 1.6 0.8
Any anxiety disorder+ 19.4 11.3 5.5
- Panic Disorder 3.8 1.7 2.7
- Social Phobia 8.5 4.3 0.8
- Obsessive-Compulsive Disorder 0.9 0.5 0.5
- Generalized Anxiety Disorder 3.4 1.4 0.8
Lifetime- and 12-month prevalence rates based on the Netherlands Mental Health Survey and Incidence 
Studies NEMESIS-1 and NEMESIS-2 [15,16]
Point prevalence rates in a GP consulting population based on De Waal et. al., 2004 [17]
* No data were ascertained for somatoform disorders
+ No data available for post-traumatic stress disorder PTSD
 MAS disorders are the most frequently observed mental disorders in primary health 
care [20,21]. The disease burden is very large, with depression as the most important single 
contributor to the global burden of disease [22]. MAS disorders frequently occur as comorbid 
disorders [23-25], possibly more frequently than often assumed [26]. The Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR) provides 
standard criteria for the classification of mental disorders and is used in (specialized) mental 
health care [27,27]. Table 1.2 shows the DSM-IV-TR criteria for a selection of MAS disorders.
 For MAS disorders various questionnaires are available, for nearly every diagnostic 
category a separate one. Although standardization of psychiatric assessments and their 
reference values are essential for patient care, for various MAS instruments reference values 
are not available. 
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Table 1.2. Examples of prevalent MAS disorders: DSM-IV-TR criteria of Major Depressive Episode, 
Panic Disorder with Agoraphobia, and Hypochondriasis
Major Depressive 
Episode
Panic Disorder With Ago-
raphobia
Hypochondriasis
A. ≥5 of the following 
symptoms present ≥2 
weeks, representing a 
change from previous 
functioning; at least one of 
the symptoms is either 1 
or 2
A. Both (1) and (2): A. Preoccupation with fears 
of having, or the idea that 
one has, a serious disease 
based on the person’s 
misinterpretation of bodily 
symptoms
1. depressed mood 1.recurrent unexpected 
panic attacks
2. markedly diminished 
interest or pleasure
2.≥1 attack has been 
followed by ≥1 month of ≥1 
of the following:
3. significant weight loss or 
weight gain, or decrease or 
increase in appetite
a. persistent concern about 
having additional attacks
4. insomnia or hypersomnia b. worry about the 
implications of the attack or 
its consequences
5. psychomotor agitation or 
retardation
c. a significant change in 
behavior related to the 
attacks
6. fatigue or loss of energy
7. feelings of worthlessness 
or excessive or 
inappropriate guilt
8. diminished ability to 
think or concentrate, or 
indecisiveness
9. recurrent thoughts of 
death or suicide
B. The symptoms do not 
meet criteria for a Mixed 
Episode
B. The presence of 
agoraphobia









Panic Disorder With Ago-
raphobia
Hypochondriasis
C. The symptoms cause 
clinically significant distress 
or impairment in social, oc-
cupational, or other impor-
tant areas of functioning
C. The Panic Attacks are not 
due to the direct physiologi-
cal effects of a substance or 
a general medical condition
C. The belief in Criterion A 
is not of delusional intensity 
(as in Delusional Disorder, 
Somatic Type) and is not 
restricted to a circumscribed 
concern about appearance 
(as in Body Dysmorphic 
Disorder)
D. The symptoms are not 
due to the direct physiologi-
cal effects of a substance 
(e.g., drug of abuse, medi-
cation) or a general medical 
condition
D. The panic attacks are 
not better accounted for by 
another anxiety disorder
D. The preoccupation 
causes clinically significant 
distress or impairment in 
social, occupational, or other 
important areas of function-
ing
E. The symptoms are not 
better accounted for by 
bereavement
E. The duration of the distur-
bance is at least 6 months
F. The preoccupation is 
not better accounted for by 
Generalized Anxiety Disor-
der, Obsessive-Compulsive 
Disorder, Panic Disorder, a 
Major Depressive Episode, 
Separation Anxiety, or an-
other Somatoform Disorder
MAS denotes Mood Anxiety Somatoform; DSM-IV-TR denotes Diagnostic and Statistical Manual of 
Mental Disorders, fourth edition, text revision.
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REFERENCE VALUES
Reference values are used for variables that can be assessed quantitatively, such as body 
temperature or depression severity. They are assessed in a reference population, i.e. a 
population not selected on pathology with respect to that variable. Reference values can be 
used to assess whether, for instance, a person suspected of influenza has a body temperature 
increased above a certain level (called ‘fever’) or whether somebody treated for depression 
still has a score increased above a certain level on a depression severity scale like the 
MADRS. The term ‘reference values’ was introduced by Gräsbeck and Saris [28]. They did 
so to replace the older, more ambiguous, terminology of ‘normal values’ by a well-defined 
nomenclature and recommended procedure in the field [28,29]. The term ‘normal values’ 
caused confusion because the word ‘normal’ has multiple, rather different connotations (e.g., 
statistical, epidemiological, psychological, or clinical).
 The selection of the reference population and the definition of reference values are 
important. The reference population should consist of individuals with a well-defined state 
of health [29,30]. Health can be operationalized in different ways: medically and statistically. 
The medical approach considers health as absence of pathology, in absolute terms, or at least 
of a certain type of pathology. Thus, individuals with that disorder are excluded from the 
reference population. For instance, in the medical approach, to obtain reference values for 
depression, depressed patients are excluded from the reference population. The statistical 
approach is based on the distribution of scores of a quantifiable variable in a population, 
the reference population, not selected on certain values of that variable. For instance, in 
the statistical approach of reference values for depression severity, the latter is assessed 
in a population not selected on certain scores of depression, for instance a sample of the 
general population. In the statistical approach the middle range of scores of the distribution 
of that variable is considered as healthy and extreme high or low scores as deviant [31]. 
Healthy values usually are based on the middle 95% of the reference population. However, 
extreme high and low variables are not always deviant. For many variables used in ROM, 
like depression severity, only one extreme, mostly the highest score, is considered deviant. 
In such cases, deviancy is restricted to the top 5%. Individuals with current elevated levels 
of psychopathology (i.e., who display characteristics similar to those being addressed in the 
treatment) are not excluded from the reference group, because otherwise, a ‘supernormal’ 
sample would be created. Resulting reference values would be overly stringent [32]. 
Similarly, the bottom 5% of the psychiatrically-ill population can be considered “deviant”; 
their symptoms may have become subsyndromal. Deviancy at the top of the distribution is 
clinically meaningless (i.e., too ill). In this study the statistical approach was followed.
  1
General introduction 19
If it is clinically relevant, partition criteria can be used to characterize subgroups from the 
reference population, which could be based for example on gender and age categories, as 
clinically important differences in reference values may be present in these subgroups [9].
Methods of comparison
Reference values will be used to assess clinical efficacy of a treatment. To assess a change 
from pre-test to post-test as clinically meaningful, the proposal of Jacobson and colleagues 
[33] is followed in ROM. They proposed two criteria for clinically significant change: (1) the 
change must be greater than the measurement error of the instrument (statistically reliable 
change), and (2) the treated patient displays a severity of symptomatology that is equivalent 
to or beyond levels found in the general population. The transition from illness to health 
signifies recovery, the transition vice versa signifies relapse. When only the first criterion is 
met there is reliable improvement or deterioration, but no recovery or relapse yet. When only 
the second criterion is met there is indeed a transition from illness to health or vice versa, but 
both the pre-test score and the post-test score is so close to the cut-off value that the change 
is not clinically significant.
 The Jacobson method is based on the assumption that the distribution of 
psychopathology scores in a patient population is Gaussian (normal). However, 
psychopathology scores like many biological data are often not symmetrically distributed in 
the general population [30] and the distribution is non-Gaussian. Indeed, psychopathology 
questionnaires measure the severity of symptoms, not the level of healthy functioning. The 
analytical procedures need to take these non-Gaussian distributions into account through 
nonparametric methods [34]. Therefore, the Jacobson method is not directly appropriate for 
the ROM reference group scores. Percentile scores (5th, 25th, 50th, 75th, and 95th) however 
can be used as a modification for both Gaussian and non-Gaussian distributions. They are 
introduced in this thesis for both the ROM reference group and the ROM patient group as is 
discussed in the section about percentile scores.
Sensitivity and specificity 
Sensitivity and specificity are statistical performance characteristics of a test. Sensitivity 
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 The terms positive predictive value and negative predictive value are used when 
considering the value of a test to a clinician: they answer the questions “How likely is it that 
the patient has the disease given that the test result is positive” and “How likely is it that 
the patient does not have the disease given that the test result is negative”. The relationship 
among the terms is depicted in the following crosstab.
Condition positive Condition negative
Test outcome 
positive True Positive Fals Positive Positive Predictive 
Value
Test Outcome 









 If a test results in a completely correct separation of healthy and diseased individuals, 
there would be no overlap between a reference group and a patient group, and sensitivity and 
specificity of a test would be 1. But in reality there is virtually always some overlap: i.e., there 
are people in the reference group who are ill and persons in the patient group who are not ill. 
However, in psychiatric disorders the situation is more complicated: absolute definitions of 
having a psychiatric disorder or not do not exist. They have to be defined on the basis of cut-
off scores. In fact, it would be more correct to speak of cut-off scores indicating a severity 
necessitating treatment. When the cut-off scores are changed the sensitivity and specificity of 
the test will change. By studying several cut-off scores, optimal cut-off scores for both high 
sensitivity and specificity can be computed.
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The sensitivity and specificity of a test are dependent on the cut-off value above which the 
test is considered positive and when the cutoff value is changed, the two test characteristics 
will change complementary: for a higher cutoff value, the specificity will increase and the 
sensitivity will decrease, and vice versa [35]. A cautious, high cut-off point results in a high 
specificity with a high percentage of true negative results in non-diseased individuals, but at 
the cost of a lower sensitivity, with more diseased subjects being rated as false negatives. A 
strict, low cut-off point will result in a high sensitivity (i.e., few false negatives at the cost 
of more false positives). When false negatives and false positives are equally undesirable 
(and the disease is not uncommon), a trade-off is commonly proposed where sensitivity and 
specificity are equal. Two important factors that determine the optimal balance between high 
sensitivity and high specificity are: a) the prevalence or a priori probability of the disorder; 
and b) the relative cost or undesirability of errors [36]. First, testing for low-frequency 
diseases is always problematic. It is relevant whether you use a test in the general population, 
in the primary care population, or in the psychiatric population. Given the same sensitivity 
and specificity, the positive and negative predictive values are very different for the different 
prevalence rates. Second, the ‘costs’ depend on the kind and prevalence of the disorder and 
differ for false negatives and false positives. High sensitivity is sought when the questionnaire 
is used to identify a serious but treatable disorder. The test will not be very specific, however, 
with a high proportion of clients with a positive test result who are subsequently found to 
have no underlying pathology (false positives). After initial screening with a sensitive test, a 
second test with higher specificity could identify nearly all of the false positives as disorder 
negative [35].
 In sum, we use sensitivity and specificity because they are characteristics of the test; 
they are independent on the prevalence of the disease in the population of interest. This is 
in contrast to the use of positive and negative predictive values, which are characteristics of 
the usefulness of the test in different populations: they are affected by the prevalence of the 
disease.
Receiver Operating Characteristics (ROC)
A Receiver Operating Characteristic (ROC) is a classification model that illustrates, by way of 
a graphical plot, the diagnostic performance of a questionnaire as its discrimination threshold 
(the cut-off value) is varied. It is created by plotting the sensitivity versus the specificity, for 
all possible cut-off values. The Area Under the ROC Curve (AUC) is equal to the probability 
that the questionnaire will rank a randomly chosen positive instance higher than a randomly 
chosen negative one, i.e., will discriminate illness from health. ROM questionnaires, which 
are used to assess the level of (dys-) functionality both in the reference group and the
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patient group need to have good discriminatory power. By means of ROC analyses and 
subsequent AUC analyses, the discriminative power that is illustrative of the diagnostic 
capability of the ROM questionnaires can be investigated.
Percentile scores 
Reference values are used to describe and interpret the treatment outcomes, operationalized 
as questionnaire scores. Percentile scores (e.g., 5th, 25th, 50th [i.e., median], 75th, and 95th) 
are appropriate reference values for all types of distributions, including non-Gaussian 
distributions of reference group scores and Gaussian distributed patient scores. Indeed, this 
non-parametric method makes no specific assumption regarding the distribution of the scores 
[34]. Firstly, percentile scores facilitate norm-referenced testing, so as to determine how the 
tested person scores compared to other persons from a certain population, e.g., with a similar 
disorder or of similar gender. Secondly, percentile scores allow cut-off-referenced testing 
where the questionnaire score is interpreted absolutely, by comparing the score with a clinical 
threshold (i.e., cut-off value).
Figure 1.2. Hypothetical distribution of the scores of a questionnaire measuring psychopathology 
within the reference population and within the patient population. Two cut-off values are depicted: the 
95th percentile score (P95) of the reference group and the 5th percentile score of the patient group. The 
median scores (P50) of the groups are depicted as well (which is equal to the mean only in case of a 
normal Gaussian distribution). A commonly used definition is that 1 out of 20 (or 5%) results will fall 






















 The 5th percentile score (P5) of the patient population, marking the bottom 5%, 
would be the clinical threshold for referral from primary care to specialized mental health 
care (see Figure 1.2): i.e., persons enter treatment when they are no longer part of the 
reference population, but belong to the patient population instead (see Figure 1.3). A second 
clinically relevant cut-off point is the point that the patient has to cross at the time of the post-
treatment assessment in order to be classified as changed to a clinically significant degree of 
functionality or health [34]. As can be seen in Figure 1.2, the cut-off, marking the top 5%, 
would be the 95th percentile score (P95) of the reference population. Below this value, the 
patient in specialized mental health care is more similar to the reference population than to 
the patient population, and referral back to primary care is indicated (see Figure 1.4).
 





















      
Figure 1.3. Cut-off values relevant for referral from primary care to secondary care. Patients enter 
treatment when they are no longer part of the reference population, but belong to the patient population 
instead, above the cut-off value P5  of the patient group.




















Figure 1.4. Cut-off values relevant for referral from secondary care to primary care. Patients depart from 
treatment when they no longer belong to the patient population, but belong to the reference population 
instead, below the cut-off value P95  of the reference group.
Considerations on the use of reference values
When interpreting differences between observed values and reference values, it is important 
to realize that statistical significance is only descriptive: it does not imply clinical importance 
per se [30]. Individual patient factors can affect the clinical meaning: overall level of 
functioning and the ability to carry out activities of daily living. In addition, the best-possible 
result of treatment is not necessarily statistically meaningful. Decision limits (i.e., cut-off 
values) based on reference values should not be used as a single decision criterion, but they 
can be an important adjunct to the clinical treatment. Clinicians are in the best position 
to judge the unique characteristics of their patients. A treatment strategy is most likely to 
succeed when it combines effective therapy, ROM and its reference values, and a strong 
therapeutic relationship. We do not recommend a rigid system of treatment and referral that 
eliminates the ability to respond to individual needs of the patient.
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AIMS AND OUTLINE OF THIS THESIS
Aims of this thesis
As specified above, ROM is a measurement feedback system that facilitates systematic 
evaluation of a patient’s treatment response during the course of treatment in routine clinical 
practice. ROM comprises a comprehensive assessment battery, including both generic 
and disorder-specific measures. The first aim of the study in this thesis (referred to as the 
NormQuest [i.e., quest for norms] study) was to provide empirical based, valid reference 
values for patients with one or more MAS-disorders. We aimed to generate reference 
values for both ‘healthy’ and ‘clinically ill’ MAS populations. We chose to define health 
statistically (as opposed to medically). To enable norm-referenced testing, percentile scores 
were calculated for each of the measures. To facilitate cut-off-referenced testing, we aimed 
to calculate cut-off values based on percentile scores and Receiver Operating Characteristics 
(ROC). The P5 ROM patient group cut-off values can be used by primary care physicians as 
decision indicator for referral to the specialized mental health care. The P95 ROM reference 
group cut-off values can be used by specialized mental health care as decision indicator for 
referral back to primary care physicians. For comparability with the international literature, 
we also report means and standard deviations. We calculated reference values in separate 
strata of gender and age to study the strata effects. Also, we assessed the discriminative 
power of the questionnaire scores by means of Receiver Operating Characteristics (ROC) 
analyses. Additionally, internal consistency reliabilities were calculated.
 The second aim of the NormQuest study concerned the development of public 
domain questionnaires. In this study, the Symptom Questionnaire-48 (SQ-48) was developed 
as a public domain alternative for the frequently used Brief Symptom Inventory (BSI), which 
is not free of charge.
Thesis outline
Chapter 2 describes the objectives, design, and methods of the NormQuest study in detail. 
The extensive process of recruitment and baseline characteristics of the reference group 
versus the patient group are reported.
 In Chapter 3, reference values for four generic questionnaires were calculated: 
the Brief Symptom Inventory (BSI), the Mood & Anxiety Symptom Questionnaire -30 
(MASQ-D30), the Short Form Health Survey 36 (SF-36), and the Dimensional Assessment 
of Personality Pathology-Short Form (DAPP-SF). Gender- and age effects were studied.
 In Chapter 4, we focused on the reference values for three disorder-specific 
questionnaires concerning depression: the Beck Depression Inventory-II (BDI-II), the 
Inventory of Depressive Symptoms (self-report) (IDS-SR), and the Montgomery-Äsberg 
Depression Rating Scale (MADRS). Again gender- and age effects were assessed.
 In Chapter 5, we calculated reference values for eight anxiety questionnaires: the 
Brief Scale for Anxiety (BSA), the PADUA Inventory Revised (PI-R), the Panic Appraisal 
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Inventory (PAI), the Penn State Worry Questionnaire (PSWQ), the Worry Domains 
Questionnaire (WDQ), the Social Interaction, the Anxiety Scale (SIAS), the Social Phobia 
Scale (SPS), and the Impact of Event Scale-Revised (IES-R). These questionnaires cover 
most of the anxiety disorders.
 Chapter 6 provides reference values for three disorder-specific questionnaires 
concerning somatoform disorders: the Body Image Concern Inventory (BICI), the Checklist 
Individual Strength (CIS20R), and the Whitely Index (WI). These questionnaires assess 
symptom severity in patients with body dysmorphic disorder, hypochondriasis and chronic 
fatigue syndrome.
 Chapter 7 describes the development, validation and reference values of our newly 
developed public domain questionnaire, the 48-item Symptom Questionnaire (SQ-48). This 
questionnaire was developed as a psychological distress instrument, including measures of 
vitality and work functioning, to be used as a screening / monitoring tool in clinical settings 
(psychiatric and non-psychiatric), as a benchmark tool, or for research purposes.
 Finally, in Chapter 8, we summarized the main results of this study. We discussed 
these results, the clinical implications, and provided recommendations for further 
improvement of ROM as well as suggestions for future research.
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ABSTRACT
Background: Routine outcome monitoring (ROM) was developed to establish the 
outcome of psychotherapeutic and pharmacological treatments through repeated assessments 
before, during and after treatment. Although standardization of psychiatric assessments and 
their reference values are essential for patient care, for various ROM instruments reference 
values are not available. The aim of the Leiden ROM Study is to generate reference values 
for 22 ROM instruments, covering generic and specific mood, anxiety and somatoform 
(MAS) disorders, for the general population. This article describes the extensive process of 
recruitment, as well as baseline characteristics of patient versus non-patient groups.
Method: Cross-sectional study in randomly selected participants aged 18-65 years from 
the Dutch population, included through general practitioners.
Results: Extensive demographic, psychosocial, mental health, and biological data from 
1302 participants, recruited via general practitioners, were collected during a two-hour 
standardized assessment including observer-rated and self-report scales. These data will 
be compared with corresponding data from 7840 patients with psychopathology who were 
referred to secondary care. On-going quality control and calibration ensured maintenance of 
high quality during data collection.
Discussion: This reference group study for mental health assessments is the first study 
of this size carried out in the Netherlands.The results of this study are expected to be of 
value to secondary psychiatric care because they allow the indication of progress in health, 
treatment effect and possible termination of treatment. Additionally, the reference values can 
be used by primary care physicians as decision threshold for referral to specialized mental 
health care and vice versa.
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Routine outcome monitoring (ROM) was developed to enhance the effectiveness of 
psychiatric care. ROM routinely measures treatment outcomes using different outcome 
measures that are both generic and disorder-specific. It provides clinicians with information 
on the type and severity of psychopathology and feedback on treatment efficacy. Additional 
benefits are its use in research and benchmarking [1-3]. However, several ROM instruments 
lack reference values that provide optimal discrimination between the ‘healthy’ and the 
‘diseased’, indicating whether the patient has progressed to a range of psychological health 
similar to non-patients, whilst not necessarily free of all symptoms. Also, with outcome 
variables often varying between different gender and age groups, reference values are the 
key to determining whether a group or an individual scores above or below average for their 
gender and age [4,5]. Anchoring ROM instruments in population-based reference values 
makes clinical and scientific interpretations more meaningful and is consistent with practice 
in other areas of medicine [6,7]. Furthermore, reference values are useful to determine when 
primary care physicians could refer their patients to secondary care and vice versa.
 In order to study the relationship between psychosocial factors, genetic variation, 
the effect of the hypothalamic-pituitary-adrenal (HPA) axis stress system, and the occurrence 
and course of mood, anxiety and somatoform (MAS) disorders, the Leiden Routine Outcome 
Monitoring Study was designed to generate a large ROM database [8,9]. 
 The present ROM Reference Group Study was designed to provide reference values 
for 22 ROM in the general practice population in the Netherlands. This may help to facilitate 
assessment of a clinically significant change of treatment effects, defined as returning to 
normal functioning.
 A secondary aim was to collect saliva from a large general population control 
group in order to facilitate research on genetic characteristics (DNA) and the HPA axis stress 
system in relation to the development and course of MAS disorders. Genetic factors and a 
deregulated HPA axis are involved in the etiology of MAS disorders. Twin studies [10,11] 
have shown that mood and anxiety disorders are for 30-40% determined by hereditary factors. 
Furthermore, dysregulation of the HPA axis is believed to be linked with the pathophysiology 
of depression [12-14] and anxiety disorders [15,16].
 The present study describes the methods and objectives of the ROM Reference 
Group Study, as well as baseline characteristics of patient versus non-patient groups.
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METHODS 
Participants
The ROM reference group was recruited to serve as a comparison for the ROM patient 
group. Therefore, the aim for this reference group was that it be representative of the ROM 
population referred for suspected (but not necessarily diagnosed with) MAS disorders, treated 
at the psychiatric outpatient department of the Leiden University Medical Center (LUMC) or 
at the mental health clinics of Rivierduinen (RD) (hereafter referred to as the ‘ROM patient 
group’). The sample was stratified for gender, age and urbanization level to be representative 
of the ROM patient group [17]. 
 A total of 1302 participants (18-65 years) was recruited, 1294 of whom provided 
complete data sets (Figure 2.1). In order to recruit persons reflecting normal functioning 
with different levels of subthreshold psychopathology, recruitment took place via general 
practices. In the Netherlands, because 99.9% of the general population is registered with a 
general practitioner (GP) [18], the practice registers provide a convenient frame for sampling 
the local general population. Eight university-affiliated general practices with a total of ± 
14,000 enlisted patients in the vicinity of Leiden were involved. In order to form a non-
patient control group and to secure the reliability and validity of the collected data, four 
exclusion criteria were formulated: 1) treatment in a secondary psychiatric care centre in the 
last six months for psychiatric problems and/or dependence on alcohol or drugs; 2) hearing 
impairment, limited cognitive abilities, such as aphasia, severe dyslexia or dementia; 3) 
illiteracy or insufficient mastery of the Dutch language, and; 4) a terminal disease. 
 The study protocol was approved by the Ethical Review Board (ERB) of the LUMC 
and all subjects signed informed consent.
 Since 2002 the LUMC and RD, serving a region of more than one million people, 
have implemented ROM [1]. ROM baseline assessments in the ROM patient group started 
in 2002 and are ongoing. Specially trained psychiatric research nurses assessed 80% of the 
patients (totaling 8357 ROM patients), 7840 of whom were aged 18-65 years. To facilitate 
research on genetic characteristics (DNA) and the HPA axis stress system (cortisol day 
curves) the MASHBANK (biobank for MAS disorders and the HPA-axis) was founded at 
the LUMC and RD in 2007 after approval by the ERB of the LUMC. In this biobank, saliva 
samples are stored from ± 1000 consenting MAS patients. Figure 2.1 shows the multi-stage 
recruitment flow of the ROM reference group, as well as recruitment of the ROM patient 
group.
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  Figure 2.1. Flow chart depicting recruitment of the ROM reference and patient groups
Participants of the ROM reference group were offered the full set of generic instruments. 
Since the total number of instruments was too extensive and all participants were already 
asked to complete the depression instruments, random samples of 50% each were asked 
to complete the anxiety instruments or the somatoform instruments, with even ratios of 
males and females in each subgroup. Thus, four subgroups were established: males-anxiety; 
females-anxiety; males-somatoform; females-somatoform. A sample size of at least 120 per 
subgroup was considered to provide adequate power to yield reference values [19]. In genetic 
research an adequate sample size is imperative because of the low frequency of several 
genetic variants and the problem of multiple testing. Furthermore, a sample size of 1000 
DNA donating participants was deemed to be required [20]. With an anticipated response rate 
of 30%, about 4500 people were approached. In order to get a ROM representative sample, 
four age groups were used: 18-25; 26-40; 41-55; 56-65 years, and the reference group was 
sampled accordingly.
Procedures
In order to recruit the ROM reference group, the eight participating GPs first screened their 
patient lists for those that met the inclusion/exclusion criteria. Subsequently, randomly 
selected appropriate persons were invited to participate by a letter (sent by regular postal 
service) by their GPs that was followed by an announced telephone call by the research team 
to ask for their participation. Objections against this call could be indicated on an enclosed 
reply card. To compensate for possible seasonal influences, recruitment took place all year 
long (between November 2009 and January 2011). Location was the LUMC clinic site 
and, if appreciated, at the participant’s home or in the GP’s practice. Similar to the ROM 
patient assessment procedures, dedicated web-based computer software was used for the 
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administration of all instruments and to prevent missing data within instruments. It 
was also used for data collection and storage, and for creation of summary variables [1]. 
Touch screens were used to accommodate computer-illiterate participants. A personal 
data entry program was developed in database software to organize identification codes 
for general, ROM and MASHBANK data, and to randomly assign the two specific 
instrument packets (depression and anxiety; depression and somatoform) to participants.
 For participants of the ROM reference group the interview started with 
an explanation of the study, and signing of the informed consent form. This was 
followed by a check and assessment of personal details and demographic data, general 
health, cognitive functioning, and physical examination (i.e., body weight, height, 
and blood pressure). Saliva samples were collected in participants who additionally 
consented to this biobank substudy. Next, computerised observer-rated and self-report 
questionnaires were completed. Finally, participants completed an evaluation form and 
received a gift voucher of €30 (for their time and cooperation) and a travel allowance.
 In the ROM Reference Group Study 3 psychiatric research nurses, 3 psychologists 
(Master’s degree level) and 11 Master’s students in psychology were extensively trained and 
tested at the start of and during the reference group study to ensure uniform and adequate 
quality and reliability. Topics were Mini-International Neuropsychiatric Interview Plus, 
version 5.0.0-R (MINI Plus 5.0.0.) and abbreviated Comprehensive Psychopathological 
Rating Scale (vCPRS) interviewing methods, Global Assessment of Functioning Scale 
(GAF) scoring, use of QuestManager, and additional knowledge about MAS disorders 
and MASHBANK. Three full days of training (by the primary investigator, SvM, two 
psychiatrists and two ROM-trained nurses) took place. Each interviewer also observed 
at least three interviews, and the first two interviews were carried out under supervision 
(one of which observed by the primary investigator). Supervision regarding interview 
techniques, problematic behaviour of the participants and scoring rating scales, to improve 
inter-rater reliability, took place every two months. Videorecordings of interviews were 
used to further calibrate assessments between interviewers. Using a semi-structured 
scoring scale a qualitative assessment was done, and was found to be very good in all but 
one potential interviewer. This latter interviewer with insufficient skills was considered 
unsuitable and no longer took part. The ROM patient group was assessed by two trained 
ROM psychiatric research nurses; their training has been decribed in detail elsewhere [1].
Assessments
The ROM reference group assessment comprised measurement of physical health, saliva 
collection and observer-rated and self-report instruments. Measurement of physical health 
indicators comprised blood pressure, heart rate and body mass index, and health-related 
factors (i.e., general health, chronic diseases, smoking status, and alcohol consumption).
 From participants who agreed to participate in the MASHBANK substudy, saliva 
was collected enabling cortisol measurements and DNA isolation. HPA axis activity was
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assessed by free cortisol measurements using seven saliva samples per participant, self 
collected at home. Procedures are similar to that described in detail elsewhere [14,16,21]. 
Saliva for DNA isolation was collected in DNA Genotek kits (Oragene). Measuring cortisol 
and DNA concentrations in saliva has many advantages over measurements in blood samples. 
Saliva collection is non-invasive and can be repeated frequently. Furthermore, storage of the 
material requires no special treatment because DNA and cortisol levels remain stable at room 
temperature. 
 The assessments comprised 25 instruments concerning demographic and personal 
characteristics, psychosocial function, physical health and psychopathology (Table 2.1), 22 
of which require reference values. Except for the 48-item Symptom Questionnaire (SQ-48), 
all tested ROM instruments are internationally used and validated. The generic self-report 
instrument SQ-48 was recently developed by our research group in order to assess mood, 
anxiety, somatoform symptoms, hostility and vitality.
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Statistical analyses
Reference values will be calculated for all instruments, including subscales. Both for patients 
and for the reference group reference values will be determined for all subjects combined, 
as well as for 4 groups: young males (aged 18-40 yr), older males (aged 41-65 yr), young 
females (aged 18-40 yr), and older females (aged 41-65 yr). Means and SDs, 5th, 25th, 50th, 
75th and 95th percentiles, and receiver operating characteristics (ROC) analyses (i.e., the 
cut off score with the optimal sensitivity and specificity, and area under curve values) will 
be computed. Reference limits are often defined by two standard deviations (SDs) below 
and above the mean if distributions are Gaussian. Since most distributions of total scores 
on the scales tested in the healthy reference group are expected to be strongly (positively) 
skewed, percentiles are more appropriate [47-49], with the lower interval bounded only by 
the 95th percentile being a common reference group [50]. However, trade-offs exist between 
the sensitivity and specificity, with a higher cut-off value (i.e., higher percentile boundary) 
having a relatively high specificity but low sensitivity, and vice versa (Figure 2.2; left panel). 
ROC analyses will provide additional cut offs reflecting discriminatory power [51]. Figure 
2.2 (right panel) shows psychopathology expressed as the number of MINI diagnoses of 
MAS disorders in the ROM reference group and the ROM patient group. 
Figure 2.2. Left panel: the expected distribution of many of the 22 mood, anxiety and somatoform 
(MAS) disorder-assessment instruments in the ROM reference and patient groups; Right panel: the 
actual distribution of the number of MAS disorders in the ROM reference and patient groups. In the ROM 
reference group, above the 95th percentile (P95; i.e., reference value) the probability is high for a person 
to meet the terms of psychopathology.
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Figure 2.1 shows recruitment of the ROM reference group and the ROM patient group. A total 
of 1302 persons were interviewed and their data analysed. The duration of the interview was 
shorter (range 1.5-2.0 h) in participants without psychopathology and longer (range 2.5-4.0 h) 
in participants with psychopathology. Although the interview was extensive, all participants 
finished the full assessment. Additional telephone calls after the initial mailing proved to 
have a motivating effect on the subsequent response rates. Patients from the first GP only 
received the invitation by mail (no telephone call) and showed a response of 16.3%. We tried 
to contact patients recruited from all other GPs by telephone. The response to the initial mail, 
before the telephone call by the research team, was 15.9% (768 of 4840). The response to the 
telephone call and the mail was 45.3% of those the research team managed to contact (1613 
of 3557). A total of 67 responders were not included because of a surplus in some of the age 
groups, or due to logistical reasons at the end of the study. Therefore, the response of persons 
contacted was 37.3% (1302 of 3490). However, when taking into account the large group 
of 1283 persons that could not be contacted by letter or telephone, the response of persons 
mailed was 26.9% (1302 of 4840). A total of 148 persons were excluded: 36 who consented 
following the mail (treated in a secondary psychiatric care centre, or insufficient mastery of 
the Dutch language), 101 after a telephone call (for similar reasons), and 11 during or after 
the interview (for similar reasons, as well as severe dyslexia or cognitive impairment).
 Table 2.2 presents the sociodemographic characteristics of the ROM reference 
group (n=1294) and the ROM patient group (n=7840), 543 of whom did not complete the 
Demographic Inventory. Gender and age distributions in both samples were similar, and the 
mean age in both samples was 2 years higher for men than for women. Compared to the 
ROM patient group, the ROM reference group less often lived in a rural area, was less often 
divorced, separated or widowed, was less often unemployed or disabled, and had a higher 
educational level.
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    Table 2.2. Sociodemographic characteristics of the ROM reference group (n=1294)  and the ROM  





   Male 484 (37.4%) 2700 (37.0%)
   Female 810 (62.6%) 4597 (63.0%)
Age (mean, SD) in years 40.2 (12.5) 37.9 (12.3)
   18-25 194 (15.0%) 1508 (20.7%)
   26-40 479 (37.0%) 2715 (37.2%)
   41-55 448 (34.6%) 2370 (32.5%)
   56-65 173 (13.4%) 704 (9.6%)
Urbanization level
   Urban 806 (62.3%) 3955 (54.2%)
   Rural 488 (37.7%) 3342 (45.8%)
Marital status
   Married/cohabitating 890 (68.8%) 3721 (50.9%)
   Divorced/separated/widow 78 (6.0%) 989 (13.6%)
   Single 326 (25.2%) 2587 (35.5%)
Housing situation
   Living alone 200 (15.7) 1693 (23.2%)
   Living with partner 902 (69.7) 3762 (51.6%)
   Living with family 192 (14.8) 1842 (25.2%)
Educational status
   Lower 295 (22.8) 3133 (42.9%)
   Higher 999 (77.2) 4164 (57.1%)
Employment status
   Employed part-time 508 (39.3%) 1737 (23.9%)
   Employed full-time 554 (42.8%) 1702 (23.3%)
   Unemployed/retired 197 (15.2%) 2118 (27.1%)
   Work-related disability 35 (2.7%) 1874 (25.7%)
Ethnic background
   Dutch 1160 (89.6%) 5981 (80.0%)
   Other ethnicity 134 (10.4%) 1316 (18.0%)
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 The aim for the ROM reference group was that it be a ‘normal’ group but allowed for 
prevalent psychopathology that could be treated in the GP practices and, therefore, showed 
some (co-)morbidity of psychiatric illness but to a much lesser extent than the ROM patient 
group (Figure 2.2). According to the MINI-Plus, 9.4% of the ROM reference group met 
criteria for one or more MAS disorders compared to 74.5% in the ROM patient group. A single 
MAS diagnosis was present in 7.8% participants and in 47.9% ROM patients. In the ROM 
reference group, anxiety disorders were most prevalent followed by somatoform disorders. 
In the ROM patient group, major depression was the most prevalent disorder followed by 
anxiety disorders. Thus, the ROM reference group showed lower comorbidity than the ROM 
patient group, and reflected psychiatric morbidity within the general population (Table 2.3, 
Figure 2.2). 
Table 2.3. Mood, anxiety and somatoform (co-)morbidity in the ROM reference group (n=1302) and the 
ROM patient group (n=7840). 
Anxiety disorders comprise panic disorder with or without agoraphobia, agoraphobia without history 
of panic disorder, specific phobia, social phobia, obsessive compulsive disorder, post-traumatic stress 
disorder, and generalized anxiety disorder, and anxiety disorders NOS. Mood disorders comprise major 
depressive disorders, bipolar disorder, dysthymia, Somatoform disorders comprise somatization disorder, 
undifferentiated somatoform disorder, pain disorder (chronic), hypochondriasis, bodydysmorphic disorder, 
and conversion disorder.
                                                     ROM reference group
                                                                  Frequency         Percent
ROM patient group
Frequency     Percent
MINI diagnoses (%)
None 1193 90.6 1998 25.5
Anxiety 54 4.1 1568 20.0
Mood 7 0.5 1682 21.5
Somatoform 42 3.2 500 6.4
Anxiety & Mood 7 0.5 1377 17.6
Anxiety & Somatoform 9 0.7 209 2.7
Mood & Somatoform 1 0.1 275 3.5
Anxiety & Mood & Somatoform 2 0.2 231 2.9
Total Anxiety 72 5.5 3385 43.2
Total Mood 17 1.3 3565 45.5
Total Somatoform 54 4.2 1215 15.5
Total 1302 100.0 7840 100.0
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DISCUSSION
This cross-sectional study in a randomly selected sample from a Dutch general population 
(aged 18-65 years) aimed to provide reference values for ROM instruments (and to serve 
as a control group for the biobank) for patients with MAS disorders. It is the first reference 
group study for mental health assessments of this size carried out in the Netherlands. The 
large sample size and extensive assessment of psychopathology provide data which, by 
comparison with data from ROM patients, is expected to yield reliable reference values for 
ROM instruments (across a wide age range) that are not yet available. Genetic and HPA axis 
data enable further biological research into MAS disorders.
 Comparison of the demographics of the ROM reference and patient groups showed 
a similar gender and age distribution, as expected given the sampling frame. There was a 
slightly (unintentional) different urbanization level. However, the effects of urbanicity 
on psychopathology are generally of limited significance in international [52] and Dutch 
(NEMESIS) [4] comorbidity studies. Moreover, differences between rural and urban areas 
are declining in the Netherlands. Compared to the ROM patient group, the ROM reference 
group showed higher levels of education and less unemployment or work-related disability. 
Accordingly, both comorbidity studies [4,52]reported the highest morbidity rates for those 
with the lowest levels of education, and the lowest morbidity rates for those with the highest 
levels of education. Mental disorders were reported to be least prevalent amongst people 
in paid employment. Overall morbidity and comorbidity were strongly associated with 
occupational disability and unemployment. 
 As expected, morbidity of any current MAS disorder in the reference group was 
much lower than in the ROM patient group. Anxiety disorders were equally prevalent in the 
ROM reference group compared to a study in the general practice population (n=1778) in the 
Netherlands (5.5%) [53]. Mood disorders were less prevalent in the reference group (1.3%) 
than in the general practice population (4.1%) as well as compared to prevalence rates in 
various European countries, ranging between 4.6% and 7.4% [54]. The current prevalence 
rate for somatoform disorders was 4.2% in our ROM reference group, compared to 16.1% in 
a general practice population [53]. This discrepancy can probably be ascribed to differences 
in the recruitement procedure, as the latter study included consultation seeking patients 
whereas we included a random sample of the general practice population. Also, in our study 
most interviews took place in hospital versus home interviews in the study of De Waal et al. 
Another explanation could be differences in the ascertainment of depressive and somatoform 
disorders (MINI Plus 5.0.0. in our study versus the Scan diagnostic interview in the study of 
De Waal et al.). Moreover, selection and non-response bias may have occurred in our study, 
as depressed people are often less inclined to participate because of fatigue or loss of energy.
Comorbidity rates of psychopathology in the reference group were similar to those reported 
in the Dutch comorbidity study [4] and very low compared to the ROM patient group.
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 Several issues need to be considered when analyzing reference values for psychiatric 
assessment scales from healthy populations. Reference values need to be accurate and 
reproducible. First, in samples derived from the general population many of the total scores 
do not have a bell-shaped Gaussian distribution, but rather an asymmetrical, right-sided, 
skewed distribution. When log-Gaussian curves are also not normally distributed, means 
with (1.96 times) SDs cannot be used to yield the central 95% of the reference population 
of subjects. Rather, percentile values (e.g., 97.5th, 95th or 90th) can be used, as this non-
parametric method makes no specific assumption regarding the distribution from which the 
data are obtained. Nevertheless, extreme values can still have a profound effect in defining 
reference values and, therefore, sample sizes (in subgroups) of at least 120 are needed (for 
90% confidence intervals) to reduce the amount of uncertainty [19,55].  Second, outliers 
can be removed before the analysis, using outlier detection methodology. For example, if 
the difference between the extreme and the next most extreme value exceeds 1/3rd of the 
range, the extreme value can be deleted (i.e., the Dixon test method) [19]; this may yield 
better reference values. However, an attempt should first be made to determine whether these 
extremes are errors in the assessment procedure. Third, there may be a profound influence 
from healthy and nonhealthy (psychiatrically ill individuals) individuals on the estimation 
of reference values. About 10% narrower reference intervals will be derived from samples 
that excluded nonhealthy subjects [56] but could make the reference range unreasonably 
narrow. Therefore, we chose to study a ‘control’ group rather than a ‘healthy’ group. Overall, 
there are many trade-offs between the different parametric, transformed parametric, and 
nonparametric methodologies.
 Reference values for psychiatric instruments are essential for patient care. In this 
ROM reference group, data were collected enabling the calculation of reference values for 22 
ROM instruments that often lack these values, because recruiting valid groups of reference 
subjects is costly and time intensive. These reference values are of major clinical importance 
because they can help to weigh the severity of symptoms and provide criteria that signify 
the transition from illness to health, and potential treatment termination. They can also be 
used by primary care physicians for referral to secondary care, and vice versa. Additionally, 
reference material to facilitate research on genetic characteristics (DNA) and the HPA axis 
stress system was collected. 
 Our study has specific strengths. First, to yield reliable and stable reference values 
the group has to be of sufficient size and representative for the patient group of interest. Tests 
for decisions at the individual level such as therapy indication or monitoring require a sample 
size of at least 250 subjects per reference group standardized for age and gender [57,58]. The 
size of the group and four subgroups surpassed this number and the previously described 
size of the 120 recommended participants [19,55], even when partitioning the test subjects 
by gender and age groups. Second, the diagnostic interview was structured leading to better 
identification of diagnostic comorbidity than unstructured interviews [59]. Next to self report 
data, observational data were collected using the MINI-Plus. This approach provided 
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comprehensive clinical information according to international standards (DSM-IV). Third, 
standardization of the interviews was assured, as both observation scales and self-report 
questionnaires were administered via a web-based computer program, implying a fixed 
order in administration of instruments with no instruments skipped or data missing, and no 
errors due to manually entering data. Fourth, recruitment through GPs allowed for a good 
description of the sample characteristics. Furthermore, contacting possible participants 
by telephone presumably increased the response rate. Finally, an on-going quality control 
and calibration among interviewers ensured that a high quality was maintained during data 
collection.
 The present study also has some limitations. First, because recruitment of the ROM 
reference and patient group took place in the Dutch region of Leiden, reference values may 
not be directly internationally generalizable. Moreover, because ethnic participants formed 
a minority, generalizability of reference values to other countries and ethinicities is limited. 
Second, children and elderly were not included, thus requiring their own reference group 
studies. Third, non-response was significant, involving a possible, unknown bias. Finally, 
information about the characteristics of those who did not participate is lacking. It is unclear 
whether non-responders differed in a systematic way from the participating subjects.
 In conclusion, we succeeded in collecting extensive data from 1302 persons from 
the general population, enabling the calculation of reference values for 22 ROM instruments. 
The results of the reference values are expected to become available within the next two 
years and will be useful for current and future diagnostic and research purposes in patients 
with MAS disorders.
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ABSTRACT
Background: The Brief Symptom Inventory (BSI), Mood & Anxiety Symptom 
Questionnaire -30 (MASQ-D30), Short Form Health Survey 36 (SF-36), and Dimensional 
Assessment of Personality Pathology-Short Form (DAPP-SF) are generic instruments that can 
be used in Routine Outcome Monitoring (ROM) of patients with common mental disorders. 
We aimed to generate reference values usually encountered in ‘healthy’ and ‘psychiatrically 
ill’ populations to facilitate correct interpretation of ROM results.
Method: We included the following specific reference populations: 1294 subjects from 
the general population (ROM reference group) recruited through general practitioners, and 
5269 psychiatric outpatients diagnosed with mood, anxiety, or somatoform (MAS) disorders 
(ROM patient group). The outermost 5% of observations were used to define limits for 
one-sided reference intervals (95th percentiles for BSI, MASQ-D30 and DAPP-SF, and 5th 
percentiles for SF-36 subscales). Internal consistency and Receiver Operating Characteristics 
(ROC) analyses were performed.
Results: Mean age for the ROM reference group was 40.3 years (SD=12.6) and 37.7 
years (SD=12.0) for the ROM patient group. The proportion of females was 62.8% and 
64.6%, respectively. The mean for cut-off values of healthy individuals was 0.82 for the BSI 
subscales, 23 for the three MASQ-D30 subscales, 45 for the SF-36 subscales, and 3.1 for the 
DAPP-SF subscales. Discriminative power of the BSI, MASQ-D30 and SF-36 was good, but 
it was poor for the DAPP-SF. For all instruments, the internal consistency of the subscales 
ranged from adequate to excellent.
Discussion and conclusion: Reference values for the clinical interpretation were 
provided for the BSI, MASQ-D30, SF-36, and DAPP-SF. Clinical information aided by ROM 
data may represent the best means to appraise the clinical state of psychiatric outpatients.
 
Reference values for generic instruments used in Routine Outcome Monitoring 55
  3
INTRODUCTION
Routine outcome monitoring (ROM) was developed to enhance the effectiveness of 
Routine Outcome Monitoring (ROM) is a method for the continuous monitoring of patients’ 
symptomatic and functional status. It provides the clinician with systematic information on 
type and severity of psychiatric complaints before, during, and after treatment. The web-
based ROM assessment battery, which is used in the Leiden ROM Study, comprises both 
generic and disorder-specific measurement instruments. Generic instruments can be used 
to assess a broad range of psychopathological symptoms, maladaptive personality traits, 
and quality of life in any patient irrespective of their psychiatric disorder(s) [1]. In contrast, 
disorder-specific instruments are administered only to those patients who meet the criteria 
for a particular disorder.
 Responsible clinical decision making (e.g., regarding the effectiveness and possible 
termination of treatment or referral from primary care to specialized mental health care 
and vice versa), based on ROM assessment, depends on the correct interpretation of the 
measures. Correct interpretation is only possible if patients’ ROM data can be compared to 
reliable reference values (from a reference population). 
 Reference values [2] are often established in healthy populations [3]. Health, a 
relative condition lacking a universal definition, should nevertheless be clearly defined, a 
priori, via inclusion and exclusion criteria [4-6]. In non-realistic ‘supernormal’ (i.e., too 
healthy) reference groups [7] unreasonable narrow reference intervals can be expected. Horn 
and colleagues (2001) studied the effect of including physician-determined non-healthy 
individuals in a reference sample. Physician-defined healthy groups with and without non-
healthy individuals were compared. Even in healthy samples, outliers may exist. There are 
marked effects to be expected of non-healthy individuals in the computation of reference 
values. As non-healthy individuals likely increase the chance of outliers, the width of reference 
intervals may increase by about 10% [8]. Thus, if non-healthy individuals are included in the 
reference group, then some subjects would be categorized as having responded to treatment. 
This would not have happened if only healthy individuals were included. Outlier removal 
would be an alternative methodology applied in the generation of reference values. Since 
extreme values can have a profound effect in establishing reference values, sample sizes 
of at least 120 (after partitioning in relevant subclasses) are needed to reduce the amount 
of uncertainty and error [9]. Common reference values are means and standard deviations 
(SDs), which can help to determine whether an individual or a group scores below or above 
the average of the ‘healthy’ or the ‘psychiatrically ill’ subjects. Also, percentile scores are 
often used as reference values. These non-parametric values do not rely on Gaussian data 
distributions [3,9]. The lower interval, bounded by the 95th percentile, commonly serves as 
the reference group [3]. When both reference and patient group data are available, Receiver 
Operating Characteristics (ROC) analyses can provide additional cut-offs, reflecting the
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trade-off between sensitivity (measure of positivity; the proportion of actual positives correctly 
identified as such) and specificity (measure of negativity; the proportion of negatives which 
are legitimately ruled out) [10].
 Some frequently used generic self-report ROM instruments include the Brief 
Symptom Inventory (BSI) [11,12], the Mood & Anxiety Symptom Questionnaire -30 
(MASQ-D30) [13,14], the Short Form Health Survey 36 (SF-36) [15,16], and the Dimensional 
Assessment of Personality Pathology - Short Form (DAPP-SF) [17,18]. In this generic set of 
instruments the DAPP-SF is intended not so much for Axis II diagnoses of psychopathology 
according to the DSM-IV but for the assessment of (dysfunctional) personality traits. 
Previous studies mainly reported means and SDs for the general population for the BSI [11,19] 
and SF-36 [15,20-22], and for the general population and psychiatric patients for the DAPP-
SF [18,23], while for the MASQ-D30 no such reference values have been published. Except 
for the BSI [11], no clinically relevant cut-off scores between ‘healthy’ and ‘psychiatrically 
ill’ have been reported. In most of the studies the population-based reference groups were 
relatively small, ranging from 200 [11] to 719 [19] for the BSI, and between 51 [24] and 478 
[18,23] for the DAPP-SF, leading to somewhat imprecise reference values [4,8]. Reference 
values subcategorized according to gender and age were reported for the SF-36 [20,21,25] 
but they are not available for the BSI, MASQ-D30 or DAPP-SF.
 We aimed to establish reference values, means and SDs, percentile scores, and cut-
off points, for a comprehensive set of generic ROM instruments that can be offered to every 
patient referred for (but not necessarily diagnosed with) mood, anxiety, or somatoform (MAS) 
disorders. These comprise the vast majority of psychiatric patients, notwithstanding those 
with addiction disorders. In this set, the severity of general psychopathology, (dysfunctional) 
personality traits, and subjective mental and physical well-being are covered respectively 
by the BSI, the MASQ-D30, the DAPP-SF, and the SF-36. We tested an apparently healthy 
population of 1294 subjects who were recruited through general practitioners, and examined 
similar data from a ‘psychiatrically ill’ population of 5269 outpatients diagnosed with MAS 
disorders. A novel aspect of the current study is that we could include samples of sufficient 
size for both the healthy reference and the well-defined psychiatric outpatient group.




The group of participants comprised a reference sample from the general population (ROM 
reference group) and a ROM sample of psychiatric outpatients (ROM patient group), as 
previously described in detail [26]. 
 The ROM reference group consisted of 1294 participants aged 18 to 65 years (62.8% 
females; mean age=40.3 years; SD=12.6) from the ‘Leiden Routine Outcome Monitoring 
Study’. The study design, objectives, and methods have been described elsewhere [26,27]. 
Participants were randomly selected from registration systems of eight general practitioners 
(GPs) in the province South-Holland, the Netherlands. In the Netherlands, 99.9% of the 
general population is registered with a GP [28]. Therefore, non-consulting GP patients are 
a very good representation of the Dutch general population. The ROM reference group 
was stratified for gender, age, and urbanization-level (62.3% urban), to make the group 
demographically comparable to the ROM patient group. Invitations for this study were sent 
to 4840 persons; 1283 could not be contacted and 67 were not included because of time 
constraints. Of the remaining 3490 potential participants, 1302 were assessed and 1294 
generated complete datasets, resulting in a response rate of 37.1%. 
 The ROM patient group consisted of 5269 psychiatric outpatients, aged 18 to 65 
years (64.6% females; mean age=37.7, SD=12.0). They were diagnosed with and treated for 
one or more MAS disorders in the Leiden University Medical Center (LUMC) Department 
of Psychiatry or in the Rivierduinen Psychiatric Institute, the regional provider of specialized 
mental health care. 
Procedures
Procedures for the web-based ROM program of the LUMC Department of Psychiatry are 
described elsewhere [27,29]. The participants in the ROM reference group were assessed in 
a similar way to the ROM patient group. Subjects from the ROM reference group completed 
the self-report instruments BSI, MASQ-D30, and SF-36, and due to time constraints, 
a random sample of 50% completed the DAPP-SF [26]. The BSI, MASQ-D30, and SF-
36 were completed by all 5269 subjects from the ROM patient group, while 234 (4.6%) 
did not complete the DAPP-SF, again due to time constraints. To facilitate diagnoses of 
psychopathology according to the DSM-IV, the procedure for the two groups included a 
standardized diagnostic interview (i.e., the Mini-International Neuropsychiatric Interview 
plus (MINI-Plus 5.0.0.) [30,31]). The Medical Ethical Committee of the LUMC approved the 
general study protocol regarding ROM, in which ROM was organized as part of the treatment 
process for patients. It involved a comprehensive protocol (titled “Psychiatric Academic
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Registration Leiden database”) which safeguarded the anonymity of patients and participants 
and ensured proper handling of the ROM data. All patients gave permission for the use of their 
ROM data for scientific purposes (written informed consent for this study was not required). 
In addition, participants of the ROM reference group (non-patients) signed informed consent 
for the purpose of this study.
Instruments
The BSI, a short version of the Symptom Checklist (SCL-90) [19], measures psychopathological 
symptoms. The BSI consists of 53 items divided into 9 subscales: Somatization (SOM), 
Obsessive-Compulsive (O-C), Interpersonal Sensitivity (I-S), Depression (DEP), Anxiety 
(ANX), Hostility (HOS), Phobic Anxiety (PHOB), Paranoid Ideation (PAR), and Psychoticism 
(PSY). Item scores range from 0 (“not-at-all”) to 4 (“extremely”). The subscale and total 
scores are calculated as an average of the relevant items, with higher scores indicating more 
severe psychopathology.
The MASQ-D30 measures the dimensions of Clark and Watson’s tripartite model, covering 
both shared and distinct symptoms of depression and anxiety [13,14]. The MASQ-D30 
consists of 30 items, divided into three subscales: Negative Affect (NA), associated with both 
depression and anxiety; lack of Positive Affect (PA), associated with depressive moods; and 
Somatic Arousal (SA), associated with anxiety. The items are rated on a 5-point Likert scale, 
with scores ranging from 1 (“not at all”) to 5 (“extremely”). Subscale scores are calculated 
as the sum of the relevant items, ranging from 10 to 50, with higher scores indicating more 
severe psychopathology.
 The SF-36, derived from the Rand Medical Outcome Study (MOS) [15,16], 
measures functional health status and well-being. It can be used as a population-based 
assessment of quality of life. The SF-36 consists of 36 items divided into eight subscales: 
Physical Functioning, Role limitations due to Physical health problems (Role-Physical), 
Bodily Pain, Social Functioning, General Mental Health (Mental Health), Role limitations 
due to Emotional problems (Role-Emotional), Vitality, General Health Perceptions (General 
Health) and a question about perceived change of health during the last year (Health 
Transition). Subscale scores are calculated as the sum of the relevant items, ranging from 0 
to 100, with higher scores indicating better functioning. 
 The DAPP-SF, the short form of the Dimensional Assessment of Personality 
Pathology – Basic Questionnaire (DAPP-BQ) [17,18], measures personality pathology. 
It consists of 136 items divided into 18 subscales: Submissiveness, Cognitive Distortion, 
Identity Problems, Affective Lability, Stimulus Seeking, Compulsivity, Restricted 
Expression, Callousness, Oppositionality, Intimacy Problems, Rejection, Anxiousness, 
Conduct Problems, Suspiciousness, Social Avoidance, Narcissism, Insecure Attachment, and 
Self-harm. Item scores range between 1 (“very unlike me”) and 5 (“very like me”). Subscale 
scores are calculated as an average of the relevant items, ranging from 1 to 5, with higher 
scores indicating more maladaptive personality traits.
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 The Dutch version of the Mini-International Neuropsychiatric Interview plus 
(MINIplus 5.0.0.) [30,32] was used to establish the presence of Axis I diagnoses according 
to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). This standardized 
diagnostic interview comprises 23 modules for mood, anxiety, psychotic, somatoform, and 
eating disorders.
Statistical analyses
Means, standard deviations (SDs), and percentile scores were calculated for the two 
samples separately, while ROC analyses were performed in the combined groups. In both 
samples, subjects with 1 or more missing values per subscale were excluded. This allowed 
us to conduct a robust evaluation of the use of the instruments. The occurrence of missing 
values is not completely random, and it depends on unobserved predictors. Therefore we 
decided to use an almost complete-case analysis, as bias due to missing values was likely 
to be small due to the small percentage (i.e., 0.01%) of cases that needed to be excluded. A 
descriptive analysis of sociodemographic and psychopathological variables was performed, 
using percentages in the case of categorical variables and means and SDs for the continuous 
variables. Internal consistency was assessed using Cronbach’s alpha, with >0.70 indicating 
adequate internal consistency. ROC analyses provided cut-off scores, indicating an optimal 
discrimination threshold between ‘healthy’ (reference population) and ‘psychiatrically ill’ 
(psychiatric outpatients). The cut-off was chosen at the value representing equal sensitivity 
and specificity, since this is the point that yields the best compromise between specificity and 
sensitivity, with the lowest number of false results (false positive plus false negative). The 
areas under the ROC curve (AUCs) were calculated to indicate the discriminatory power of 
the instrument (sub) scales, where AUCs over 0.75 were considered clinically useful with 
0.85 showing moderate discriminatory power and 0.95 very high discriminatory power 
[33]. Furthermore, means and SDs were calculated, together with 5th, 25th, 50th, 75th and 95th 
percentile scores. When instruments merely assess the level of dysfunctionality, and the 
discriminative power to detect the level of ‘health’ or normal functionality is limited (i.e., 
no persons can be earmarked as ‘abnormally healthy or good functioning’), the lowest 2.5% 
is irrelevant. Therefore, the top 5% (or lower 5% in case of SF-36 subscales) was chosen 
as representing ‘abnormal’. Reference values were also presented for 4 subgroups: young 
women (aged 18-40 years), older women (aged 41-65 years), young men (aged 18-40 years), 
and older men (aged 41-65 years). SPSS for Windows version 17.0 (SPSS Inc., Chicago, 
IL, USA) was used for data analysis. To test our decision not to exclude those individuals in 
the ROM reference group with a current psychiatric diagnosis, we performed a sensitivity 
analysis.
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RESULTS 
Sociodemographic and psychiatric characteristics of the samples
The sociodemographic and psychiatric characteristics of the ROM reference group and the 
ROM patient group are shown in Table 3.1.
Table 3.1: Sociodemographic and psychiatric characteristics of the ROM reference (n=1294) patient (n=5269) 
groups.
                                                                ROM reference group           ROM patient group
Gender (%)
   Male 481 (37.2) 1864 (35.4)
   Female 813 (62.8) 3405 (64.6)
Age (mean, SD) in years 40.3 (12.6) 37.7 (12.0)
   Male 41.3 (12.6) 39.1 (11.9)
   Female 39.8 (12.6) 36.9 (12.0)
Marital status (%)
   Married/cohabitating 890 (68.8) 25.19 (47.8)*
   Divorced/separated/widow 77 (6.0) 688 (13.1)*
   Single 327 (25.2) 1730 (32.8)*
Housing situation (%)
   Living alone 201 (15.5) 1128 (21.4)*
   Living with partner 903 (69.8) 2568 (48.7)*
   Living with family 190 (14.7) 1241 (23.6)*
Educational status (%)***
   Lower 295 (22.8) 2112 (40.1)*
   Higher 999 (77.2) 2824 (53.6)*
Employment status (%)
   Employed part-time 512 (39.6) 1141 (21.7)*
   Employed full-time 552 (42.7) 1105 (21.0)*
   Unemployed/retired 194 (15.0) 1337 (25.4)*
   Work-related disability (%) 36 (2.7) 1354 (25.7)*
Ethnic background (%)
   Dutch 1163 (89.9) 4335 (82.3)
   Other ethnicity 131 (10.1) 934 (17.7)
Reference values for generic instruments used in Routine Outcome Monitoring 61
  3
Table 3.1 continued
                                                                ROM reference group           ROM patient group
MINI diagnoses (%)
   Currently None 1153 (89.1) 0**
   Anxiety disorder 53 (4.1) 1449 (27.5)
   Mood disorder 7 (0.5) 1573 (29.9)
   Somatoform disorder 41 (3.2) 403 (7.6)
   Anxiety & Mood disorders 7 (0.5) 1257 (23.9)
   Anxiety & Somatoform disorders 9 (0.7) 172 (3.3)
   Mood & Somatoform disorders 1 (0.1) 228 (4.3)
   Anxiety & Mood & Somatoform 2 (0.2) 187 (3.5)
   Total Anxiety disorder 71 (5.5) 3065 (58.2)
   Total Mood disorder 17 (1.3) 3245 (61.6)
   Total Somatoform disorder 53 (4.1) 990 (18.8)
*No data from 332 (6.3%) patients
**Selection criterion
*** Lower educational status: general basic education or lower vocational education; higher educational 
status: middle or higher vocational education, college or university.
Mean age (40.3 years versus 37.7 years, p<.001) and gender distribution (62.8% females versus 
64.6% females, p=.80) were comparable for the ROM reference group and the ROM patient 
group, as expected due to the stratification. The ROM reference group showed higher levels 
of education (77.2% versus 53.6% higher education), were more often married (68.8% versus 
47.8%), and were less often living alone (15.5% versus 21.4%) relative to the ROM patient 
group. Unemployment and work-related disability were less prevalent in the ROM reference 
group (17.7% versus 51.1%). In keeping with our decision to exclude patients without a MINI 
diagnosis, all subjects from the ROM patient group had at least one DSM-IV disorder. In the 
ROM reference group, on the other hand, 10.9% had a DSM-IV disorder. 
REFERENCE VALUES
Percentiles, means and SDs 
Table 3.3 presents the percentile scores and mean values of the BSI, SF-36, and MASQ-D30 
subscales for the ROM reference group and the ROM patient group. For the ROM reference 
group, the distribution of each total score and subscale score was positively skewed, showing 
apparent health. This was also demonstrated by the substantial percentage of participants 
having the lowest possible scores (highest for the SF-36). For apparently healthy individuals, 
the mean of cut-off (P95) values was 0.82 for the BSI subscales, 23 for the three MASQ
    Chapter 362
dimensions, 45 for the SF-36 subscales, and 3.1 for the DAPP-SF subscales. By contrast, 
the mean of P5 values for the SF-36 subscales was 45.
Table 3.2. Internal consistency and cut-off scores in combined ROM reference (n=1294) and patient 









Brief Symptom Inventory 
(BSI)
  Somatization (SOM) 7 0.86 0.23 0.87 0.80
  Obsessive-Compulsive 
(O-C)
6 0.88 0.69 0.91 0.84
  Interpersonal Sensitivity 
(I-S)
4 0.83 0.54 0.88 0.81
  Depression (DEP) 6 0.91 0.50 0.93 0.87
  Anxiety (ANX) 6 0.89 0.50 0.92 0.85
  Hostility (HOS) 5 0.86 0.30 0.82 0.75
  Phobic Anxiety (PHOB) 5 0.83 0.25 0.90 0.84
  Paranoid Ideation (PAR) 5 0.84 0.37 0.83 0.76
  Psychoticism (PSY) 5 0.77 0.37 0.92 0.85
  BSI total score* 53 0.97 0.48 0.96 0.90
MASQ-D30
  General distress (GD) 10 0.84 19.0 0.96 0.90
  Anhedonic depression (AD) 10 0.92 23.0 0.88 0.80
  Anxious arousal (AA) 10 0.74 18.0 0.99 0.96
Short Form 36 (SF36)*
  Physical Functioning 10 0.92 93.5 0.76 0.68
  Role-Physical 4 0.88 82.5 0.82 0.78
  Bodily Pain 2 0.87 83.7 0.72 0.68
  Social Functioning 2 0.85 72.9 0.92 0.79
  Mental Health 5 0.90 63.0 0.95 0.89
  Role-Emotional 3 0.83 79.6 0.88 0.88
  Vitality 4 0.84 52.5 0.92 0.85
  General Health 5 0.84 67.5 0.82 0.76
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  Submissiveness 8 0.87 2.40 0.76 0.71
  Cognitive Distortion 6 0.84 1.55 0.83 0.76
  Identity Problems 6 0.87 2.08 0.90 0.83
  Affective Lability 8 0.86 2.56 0.85 0.77
  Stimulus Seeking 8 0.81 1.94 0.55 0.54
  Compulsivity 8 0.84 2.69 0.60 0.57
  Restricted Expression 8 0.82 2.75 0.78 0.71
  Callousness 10 0.79 1.65 0.53 0.51
  Oppositionality 9 0.87 2.22 0.79 0.73
  Intimacy Problems 9 0.79 2.18 0.60 0.57
Rejection 8 0.83 2.36 0.56 0.55
  Anxiousness 6 0.84 2.64 0.85 0.78
  Conduct Problems 7 0.73 1.14 0.57 0.56
  Suspiciousness 7 0.90 1.40 0.78 0.72
  Social Avoidance 6 0.88 2.20 0.80 0.73
  Narcissism 8 0.82 2.20 0.56 0.55
  Insecure Attachment 6 0.89 2.10 0.80 0.74
  Self-Harm 6 0.89 1.08 0.75 0.57
*Higher score corresponds with better functioning
AUC: Area under the curve; MASQ-D30: Mood & Anxiety Symptom Questionnaire 30-item short 
adaptation; DAPP-SF : Dimensional Assessment of Personality Pathology – short form; The optimal 
cut-off derived by the ROC analysis is defined by equal sensitivity and specificity 
*The BSI total score comprises 4 additional items next to the subscale items.
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 The BSI subscale scores ranged between 0 and 4. The P95 reference scores for the 
BSI subscales ranged between 0.60 for Phobic Anxiety (PHOB) and 1.17 for Obsessive-
Compulsive (O-C) 1.17; for the BSI total score it was 0.68. For six of the nine subscales, the 
median value (P50) was equal to the minimum possible score of 0. 
The MASQ-D30 subscale scores ranged between 10 and 50. The P95 reference scores for the 
three MASQ-D30 subscales were: General Distress (GD) - 23; Anhedonic Depression (AD) 
- 29; and Anxious Arousal (AA) - 17. 
 The SF-36 subscale scores ranged between 0 and 100, with higher scores indicating 
better health. Therefore the P5 indicates the cut-off for a low level of functioning. The P5 
reference scores for the SF-36 subscales ranged between 65 for Physical functioning and 
33 for Emotional problems, with the exception of the P5 value for Physical health problems, 
which was 13. The scales that measure well-being as well as health-related limitations 
(General Health,Vitality,Mental health) showed lower average values, as expected [33]. The 
other five health-related disability scales had the highest mean subscale scores. For four of 
the eight subscales, the median value (P50) was equal to the maximum possible score of 100. 
The DAPP-SF subscale scores ranged between 1 and 5. The range of P95 reference scores for 
the 18 subscales was between 1.50 for Self-Harm and 4.00 for Compulsivity. 
 Analyses of gender and age indicated that advancing age was associated with more 
symptoms of psychopathology for both sexes (see Supplementary Tables 3.1 through 3.4). 
There was a tendency for healthy women to show higher cut-off scores on the BSI and the 
MASQ-D30 relative to healthy men, while the two sexes showed a different pattern of cut-off 
scores on the DAPP-SF. Men, and especially young men, reported better health as reflected 
in higher scores on several subscales of the SF-36. 
 In a sensitivity analysis, we excluded all 122 (9.5%) subjects in the ROM reference 
group who had a MINI-diagnosis. Among the remaining 1161 subjects, we found that the 
median scores on the BSI total score, MASQ-D30 subscales, SF-36 subscales, and DAPP-SF 
subscales changed on average 2% (interquartile range 1 to 6%). The median P95 scores (P5 
score for the SF36) changed on average 5% (interquartile range 0 to 18%).
Receiver operating characteristic (ROC) curves
The results of the ROC analyses are presented in Table 3.2. 
 BSI: The cut-off point of the BSI total score, which discriminated the ROM 
reference group from the ROM patient group, was 0.48, with a sensitivity and specificity 
of 90%. Therefore, for subjects without psychopathology, 10% with a total score of 0.48 or 
higher would be classified wrongly as a patient with psychopathology. By the same token, 
the 10% of subjects from the ROM patient group with a total score of 0.48 or lower would 
be classified wrongly as a psychiatrically ‘healthy’ subject. The AUC values showed that all 
BSI subscales performed well in making a distinction between patients and non-patients. The 
discriminating performance of the total score was excellent (AUC=0.96).
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 The best performing subscale was DEP, followed by ANX and PSY. The HOS and PAR 
subscales showed the least distinctiveness but might perform better in specific subpopulations 
of patients. Figure 3.1 presents the discriminative power of the BSI total score.
 
          
  
      
Figure 3.1: Distribution of the scores of Brief Symptom Inventory (BSI) total scale, and the subscales 
of Short Form-36 (SF-36) General Mental Health, Mood and Anxiety Symptom Questionnaire 30 
(MASQ-D30) General Distress and Dimensional Assessment of Personality Pathology - Short Form 
(DAPP-SF) Oppositionality. Three types of cut-off points are depicted: the 75th percentile score (P75), 
the 95th percentile score (P95) and the Receiver Operating Characteristics (ROC) cut-off point defined by 
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MASQ-D30: The cut-off score of 19 on the General Distress (GD) dimension, which 
discriminated the ROM reference group from the ROM patient group, had a sensitivity and 
specificity of 90%. For the cut-off of 23 on the Anhedonic Depression dimension, the sensitivity 
and specificity were only 80%. The cut-off score of 18 on the Anxious Arousal dimension, 
discriminating health from disease, had a sensitivity and specificity of 96%. The AUC values 
showed that all three scales performed well in discriminating between outpatients and non-
patients. The most discriminating subscale was Anxious Arousal (AUC=0.99), followed by 
General Distress (AUC=0.96) and Anhedonic Depression (AUC=0.88). See Figure 3.1 for 
the discriminative power of the General Distress score.
 SF-36: The cut-off point of the Mental Health score, which discriminated the ROM 
reference group from the ROM patient group, was 63, with a sensitivity and specificity of 
89%. The AUC values showed that all SF-36 subscales performed well in making a distinction 
between patients and non-patients. The discriminating performance of Mental Health was 
excellent (AUC=0.95). The next best discriminating subscales were Social Functioning 
(AUC=0.92) and Vitality (AUC=0.92). The Bodily Pain and Physical Functioning scales 
showed the least distinctiveness, but they were still adequate, and are therefore still clinically 
useful. The discriminative power of General Mental Health is presented in Figure 3.1.
 DAPP-SF: The cut-off point of the Identity Problems score, which discriminated 
the ROM reference group from the ROM patient group, was 2.08, with a sensitivity and 
specificity of 83%. The cut-off point of the Oppositionality score was 2.22 with a sensitivity 
and specificity of 73%. The discriminating performance of the DAPP-SF was moderate. The 
AUC values showed that 11 subscales performed well in distinguishing between patients and 
non-patients. The best performing subscale was Identity Problems (AUC=0.90), followed by 
Affective Lability (AUC=0.90) and Anxiousness (AUC=0.90). Seven subscales showed no 
clinically useful discriminatory power, with AUC values ranging from 0.53 to 0.60. All scales 
might perform better in the specific subpopulation of patients with personality disorders. As 
an example, the distributions of Oppositionality in the ROM reference group and the ROM 
patient group are presented in Figure 3.1. (This subscale was selected because it showed 
substantial interperson variability.)
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DISCUSSION
We report reference values (95th percentiles) for the generic instruments BSI, MASQ-D30, 
SF-36 and DAPP-SF in large samples from ‘healthy’ and ‘psychiatrically sick’ populations. 
The internal consistency of the total score and subscale scores of the four generic instruments 
was consistently high. In the two samples, the expected differences in mean scores were 
confirmed, validating the clinical application of the ROC cut-off values or the 95th percentile 
scores (or 5th percentile for the SF-36). A clear gender difference in reference values was 
observed, with women showing higher values than men. It is remarkable that “healthy” men 
and women differed, and that the gender-specific distributions of the generic scales overlapped 
but did not coincide. Our data suggested that the degree of overlap between the sexes was 
not negligible, and that sex-specific reference values would increase the precision of the 
assessment of the clinical state of psychiatric outpatients. Advancing age was associated 
with more symptoms of Axis I psychopathology. Consequently, to be regarded as recovered, 
a young man would need to have lower scores on generic scales than would an older woman.
 ROC analyses showed good discriminative power for the BSI, MASQ-D30, and 
SF-36 but not for the DAPP-SF subscales. The former three instruments address Axis-I 
psychopathology or distress, whereas the DAPP-SF measures Axis-II personality traits that 
are rather stable and less affected by psychopathology and treatment. The higher AUC values 
represent the more state-like than trait-like characteristics of the BSI, MASQ-D30, and SF-
36, compared to the DAPP-SF. 
 The high internal consistency of the BSI, MASQ-D30, SF-36, and DAPP-SF are in 
accordance with previous studies [11,14,18,19,23,34]. Subscale means for the ROM reference 
group were somewhat lower than reported in previous studies of general population samples 
for the BSI [11,19]. In addition, they were slightly higher than in most [15,34-37] but not 
all [38] SF-36 studies and lower than in a DAPP-SF study [18]. Regarding the ROM patient 
group, means for the BSI, SF-36, and DAPP-SF approximated previously reported values 
in most clinical populations [11,15,19,23]. Previously, reference values subcategorized by 
gender and age have only been reported for the SF-36 [20,21,25]. Given that the assessment 
results for our ROM instruments generally had skewed distributions with a long tail toward 
the extreme values (i.e., lower in the case of the SF-36), we preferred percentile scores 
rather than means and SDs, in contrast to previous studies. For the BSI, ROC cut-off scores 
approximated cut-off scores with optimal sensitivity, as reported by De Beurs and Zitman 
(2006). Further, P95 reference scores approximated De Beurs and Zitman ‘s cut-off scores 
with optimal specificity [11]. Reference values derived from the ROM reference and patient 
groups have different functions. Reference values from the ROM reference and patient groups 
are important for screening a patient who is considered to have more than mild abnormalities.
A precisely defined reference value will allow for the detection of subjects with 
psychopathology who could benefit from therapy or from referral from primary care to 
specialized mental health care (and vice versa). For screening purposes, we recommend the 
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use of cut-off scores with a high sensitivity, to be sure that a minimal number of patients with 
psychopathology get through undetected, although this would result in higher false positives. 
So, for the purpose of screening, ROC-based cut-offs, 75th percentile scores from the ROM 
reference group, or 5th percentile scores from the ROM patient group may be appropriate; 
for the SF-36 this would be represented by the 25th and 95th percentiles, respectively [26]. 
However, if the consequences of missing the disease are relatively minor, and if the costs of 
therapy providing for subjects who are wrongfully diagnosed are substantial, a somewhat 
higher specificity with lower sensitivity may be used [39]. The reference values established 
in the present study can be used to determine whether a patient’s level of symptoms falls 
within the normal range of values after treatment (e.g., whether a treated patient is no longer 
any different from normal controls with respect to the level of depressive symptoms). These 
reference values are to be used to determine treatment goals. 
 Normality can be defined statistically or medically. The statistical model is based 
on the distribution of scores from the general population (including all individuals) and on 
deviation from the mean. The middle range of scores of the normal distribution is considered as 
normal (within 2 SD of the mean), and extreme high or low scores are considered deviant. The 
medical model considers psychopathology and normality (i.e. absence of psychopathology) 
in absolute terms. It excludes individuals with a disorder from a reference group [40]. In our 
study we chose the statistical approach and therefore included all non-consulting individuals, 
both with and without (sub clinical) symptoms. So, there are different viewpoints as to 
whether the general population should consist of non-treated subjects or whether it should be 
more restricted (i.e., only including subjects without psychiatric diagnoses). We have chosen 
for the former definition, because we tested generic instruments which are not confined to a 
single DSM-IV diagnosis. If we had excluded 122 (9.5%) subjects with a MINI-diagnosis 
from the main analysis, we think that the reference values would have been too strict. 
Nevertheless, we have already shown above that the reference values were not affected to 
any large extent by our inclusive methodology.
 The present study has several strengths. The ROM reference group was sufficiently 
large, clearly defined, and similar to the ROM patient group with respect to age, gender, and 
level of urbanization. These non-consulting GP patients were highly representative of the 
general population, given the extremely high GP registration percentage. This was further 
illustrated by the fact that sufficient psychiatric symptoms were reported by approximately 
10% of the population-based reference group to the point of warranting a DSM-IV diagnosis, 
which is in line with a Dutch (NEMESIS) comorbidity study [41]. Stratification of the 
ROM reference group into more homogeneous gender- and age-subsets resulted in a better 
differentiation of reference values. Assessment and analytical procedures were standardized 
and of high quality, similar to the ones used for the ROM patients. Limitations of our study 
that should be mentioned include the high non-response (63.2%) in the ROM reference 
group, which may have resulted in bias due to selection. Some populations (i.e., younger 
males with full-time employment) may have been underrepresented. We believe that this may 
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have resulted in a slight under-representation of the healthiest subjects, overly conservative 
estimates of the discriminative power of the instruments, slightly low percentile scores, and 
slightly high cut-off points for the transition from healthy to psychiatrically sick. At the 
same time, analyses of data from the ROM reference group without the 10.9% of subjects 
with a MINI diagnosis did not substantially alter our findings, suggesting that our reference 
values were fairly robust. As no information was available for non-responders and excluded 
individuals, they could not be compared with the ROM reference group for demographic 
variables. Furthermore, ethnic and cultural differences were not considered. Therefore, our 
reference values for the Dutch general population may not directly apply to other ethnic 
or cultural groups. Likewise, reference values for children and the elderly remain to be 
assessed. Another issue concerns the use of the DAPP-SF for the assessment of dysfunctional 
personality traits. It has been suggested that the limited validity of self-report instruments for 
assessing personality pathology is particularly relevant in clinical populations [42], especially 
among depressed [43] and psychotic patients [44]. Finally, it is important to recognize the 
limitations of population-based reference values. They should not be interpreted too rigidly. 
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CONCLUSION
This large-scale population-based study provides reference values for the BSI, MASQ-D30, 
SF-36, and DAPP-SF. These reference values are essential for use in clinical psychiatry 
care. The scales are commonly incorporated in the comprehensive set of generic ROM 
instruments and they can be administered with every patient with psychiatric disorders for 
the purpose of routine screening, referral, and treatment. This set of four scales thoroughly 
covers general psychopathology, mood- and anxiety disorders (which represent 80% of 
psychiatric disorders), personality disorders, and quality of life. ROM reference values 
inform therapists and patients on the severity of the complaints at intake, and the waxing 
and waning of symptoms over the course of treatment. Furthermore, they enable research of 
the effectiveness of treatments in everyday clinical practice and managers can use them for 
benchmarking.
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ABSTRACT
Background: The Beck Depression Inventory-II (BDI-II), the Inventory of Depressive 
Symptoms (Self-Report) (IDS-SR), and the Montgomery-Åsberg Depression Rating Scale 
(MADRS) are questionnaires that assess symptom severity in patients with a depressive 
disorder. They are often incorporated in Routine Outcome Monitoring (ROM). We aimed to 
generate reference values for both ‘healthy’ and ‘clinically depressed’ populations to promote 
correct interpretation of ROM results.
Method: We included 1295 subjects from the general population (ROM reference-group) 
recruited through general practitioners, and 4627 psychiatric outpatients diagnosed with 
major depressive disorder (MDD) or dysthymic disorder (DD) (ROM patient-group). The 
outermost 5% of observations were used to define limits for one-sided reference intervals 
(95th percentiles; P95). Receiver Operating Characteristics (ROC) analyses were used to yield 
alternative cut-off values. Internal consistency reliability of the instruments was assessed.
Results: There was no significant difference between groups with respect to age and 
gender ratio. Mean age for the ROM reference-group was 40.3 years (SD=12.6) and for the 
ROM patient-group it was 39.3 years (SD=12.3). The proportion of females was 62.8% and 
61.0% respectively. Cut-off values (P95) were significantly different for women and men. 
Respectively, the cut-off values were 15 and 12 for the BDI-II, 23 and 18 for the IDS-SR, 
and 13 and 9 for the MADRS. ROC analyses yielded very similar reference values. The 
discriminative power of the BDI-II, IDS-SR, and MADRS scores was very high. Moreover, 
internal consistency was excellent for the total scores of all instruments. Internal consistency 
was satisfactory for all subscales with the exception of the IDS-SR subscale Atypical 
Characteristics.
Limitations: Non-response of 63% and limited generalizability (children, elderly, ethnic 
minorities).
Conclusion: For the BDI-II, IDS-SR, and MADRS a comprehensive set of reference 
values were provided. Reference values in the general population were higher in women 
than in men, suggesting the need to use gender-specific cut-off values. Each instrument can 
be offered to patients with mood-, anxiety or somatoform disorders to facilitate responsible 
decision-making with respect to continuing, changing or terminating therapy.
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INTRODUCTION
Routine Outcome Monitoring (ROM) is the periodically repeated assessment of the condition 
of patients using diagnostic instruments and severity scales. It may thus aid in the evaluation 
of treatment outcome. Both generic and disorder-specific measurement instruments are 
used. Generic instruments are completed by all patients. They assess a broad range of 
psychopathological symptoms irrespective of the psychiatric disorder(s) experienced by 
patients. Disorder-specific instruments are administered to patients who meet the criteria for 
a particular disorder [1-3].
 Reliable ratings from reference populations are essential for the correct interpretation 
of ROM results when making clinical decisions about continuing, altering, or terminating 
treatment [4]. Furthermore, reliable reference values can facilitate referral from specialized 
mental health care back to primary care. When establishing and interpreting reference values, 
several issues need to be considered. First, reference values [5] are often established in 
healthy populations [6] with health clearly defined by a priori inclusion and exclusion criteria 
[7-9]. As a consequence ‘supernormal’ (i.e., overly healthy) participants are sometimes 
selected [10], resulting in unreasonable reference intervals which are often 10% narrower 
[11]. Second, (sub)sample sizes of at least 120 are needed to reduce the amount of uncertainty 
and error caused by potential outliers [12]. Third, when data tend toward a non-Gaussian 
distribution, non-parametric percentile scores are more appropriate reference values than 
parametric mean values (and standard deviation (SD) of confidence interval (CI) values) 
[6,12]. For non-Gaussian distributions, weighted cut-off scores calculated by the Jacobson 
& Truax method [13] are equally unsuitable. In the case of non-Gaussian distributions, the 
95th percentile (P95) commonly serves as the reference value [6]. Finally, Receiver Operating 
Characteristics (ROC) analyses can provide cut-offs when both reference and patient data are 
available, reflecting the optimal trade-off between sensitivity and specificity [14].
 The self-report Beck Depression Inventory-II (BDI-II; [15-17], the Inventory of 
Depressive Symptoms - Self-Report (IDS-SR) [18,19], and the observer-rated Montgomery-
Åsberg Depression Rating Scale (MADRS; [20] are three frequently used ROM instruments 
that assess symptom severity of major depressive disorder (MDD). The BDI-II, unlike the 
IDS-SR and MADRS, can also be used as a diagnostic screening instrument for MDD [18]. 
Previous BDI-II studies reported cut-off and reference values for MDD outpatients [21,22] 
and inpatients [23,24]. A study in 376 undergraduates (17-29 years of age) and older adults 
(55-90 years of age) reported a mean total score of 8.6 (SD=7.7) [25]. IDS-SR reference 
values have been reported for depressed outpatients [26-29] and inpatients [30]. Based on 
23 normal controls, a mean of 2.1 (SD=2.2) was reported. Based on 118 normal controls, a 
cut-off value of ≥ 18 was recommended [19]. on 118 normal controls, a cut-off value of ≥ 18 
was recommended [19]. Many studies have reported means with SDs or cut-off values for 
the MADRS but these studies were conducted with outpatients with MDD [31-34], inpatients 
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with MDD [32,35,36], stroke patients [37], and old age pensioners [38]. In a review of studies 
of healthy controls (total n=569), Zimmerman et al. [39] reported means, SDs, and optimal 
cut-off scores. However, because of the strongly positively skewed distributions of all these 
total scores in healthy populations, the assumption of a normal distribution does not seem to 
be satisfied. Preferably, reference values would be based on a distribution-free percentile or 
ROC methodology.
 The aim of this study was to establish reference values for the BDI-II, the IDS-SR, 
and the MADRS. Percentiles and ROC-based cut-off points were calculated, together with 
the more commonly reported means with SDs. A sample from the general population was 
recruited through general practitioners (GPs). These subjects were compared with a sample 
of outpatients diagnosed with MDD or DD (with or without other psychiatric disorders). 
Thus, we focused on a well-defined psychiatric patient group, we included a reference-group 
which was healthy but not necessarily symptom-free, and both samples were large in size.
METHODS
Participants
Our analyses of reference values were based on two study samples: a ROM reference sample 
from the general population and a ROM sample of psychiatric outpatients. 
 A total of 1295 participants (62.8% females) aged 18 to 65 years (M=40.3 years; 
SD=12.6) were included in the ROM reference-group as part of the ‘Leiden Routine Outcome 
Monitoring Study’ [2,3,40]. They were randomly selected from the registration systems of 
eight general practitioners (GPs) in the region of Leiden, the Netherlands. The response 
rate was 37.1%, as described elsewhere [2,3]. Inclusion criteria and exclusion criteria 
(e.g., treatment for psychiatric disorders and/or dependence on alcohol or drugs within six 
months prior to assessment) are described in detail elsewhere [2,3,40]. To make the group 
demographically comparable to the ROM patient-group the reference-group was matched for 
gender, age, and urbanization-level (62.3% urban). 
 The ROM patient-group consisted of a baseline sample of 4627 psychiatric 
outpatients, (61.0% females) aged between 18 and 65 years (M=39.3 years, SD=12.3). These 
outpatients were diagnosed with and treated for depressive disorders (MDD or dysthymic 
disorder, DD) in the Leiden University Medical Center (LUMC) Department of Psychiatry 
or the Rivierduinen specialized mental healthcare centres. Baseline assessment was part of 
the usual ROM procedure. About 80% of the referred patients with a tentative diagnosis of 
mood-, anxiety- and/or somatoform (MAS) disorder were assessed with ROM during the 
study period 2004-2009 [40].
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Procedures and instruments
Procedures for the web-based ROM program of the LUMC Department of Psychiatry are 
described elsewhere [40,41]. All patients gave permission for the use of their ROM data for 
scientific purposes (written informed consent for this study was not required). In addition, 
participants of the ROM reference-group (non-patients) signed informed consent for the 
purpose of this study. For our study we used baseline data of ROM assessments. This included a 
standardized diagnostic interview (Dutch version of the Mini-International Neuropsychiatric 
Interview Plus, version 5.00-R: MINI-Plus; [42,43], the collection of sociodemographic and 
socioeconomic data, observer-rated scales, and self-report instruments. The BDI-II [16,17] 
was completed by 455 reference subjects and 4019 patients. The IDS-SR was completed by 
another group of 769 reference subjects and 474 patients. The MADRS was completed by 
the majority of the reference group (n=1291)and by all patients (n=4627). Halfway through 
the study we replaced the BDI-II with the IDS-SR. The IDS-SR is also a depression severity 
scale and is license-free. The MADRS is license-free as well. 
 The BDI-II, a revised version of the BDI [15], measures the severity of self-reported 
depression in adolescents and adults according to the criteria for diagnosing MDD as presented 
in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) [44]. The BDI-II 
total score is derived by summing the scores for each of the 21 items. Each item is rated on 
a 4-point scale ranging from 0-3, with higher scores indicating higher levels of depression. 
The total score ranges from 0-63, where scores between 0-13 denote “minimal” depression, 
scores between 14-19 denote “mild” depression, scores between 20-28 denote “moderate” 
depression, and scores between 29-63 denote “severe” depression. In the international 
literature, two subscales [22,45,46], three subscales [17], and zero subscales [25] have been 
identified. The Cognitive and Somatic-Affective subscales are most commonly reported 
[22,23]. Respectively, they consist of 8 and 13 items, and subscale total scores range between 
0-24 and between 0-39 [16]. The time-frame for the BDI-II is “the past two weeks, including 
today”.
 The IDS-SR self-report instrument [18,19] is designed to measure overall 
depressive symptom severity. The IDS-SR consists of 30 items, 23 of which cover the DSM-
IV diagnostic criteria for MDD (including its atypical and melancholic subtypes). Seven 
items are not related to diagnostic criteria but to symptoms commonly associated with MDD 
(e.g. irritable mood, anxious mood). The items are rated on a 4-point Likert scale, with scores 
ranging from 0 (no symptomatology) to 3 (most severe). The total score ranges between 0-84, 
because only 28 of 30 items are scored (either decreased or increased weight are scored, and 
either decreased or increased appetite are scored). Scores between 0-13 denote “normal/no” 
depression, scores between 14-21 denote “possible/mild” depression, scores between 22-30 
denote “moderate” depression, scores between 31-38 denote “severe” depression, and scores 
of 39 or higher denote “very severe” depression [47]. Frequently used subscales are the 
10-item Atypical Characteristics subscale [48] and the 11-item Melancholic Characteristics 
subscale [49]. The time frame for the IDS-SR pertains to the previous 7 days, except in the 
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case of weight change which is rated for the previous 14 days.
 The MADRS [20] is a clinician-rated instrument assessing the range and severity of 
depressive symptoms. The 10 items were designed to be particularly sensitive to treatment 
effects. The symptoms occur in the majority of cases although they do not cover all 9 DSM-
IV MDD criteria. Rather, the items emphasize psychological symptoms such as apparent 
sadness and concentration problems [50]. Items are rated on a 7-point Likert scale anchored 
at 4 points (0: symptom is absent; 6: symptom is totally dominant) and summed to yield a 
total score between 0 and 60. Total scores between 0-8 denote “normal/no” depression, scores 
between 9-18 denote “possible/mild” depression, scores between 19-26 denote “moderate” 
depression, scores between 27-34 denote “severe” depression, and scores of 35 or higher 
denote “very severe” depression [35]. The time frame for the MADRS is for the previous 
seven days.
 The MINI-Plus [42,43] was used to establish the presence of Axis I diagnosis 
according to the DSM-IV.
Statistical analyses
Analyses resulting in percentile scores and means (SDs) were conducted for the two groups 
separately, while ROC and internal consistency reliability analyses were conducted using 
data from both groups combined. In both groups, subjects who had 1 or more missing 
values per subscale were excluded. This permitted a robust evaluation of the use of the 
instruments [3]. Sociodemographic and psychopathological variables were descriptively 
analyzed (percentages in the case of categorical variables, means and SDs for the continuous 
variables). Cut-off scores indicating an optimal discrimination threshold between ‘healthy’ 
and ‘diseased’ were obtained by ROC analyses. Sensitivity and specificity were chosen to 
be equal, taking into account the trade-off between the two [14]. Although the scales are not 
diagnostic instruments, we assessed the discriminatory power of the instrument total scales 
and subscales, using the associated areas under the ROC curve (AUCs). AUCs over 0.75 were 
considered clinically useful, with values above 0.85 showing moderate discriminatory power 
and values above 0.95 showing very high discriminatory power [51]. The 5th, 25th, 50th, 75th, 
and 95th percentiles were calculated. In reference groups, the central 95% of the distribution 
is commonly used in the case of non- Gaussian distributions [5,7]. The remaining 5% is 
commonly categorized as ‘abnormal’ [52]. We regarded the top 5% of the reference-group 
(95th percentiles, P95) as ‘abnormal’ because the lowest 2.5% (i.e., functioning ‘abnormally’ 
good) is not identifiable in general population samples. That is, the BDI-II, IDS-SR, and 
MADRS merely assess the level of dysfunctionality and not the level of ‘health’ or normal 
functionality. Likewise, the bottom 5% of the patient-group (5th percentiles, P5) can be 
considered as indistinguishable from people in the normal range. Furthermore, means and 
SDs were calculated. Reference values were calculated for the entire reference-group and the 
entire patient-group, as well as for 4 strata in each group: young women (aged 18-40 years), 
older women (aged 41-65 years), young men (aged 18-40 years), and older men (aged 41-65 
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(aged 41-65 years). The internal consistency reliability of the instruments was tested using 
Cronbach’s alpha for the total scale and for subscales when present. To test our decision not to 
exclude those individuals in the ROM reference-group with a current psychiatric diagnosis, 
we performed a sensitivity analysis. For all analyses, SPSS version 17.0 was used.
RESULTS
Statistical analyses
The sociodemographic and psychopathological characteristics of the ROM reference-group 
and ROM patient-group are shown in Table 4.1.
 The ROM reference-group and the ROM patient-group were comparable with 
respect to age (M=40.3 years [SD=12.6] and M=39.3 [SD=12.3] respectively, p=0.14) and 
gender distribution (62.8% females and 61.0% females, respectively, p=0.25). Participants 
from the ROM reference-group were more often married than those from the ROM patient-
group (68.7% versus 43.5%, p<0.001) and were less often living alone (15.5% versus 22.0%, 
p<0.001). The ROM reference-group showed higher levels of education relative to the ROM 
patient-group (77.2% higher education versus 49.5%, p<0.001).
Table 4.1. Sociodemographic and psychopathological characteristics of the ROM reference (n=1295) 
and ROM patient (n=4627) groups.
                                   ROM reference group       ROM patient group
                                       (n= 1295)                            (n=4627)
Gender (%)
   Male 482 (37.2) 1779 (38.4)      (p=0.41)
   Female 813 (62.8) 2848 (61.6)      (p=0.36)
Age (mean. SD) in years 40.3 (12.6) 39.3 (12.3)      (p=0.12)
   Male 41.2 (12.6) 41.2 (12.0)      (p=0.98)
   Female 39.7 (12.6) 38.1 (12.3)    (p=0.001)
Marital status (%)* (p<0.001)
   Married/cohabitating 890 (68.7) 2027 (43.8)
   Divorced/separated/widow 78 (6.0) 689 (14.9)
   Single 327 (25.3) 1382 (39.9)
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Table 4.1: continued.
                                           ROM reference group       ROM patient group
                                       (n= 1295)                            (n=4627)
Housing situation (%)* (p<0.001)
   Living alone 201 (15.5) 995 (21.5)
   Living with partner 902 (69.7) 2067 (44.7)
   Living with family 192 (14.8) 1036 (22.4)
Educational status (%)*¹ (p<0.001)
   Lower 295 (22.8) 1843 (39.8)
   Higher 1000 (77.2) 2253 (48.7)
Employment status (%)* (p<0.001)
   Employed part-time 509 (39.3) 838 (18.1)
   Employed full-time 554 (42.8) 803 (17.4)
   Unemployed/retired 197 (15.2) 1189 (25.7)
   Work-related disability (%) 35 (2.7) 1268 (27.4)
Ethnic background (%)* - ** (p<0.001)
   Dutch 1150 (88.8) 3103 (67.1)
   Other ethnicity 134 (10.3) 954 (20.6)
MINI diagnoses (%) (p<0.001)
   Currently None 1174 (90.7) 0***
   Mood disorder (single) 7 (0.5) 2159 (46.7)
   Mood disorder (with comorbidity) 10 (0.8) 2468 (53.3)
   Other psychiatric disorder 104 (8.1) 0***
*No data from 70 (1.5%) - 570 (12.3%) patients;  **No data from 11 reference  subjects
***Selection criterion 
¹ Lower education: general basic education only, or lower vocational education
  Higher education: middle or higher vocational education, college or university
 Furthermore, work-related disability and unemployment were less prevalent in 
the ROM reference-group (17.9% versus 54.3%, p<0.001). Fewer participants in the ROM 
reference-group were of ethnic origin (defined as oneself or both parents not being born in 
the Netherlands). In keeping with our decision to exclude patients without a diagnosis of 
MDD or DD, all subjects from the ROM patient-group had at least one DSM-IV disorder.
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In the ROM reference-group, on the other hand, 10.9% had a DSM-IV disorder. In the 
ROM patient-group, a high proportion of subjects (53.3%) reported psychopathological co-
morbidity (e.g. anxiety disorders and/or somatoform disorders).
REFERENCE VALUES
Percentiles, means and SDs 
Table 4.2 presents the percentile scores and the mean scores for the BDI-II, IDS-SR, and 
MADRS for both the ROM reference-group and the patient-group. For the ROM reference-
group, the distributions of total scores and subscale scores were positively skewed, indicating 
apparent health. This was also demonstrated by the substantial percentage of participants 
with the lowest possible scores. The Supplementary Tables 4.1-4.3 depict the percentile 
scores and the mean scores for men and women separately.
 For the ROM reference-group, the cut-off (P95) value was 13 for the BDI-II total 
score, 20 for the IDS-SR total score, and 11 for the MADRS total score. For the ROM 
patient-group the cut-off (P5) value was 14 for the BDI-II total score, 18 for the IDS-SR total 
scale, and 11 for the MADRS total score. The mean BDI-II total score was 3.7 (SD=4.7) for 
the ROM reference-group, indicating that the majority was not depressed. For comparison, 
in the MDD patient-group the mean was 30.8 (SD=10.5), indicating severe depression in the 
majority of patients. The mean IDS-SR total score was 6.7 (SD=6.9) for the ROM reference-
group, compared to 38.1 (SD=12.1) for the MDD patient-group. The mean MADRS score 
was 2.8 (SD=3.8) for the ROM reference-group, compared to 23.4 (SD=7.8) for the MDD 
patient-group.
 For the self-report instruments (BDI-II and IDS-SR), analyses of gender and age 
indicated that advancing age was associated with more symptoms of psychopathology for 
both genders (see Supplementary Tables 4.3 through 4.5). There was a tendency for healthy 
women to show higher cut-off scores on all three MDD severity scales relative to healthy 
men.
 In a sensitivity analysis, we excluded from the ROM reference-group all 126 
subjects (9.7%) with a MINI-diagnosis. Among the remaining 1169 subjects, we found that 
the median of the changes on the BDI-II, the IDS-SR total score and subscale scores, and the 
MADRS was 11% (interquartile range 9 to 14%). The median of the changes of the P95 scores 
was 15% (interquartile range 11 to 20%).
Receiver operating characteristic (ROC) curves 
Cut-off points, defined by equal sensitivity and specificity, were calculated with ROC 
analyses (see Table 4.3). See also Figure 4.1 for the discriminative power of each of the three 
MDD scales.
 The cut-off point of the BDI-II, which discriminated health from disease (i.e.,, 
the ROM reference-group from the ROM patient-group), was 13.5, with a sensitivity and 
specificity of 96%. Therefore for subjects without psychopathology, 4% of those with a total 
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score of 13.5 or higher would be incorrectly classified as depressed. By the same token, 
4% of the ROM patient-group who had a total score of 13.5 or lower would be incorrectly 
classified as non-depressed. The AUC value (0.99), indicating the discriminating 
performance, showed that the BDI-II performed excellently in making a distinction 
between patients and non-patients. Both subscales showed excellent discriminative power. 
The best performing subscale was the Somatic-Affective subscale, with AUC=0.99.
 The cut-off point of the IDS-SR total score, which discriminated the ROM 
reference-group from the ROM patient-group, was 18.5 with a sensitivity and specificity 
of 94%. The AUC value was 0.98 for the total score, showing excellent discriminative 
power. The best performing subscale was Melancholic Characteristics (AUC=0.97).
 The cut-off point of the MADRS total score, which discriminated the ROM 
reference-group from the ROM patient-group, was 10.5 with a sensitivity and specificity 
of 95%. The AUC value was 0.99, showing excellent discriminative power. 
Internal consistency reliability
The internal consistency reliability of the instruments (for all subjects combined) is 
presented in Table 4.3. The total scales of all three instruments showed excellent internal 
consistency. Except for the IDS-SR Atypical Characteristics subscale (with a questionable 
alpha of 0.68), none of the subscales had Cronbach’s alphas below the critical cut-off of 
0.70, indicating adequate internal consistency.




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.1: Distribution of the scores of Beck Depression Inventory-II (BDI-II) total scale, the Inventory 
of Depressive Symptoms (self-report) (IDS-SR) total scale and the Montgomery Äsberg Depression 
Rating Scale (MADRS). Three types of cut-off points are depicted: the 75th percentile score (P75), the 
95th percentile score (P95) and the Receiver Operating Characteristics (ROC) cut-off point defined by 
equal sensitivity and specificity.
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DISCUSSION AND CONCLUSION
We reported reference values for the generic instruments BDI-II, IDS-SR, and MADRS in 
large samples from a ‘healthy’ population (i.e., ROM reference-group) and a ‘psychiatrically 
ill’ population (i.e., ROM patient-group). P95 values of the ROM reference-group, ROC 
analysis based cut-off scores, and P5 values of the ROM patient-group yielded almost equal 
values. A remarkable gender-specific pattern in reference values was observed, with women in 
the general population showing higher values than men. Our data suggest that gender-specific 
reference values will increase precision in the assessment of the clinical state of psychiatric 
outpatients. Advancing age was associated with more symptoms of psychopathology for the 
BDI-II and IDS-SR. Therefore, to be regarded as recovered, a young man would need to 
have lower scores on generic scales than would an older woman. The BDI-II and MADRS 
showed different results. This could be explained by the fact that the BDI-II a more symptom-
specific instrument is, relative to the MADRS. However, the MADRS and the BDI-II provide 
internally consistent estimates of depression severity [53].
 The mean BDI-II scores for the ROM reference-group (mean=3.8, SD=4.7) were 
lower than the mean BDI-II scores reported by Segal et al. (2008; mean=8.6, SD=7.7), 
suggesting that our reference-group was relatively healthy. The mean IDS-SR score for our 
ROM reference-group (mean=6.7, SD=6.9), however, was slightly higher than the mean IDS-
SR scores reported by Rush et al. (1986; mean=2.1, SD=2.2). It should be noted, however, 
that their skewed distributions preclude an accurate comparison of these two estimates. The 
ROC cut-off value for the ROM reference-group (18.5) was similar to the value reported by 
Rush et al. (18.0) [19]. The mean MADRS score for the ROM reference-group (mean=2.8, 
SD=3.8) was slightly lower than the weighted mean MADRS score reported by Zimmerman 
et al. (M=4.0, SD=5.8) [39]. These differences among studies are relatively small and of minor 
clinical importance, and may be due to sociodemographic and socio-cultural differences. 
The larger size of our ROM reference-group has probably yielded rather precise estimates. 
The high internal consistencies of the BDI-II, IDS-SR, and MADRS are in accordance with 
previous studies [19,21,23-26,29,31]. 
 The GP sample in our study is representative of the general population, given that 
almost everyone in the Netherlands is registered with a family doctor/GP. The reference 
values established in the present study can be used to determine whether a patient’s level 
of symptoms falls within the normal range of values after treatment (i.e., whether a treated 
patient is no longer any different from normal controls with respect to the level of depressive 
symptoms). Normality can be defined statistically or medically. The statistical model is 
based on the distribution of scores from the general population (including all individuals) and 
on deviation from the mean. The medical model considers psychopathology and normality 
(i.e., absence of psychopathology) in absolute terms. It excludes individuals with a disorder 
from a reference-group. In our study we chose the statistical approach in which we included 
all non-treated individuals, both with and without (subclinical) symptoms. We have chosen 
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for this approach because we wanted to have reference values that were representative for 
the population that was not treated in secondary care. If we had excluded subjects with a 
MINI-diagnosis from the main analysis, the reference values would probably have been too 
strict. Our results showed that the reference values were not affected to any large extent by 
our inclusive methodology.
 Country-specific normative data are important, because reference values are not 
necessarily the same in different translations and across different cultures [54,55]. Compared 
to English reference values, our values were slightly lower for the reference population, as 
were the previously-published Dutch reference values for the BDI-II (Beck et al.  2002). 
Until now, no Dutch reference values have been reported for the IDS-SR and MADRS. Our 
data showed a somewhat lower mean total score on the MADRS relative to that reported by 
Zimmerman et al. (2004a; M=4.0, SD=5.8) in a review of studies of the MADRS in healthy 
controls.
 The following clinical implications arise from the results of the current study. The 
excellent performance of the instruments indicates that our reference values are suitable for 
different purposes: 1) decisions about treatment termination and referral back to primary 
care; and 2) identification of people who may benefit from therapy or from referral by 
primary care to specialized mental health care. Although the scales are not validated as 
diagnostic instruments, the ROC analyses suggested that the discriminative power of the 
instruments was excellent. Therefore , these cut-off values can aid in screening for MDD, 
although clinical judgment and validated diagnostic tools remain the gold standard (e.g., 
MINI [42,43]]; Composite International Diagnostic Interview [CIDI; [56]]; the Structured 
Clinical Interview for Diagnostic and Statistical Manual [SCID; [57]. Moreover, cut-off scores 
may be used to classify depression severity [16]. When making decisions about treatment 
termination or referral to primary care, specificity has to be high. The 95th percentile score of 
the ROM reference-group may result in few false positives. For referral from primary care 
to specialized mental health care, cut-off scores with a high sensitivity are more appropriate, 
and we recommend the use of ROC-based cut-offs or 5th percentile scores from the ROM 
patient-group. 
 It is noteworthy that the 95th percentile of the reference-group, the 5th percentile of the 
patient-group, and the ROC cut-off values overlapped considerably. They were also largely 
consistent with the internationally used cut-off values for the BDI-II, IDS-SR, and MADRS 
to distinguish individuals without depressive symptoms from those with mild symptoms 
(values of 14, 18, and 12, respectively; [16,19,20]. Furthermore, on average, women from 
the ROM reference-group scored higher on all three MDD severity scales relative to males. 
For the BDI-II, the respective P95 values for women and men were 15 and 12. For the IDS-SR 
the respective values were 23 and 18, and for the MADRS the respective values were 13 and 
9. It may be too early to recommend gender-specific reference values, as more research (e.g., 
replication) is needed in reference populations. Nevertheless, it was striking that reference 
values from non-depressed populations showed clinically important
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gender differences. Most previous studies did not stratify for gender [25,27,39] but in the 
one study in which stratification did occur [19], no gender difference was found. For the self-
report instruments (BDI-II and IDS-SR), higher age was associated with higher P95 reference 
scores for both women and men in the ROM reference-group; this was not the case for the 
observer-rated MADRS. Therefore, age-specific reference values seem redundant. 
The present study has several strengths. First, the assessment procedures for both groups were 
standardized and of high quality. The interviewers were specially trained research nurses and 
psychologists who were regularly supervised. Second, the ROM reference-group was large, 
it was clearly defined, and it resembled the patient-group in all relevant respects (age, gender, 
level of urbanization) other than those under investigation (level of psychopathology). 
Furthermore, the reference-group is probably quite representative of the general population, 
given the high GP registration rate in the Netherlands. 
 Limitations of the present study include the non-response in the ROM reference-
group. At 63.2%, this was substantial, pointing to potential selection bias. Bias may have 
resulted in slightly higher cut-off and percentile scores. Furthermore, because the BDI-II was 
replaced by the IDS-SR during the study, sample sizes of ROM patients that completed the 
IDS-SR (n=474) and of ROM reference subjects that completed the BDI-II (n=455) were not 
as high as the other sample sizes.  Additionally, the generalizability of the results is limited by 
the nature of our ROM reference-group; it comprised Dutch-speaking people aged between 
18 and 65 years. Reference values may not automatically be applicable to other ethnic or 
cultural groups, or to children and the elderly. 
 In conclusion, this large-scale population-based study provides reference values and 
reliability coefficients for the BDI-II, IDS-SR, and MADRS. These reference values improve 
the usability of the instruments as ROM instruments for the assessment of severity of mood 
disorder symptoms. Either instrument can be administered to every patient with a depressive 
disorder to help make responsible decisions about continuing, changing, or terminating 
therapy. Additionally, these reference values are suitable for indentifying patients that have 
recovered enough to be referred back from specialized mental health care to primary care.
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ABSTRACT
Background: The monitoring of patients with an anxiety disorder can benefit from 
Routine Outcome Monitoring (ROM). As anxiety disorders differ in phenomenology, several 
anxiety questionnaires are included in ROM: Brief Scale for Anxiety (BSA), PADUA 
Inventory Revised (PI-R), Panic Appraisal Inventory (PAI), Penn State Worry Questionnaire 
(PSWQ), Worry Domains Questionnaire (WDQ), Social Interaction, Anxiety Scale (SIAS), 
Social Phobia Scale (SPS), and the Impact of Event Scale-Revised (IES-R). We aimed to 
generate reference values for both ‘healthy’ and ‘clinically anxious’ populations for these 
anxiety questionnaires.
Methods: We included 1295 subjects from the general population (ROM reference-
group) and 5066 psychiatric outpatients diagnosed with a specific anxiety disorder (ROM 
patient-group). The MINI was used as diagnostic device in both the ROM reference group 
and the ROM patient group. To define limits for one-sided reference intervals (95th percentile; 
P95) the outermost 5% of observations were used. Receiver Operating Characteristics (ROC) 
analyses were used to yield alternative cut-off values for the anxiety questionnaires.
Results: For the ROM reference-group the mean age was 40.3 years (SD=12.6), and 
for the ROM patient-group it was 36.5 years (SD=11.9).  Females constituted 62.8% of the 
reference-group and 64.4% of the patient-group. P95 ROM reference group cut-off values for 
reference versus clinically anxious populations were 11 for the BSA, 43 for the PI-R, 37 for 
the PAI Anticipated Panic, 47 for the PAI Perceived Consequences, 65 for the PAI Perceived 
Self-efficacy, 66 for the PSWQ, 74 for the WDQ, 32 for the SIAS, 19 for the SPS, and 36 for 
IES-R. ROC analyses yielded slightly lower reference values. The discriminative power of 
all eight anxiety questionnaires was very high.
Limitations: Substantial non-response and limited generalizability.
Conclusions: For 8 anxiety questionnaires, the BSA, PI-R, PAI, PSWQ, WDQ, SIAS, 
SPS, and IES-R, a comprehensive set of reference values was provided. Reference values 
were generally higher in women than in men, implying the use of gender-specific cut-
off values. Each instrument can be offered to every patient with MAS disorders to make 
responsible decisions about continuing, changing or terminating therapy.
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INTRODUCTION
Anxiety disorders are characterized by pervasive, persistent, anxious affective states. The 
DSM-IV recognizes various specific types of anxiety disorders: panic disorder (PD); phobic 
disorders (i.e., agoraphobia (AD), social phobia (SoPD), and specific phobia (SpPD)); 
obsessive-compulsive disorder (OCD); acute stress disorder (ASD); posttraumatic stress 
disorder (PTSD); and generalized anxiety disorder (GAD). Anxiety disorders frequently 
occur as comorbid disorders. The current global prevalence of anxiety disorders is 7.3% 
(4.8–10.9%), ranging from 5.3% (3.5–8.1%) in African cultures to 10.4% (7.0–15.5%) in 
Euro/Anglo cultures [1]. Lifetime prevalence rates in the Netherlands are 19.6% for any 
anxiety disorder, 3.8% for PD, 0.9% for AD, 9.3% for SoPD, 0.9% for OCD, 7.4% for PTSD, 
and 4.5% for GAD [2-4].
 Routine outcome monitoring (ROM) is the assessment of treatment outcome at 
regular intervals in order to monitor patients’ progress during treatment. Alongside generic 
questionnaires completed by all patients, patients who meet the criteria for a particular 
disorder can be administered disorder-specific questionnaires [5,6] The correct interpretation 
of ROM results for making clinical decisions about continuing, altering, or terminating 
treatment requires reliable ratings from reference populations [7]. These ratings can be used 
to determine whether a patient’s level of symptoms falls within the normal range of values 
following treatment (e.g., whether a treated patient is now no different from normal controls 
with respect to the severity of anxiety symptoms).  
 Important issues regarding reference values appear in the literature. First, when 
data tend toward a non-Gaussian distribution, non-parametric percentile scores provide more 
appropriate reference values compared to parametric means and standard deviations (SDs) 
[8,9], and to weighted cut-off values calculated by the Jacobson & Truax method [10]. In 
that case, the 95th percentile (P95) of the reference-group and the 5th percentile (P5) of the 
patient-group commonly serve as reference values [9]. Second, when both reference data 
and patient data are available, Receiver Operating Characteristics (ROC) analyses can be 
used to provide cut-offs. The optimal trade-off between sensitivity and specificity, the point 
of (near) equality, leads to the optimal number of false results (i.e., false positives plus false 
negatives) [11], depending on the prevalence of the disorder in the general population. It 
is of note that this applies to disorders that are not very rare. Third, reference values are 
often established in healthy populations [9]. Absolute health does not exist but is a relative 
statement. Health should nevertheless be clearly defined, a priori, via inclusion and exclusion 
criteria [12-14]. Kendall et al., [15] stated that excluding with MDD participants from the 
reference group if they exhibit elevated levels of the target psychopathology, might lead 
to creating a nonrepresentative, “supernormal” sample. When comparing the patient group 
with a supernormal reference group an overly stringent criterion with unreasonable narrow 
reference intervals would be the result [16]. The inclusion of all possible participants in the
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reference group, including those who may currently be experiencing elevated levels 
of psychopathology is therefore preferable. The goal is to generate a sample that is 
representative of the general community population [15]. This is in line with a statistical 
definition of normality, as opposed to a medical definition, both proposed by Wakefield 
[17]. The statistical perspective of normality is based on the distribution of scores from 
the population, including all individuals who are not currently treated in secondary care, 
with extreme scores considered as deviant. The medical perspective excludes individuals 
with psychopathology from the reference group. A similar definition of disease was given 
by Cohen [18]: “quantitative deviations from the normal”. Fourth, to reduce the amount of 
uncertainty and random error, (sub)sample sizes of at least 120 are needed [8]. 
 Symptoms of anxiety are suitable for self-rating because anxious persons in general 
tend to have rather realistic perception and insight (relative to other psychopathological 
conditions) [19]. We focused on 8 anxiety questionnaires that are often implemented in 
ROM (Table 5.1). These questionnaires are the self-rated PADUA Inventory Revised (PI-R), 
Panic Appraisal Inventory (PAI), Penn State Worry Questionnaire (PSWQ), Worry Domains 
Questionnaire (WDQ), Social Interaction, Anxiety Scale (SIAS), Social Phobia Scale (SPS), 
and the Impact of Event Scale-Revised (IES-R). Finally, the Brief Scale for Anxiety (BSA) 
is an observer-rated scale 
 For healthy control groups, reference values (in the form of means and SDs) have 
been published for the following questionnaires: PI-R [20,21], PSWQ [22-30], WDQ [26-
28,30], both SIAS and SPS [22,31,32], and IES-R [33]. To our knowledge, no reference 
values have been reported for the BSA and the PAI. For patient groups, means and SDs were 
published for the BSA [34,35], the PI-R [20,21,36], the PAI [37-39], the PSWQ [22,23,25,40], 
the WDQ [40], both the SIAS and SPS [22,31], and the IES-R [33,41-44]. However, because 
of the strong positively skewed distribution of total scores in healthy populations, such as 
our ROM reference-group, the assumption of a normal distribution is unlikely to be satisfied 
[8,9]. Reference values should preferably be based on a distribution-free percentile or ROC 
methodology. 
 In previous studies, cut-off values (i.e., clinical thresholds) were assessed for the 
PI-R [21], the PSWQ [23], and the IES-R [33] [45]. Gender differences were reported 
previously for the PSWQ and WDQ [25,26], the SIAS and the SPS [31,32], and the IES-R 
[43] healthy control groups. All of these studies reported higher mean values for women than 
for men. Characteristics of previous studies on reference values are summarized in Table 5.1.
The aim of this study was to establish reference values for the BSA, PI-R, PAI, PSWQ, 
WDQ, SIAS, SPS, and IES-R. These reference values included percentile scores, ROC-based 
cut-off values, and the more commonly reported means and SDs. We compared a sample 
of 1295 subjects from the general population with a sample of 5066 outpatients suffering 
from anxiety disorders. A special contribution of the current study is that a healthy (but 
not necessarily symptom-free) reference-group was included, alongside a well-defined 
psychiatric patient-group and that both sample sizes were large.
 5
Reference values for anxiety questionnaires 117
METHODS
Participants
Our analyses of reference values were based on two study samples: a ROM reference-sample 
from the general population (i.e., the ROM reference-group) and a ROM sample of psychiatric 
outpatients diagnosed with at least one anxiety disorder (i.e., ROM patient-group).
 A total of 1295 participants aged 18 to 65 years (mean age=40.3 years; SD=12.6; 
62.8% females) were included in the ROM reference-group, as part of the ‘Leiden Routine 
Outcome Monitoring Study’ [6,46]. A representative general population sample was 
randomly selected from the registration systems of eight general practitioners (GPs) in the 
region of Leiden, the Netherlands. In the Netherlands, 99.9% of the general population 
is registered with a GP [47]. The aim was to recruit an apparently psychiatrically healthy 
reference-group (but not necessarily symptom-free). Therefore, persons who were receiving 
treatment for psychiatric disorders and/or alcohol or drugs dependency during the six months 
prior to assessment were excluded. Additional exclusion criteria were hearing impairment or 
limited cognitive or language abilities (i.e., aphasia, severe dyslexia or dementia; illiteracy or 
insufficient mastery of the Dutch language). To ensure that the group was demographically 
comparable to the ROM patient-group, the ROM reference-group was matched for gender, age 
and urbanization-level (62.3% urban). Participants in the ROM reference-group were assessed 
in a similar way to the ROM patient-group, except that those in the ROM reference-group 
completed every disorder-specific questionnaire. As noted previously, the response rate of the 
ROM reference-group recruitment was 37.1% [6,48], perhaps due to the extensive number 
of questionnaires which needed to be completed by participants. The BSA was completed 
by the majority of the ROM reference-group (n=1291), the self-report questionnaires were 
completed by 50% of the ROM reference-group (due to time-constraints).
 The ROM patient-group consisted of a sample of 5066 psychiatric outpatients, aged 
between 18 and 65 years (mean age=39.3, SD=12.3; 61.0% females), who were diagnosed 
with and treated for anxiety disorders at the Leiden University Medical Center (LUMC) 
Department of Psychiatry or the Rivierduinen specialized mental healthcare centres. Baseline 
assessment was part of the usual ROM procedure. On average, 80% of the patients with a 
tentative diagnosis of mood-, anxiety- and/or somatoform (MAS) disorder were assessed 
with ROM in the study period [46]. The BSA was completed by the majority of the ROM 
patient-group (n=4368), the self-report questionnaires were completed by those who were 
diagnosed with the relevant anxiety disorder. 
 To diagnose psychopathology in a standardized manner according to the DSM-IV, 
a diagnostic interview with the Mini-International Neuropsychiatric Interview plus (MINI-
Plus 5.0.0.) [49,50] was done in all participants.
Procedures and questionnaires
Procedures for the web-based ROM program of the LUMC Department of Psychiatry are
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described in detail elsewhere [46,51]. For the current study, we used baseline ROM 
assessments that comprised a standardized diagnostic interview (Dutch version of the Mini-
International Neuropsychiatric Interview Plus, version 5.00-R: MINI-Plus) [49,50], the 
gathering of sociodemographic and socioeconomic data, observer-rated scales, and self-
report questionnaires. The assessments were performed by specially trained and constantly 
supervised research nurses in outpatient clinics of the LUMC and Rivierduinen. Table 5.1 
presents the description of each questionnaire, including domains, subscales, ratings, and 
score-ranges, as well as the respective ROM sample sizes. Sample sizes were determined by 
participants that completed the particular questionnaire (and not by presence of a particular 
anxiety disorder). The MINI-Plus was used to establish the presence of Axis I diagnoses 
according to the DSM-IV.
 The Medical Ethical Committee of the LUMC approved the general study protocol 
associated with ROM, in which ROM was administered as part of the routine treatment 
process for patients. It involved a comprehensive protocol (titled “Psychiatric Academic 
Registration Leiden database”) which safeguarded the anonymity of patients and persons in 
the reference-group and ensured proper handling of the ROM data. At intake, patients were 
informed that the data would be used for research purposes, but only in anonymized form. 
If patients object to such use, their data were removed. The Medical Ethical Committee of 
the LUMC approved the regulations and agreed with this policy.  In addition, persons in the 
ROM reference-group signed informed consent for the purpose of this study.
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Statistical analyses
Analyses were performed separately for the ROM reference-group and the patient-group, 
while ROC and internal consistency analyses were conducted using data from both groups 
combined. In both groups, participants who had more than one missing value per subscale 
were excluded. This allowed us to conduct a robust evaluation of the use of the anxiety 
questionnaires. Sociodemographic and psychopathological variables were analyzed using 
descriptive statistics (percentages in the case of categorical variables, means and SDs for 
the continuous variables). Cut-off values indicating an optimal discrimination threshold 
between ‘healthy’ and ‘diseased’ were obtained by ROC analyses. We chose to allow 
sensitivity and specificity to be equal, taking into account the trade-off between the two [11]. 
The discriminatory power of the questionnaire (sub) scales was assessed with the associated 
areas under the ROC curve (AUCs). AUC’s over 0.75 were considered clinically useful, with 
0.85 showing moderate discriminatory power and 0.95 very high power [52]. The 5th, 25th, 
50th (i.e. median), 75th, and 95th percentile scores were calculated. The central 95% of the 
distribution in reference-groups is commonly used in cases of non-Gaussian distributions 
[12,53]. The remaining 5% was categorized as ‘abnormal’ [54]. We chose to categorize the 
top 5% of the reference-group (95th percentile scores, P95) as ‘abnormal’ because the lowest 
2.5% (functioning ‘abnormally’ good) cannot be identified in general population samples; the 
studied anxiety questionnaires merely assess the level of dysfunctionality and not the level of 
‘health’ or normal functionality. Likewise, we regarded the bottom 5% of the patient-group 
(5th percentile scores, P5) as indistinguishable from people in the normal range. Furthermore, 
means and SDs were calculated. Reference values were calculated for all participants 
combined, as well as for men and women separately. To test our decision not to exclude those 
individuals in the ROM reference-group with a current psychiatric diagnosis, we performed 
a sensitivity analysis. The internal consistency of the questionnaires was evaluated using 
Cronbach’s alpha for the total scores and the subscores (with >0.70 indicating adequate 
internal consistency) [55]. For all analyses, SPSS version 20.0 was used (SPSS Inc, Chicago, 
Illinois).
RESULTS
Sociodemographic and psychopathological characteristics
The sociodemographic and psychopathological characteristics of the ROM reference-group 
and patient-group are shown in Table 5.2. 
 Participants in the ROM reference-group and the ROM patient-group were 
comparable with respect to mean age and similar with respect to gender distribution. For the 
ROM reference-group the mean age was 40.3 years (SD=12.6), for the ROM patient-group 
it was 36.5 years (SD=11.9). Females constituted 62.8% of the reference-group and 64.4% 
of the patient-group. Those in the ROM reference-group were more often married relative to 
those in the ROM patient-group and they were less often living alone. Those in the ROM 
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reference-group were more often married relative to those in the ROM patient-group and they 
were less often living alone. Those in the ROM reference-group also showed higher levels of 
education relative to those in the ROM patient-group. Furthermore, work-related disability 
and unemployment were less prevalent in the ROM reference-group. Fewer participants in 
the ROM reference-group were of ethnic origin (defined as oneself not being born in the 
Netherlands or both parents not being born in the Netherlands). Of the ROM reference-group 
9.3% had at least one anxiety disorder and 5.2% met criteria for a psychiatric disorder in 
addition to an anxiety disorder as diagnosed with the MINI-Plus. There was a high rate of 
psychopathological co-morbidity (i.e., psychopathology in addition to psychopathological 
anxiety) among participants in the ROM patient-group (55.6%). 
REFERENCE VALUES
Percentile scores
Table 5.3 presents the reference values of the eight anxiety questionnaires for the ROM 
reference-group and the ROM patient-group. For the ROM reference-group, the distribution 
of each total score and sub score was positively skewed. Mental health was also demonstrated 
for the ROM reference-group by the substantial percentage of participants (5-25%) having 
the lowest possible scores (e.g., 5% for the BSA, PAI, SPS, and 25% for the IES-R).
Analyses of gender indicated that both healthy and women with anxiety disorders showed 
more symptoms of anxiety relative to the men, both in the ROM reference- and ROM patient-
groups (see Supplementary Tables 1 through 6).
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 Table 5.2.:  Sociodemographic and psychiatric characteristics of the ROM reference (n=1295) patient (n=5066) 
groups.
                                                         ROM reference group       ROM patient group
                                                        (n= 1295)                            (n=4627)
Gender: - n (%)
   Male 482 (37.2) 1806 (35.7)
   Female 813 (62.8) 3260 (64.4)
Age  in years: - mean (± SD) 40.3 (12.6) 36.5 (11.9)
   Male 41.2 (12.6) 37.8 (11.9)
   Female 39.7 (12.6) 35.8 (11.8)
Marital status¹: - n (%)
   Married/cohabitating 890 (68.7) 2206 (43.5)
   Divorced/separated/widow 78 (6.0) 539 (10.6)
   Single 327 (25.3) 1744 (34.4)
Housing situation¹: - n (%)
   Living alone 201 (15.5) 982 (19.4)
   Living with partner 902 (69.7) 2259 (44.6)
   Living with family 192 (14.8) 1248 (24.6)
Educational status1,3: - n (%)
   Lower 295 (22.8) 1867 (36.9)
   Higher 1000 (77.2) 2619 (51.7)
Employment status¹: - n (%)
   Employed part-time 509 (39.3) 1033 (20.4)
   Employed full-time 554 (42.8) 986 (19.5)
   Unemployed/retired 197 (15.2) 1298 (25.6)
   Work-related disability 35 (2.7) 1172 (23.1)
Ethnic background¹: - n (%)
   Dutch 1150 (88.8) 3505 (69.2)
   Other ethnicity 145 (11.2) 982 (19.4)
MINI diagnoses: - n (%)
   Currently None 1174 (90.7) 0²
   Anxiety disorder (single) 54 (4.2) 2246 (44.3)
   Anxiety disorder (comorbidity) 18 (1.4) 2820 (55.6)
   Other psychiatric disorder 49 (3.8) 0²
SD denotes standard deviation
¹ Data not available for 128 (2.4%) to 640 (11.8%) of patients
² Selection criterion
³ Lower education: primary or vocational school: Higher education: college or university
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 In a sensitivity analysis, we excluded the 9.7% of participants in the ROM reference-
group who had a MINI-diagnosis. Among the remaining 1161 participants we found that 
the median of the changes of the mean scores of the eight anxiety questionnaires was –8% 
(interquartile range: –5% to –13%). The median of the changes of the P95 scores was –9% 
(interquartile range: –7% to –12%).
 To facilitate comparability with the international literature, we also provided means 
and SDs in Table 5.3. However, we consider these reference values as less valid given that the 
distributions of all (sub) scores were positively skewed in the ROM reference-group (Figure 
1).
Receiver operating characteristic (ROC) curves
Cut-off values, defined by equal sensitivity and specificity, were calculated with ROC 
analyses (see Table 5.4). The discriminative power of the eight anxiety questionnaires is 
depicted in Figure 5.1.
 ROC analyses, used to discriminate between health and disease, yielded the 
following cut-off values: 8.5 for the BSA total score, 30,5 for the PI-R total score, 23.5 for the 
PAI Anticipated Panic subscale score, 21.5 for the total of the PAI Perceived Consequences, 
and 43.5 for the PAI Perceived Self-efficacy subscale. The cut-off values were as follows: 
55.5 for the PSWQ, 55.5 for the WDQ total scale, 24.5 for the SIAS, 14 for the SPS, and 
27.5 for the IES-R total scale. AUC values indicated very high discriminatory power for the 
BSA, the SIAS, the SPS, and the IES-R. Two subscales, PI-R Washing and WDQ Financial, 
showed clinically useful discriminatory power. All other (sub) scales proved to have moderate 
discriminatory power. Sensitivity and specificity exceeded 85% for most (sub) scales; for 
PI-R subscales and WDQ subscales sensitivity and specificity were somewhat lower.
Internal consistency
The internal consistencies of the total scales and subscales of the questionnaires (for all 
subjects combined) are shown in Table 5.4. The total scales and subscales of all seven self-
rating questionnaires showed excellent internal consistencies, with the exception of WDQ 
subscale Work Incompetence which possessed adequate internal consistency. The internal 
consistency of the BSA was also adequate.
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Reference values for anxiety questionnaires 131
Figure 5.1: Distribution of the scores of the Brief Scale for Anxiety (BSA), PADUA Inventory Revised (PI-R), Panic 
Appraisal Inventory (PAI) subscale Panic Consequences, Penn State Worry Questionnaire (PSWQ), Worry Domains 
Questionnaire (WDQ), Social Interaction and Anxiety Scale (SIAS), Social Phobia Scale (SPS), and Impact of Event 
Scale-Revised (IES-R). Three types of cut-off values are depicted: the 75th percentile score (P75), the 95th percentile 
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DISCUSSION AND CONCLUSION
We reported reference values for a broad range of anxiety questionnaires in two large samples 
from ‘healthy’ and ‘psychiatrically ill’ populations. P95 values of the ROM reference-group, 
cut-off values based on ROC analysis, and P5 values of the ROM patient-group yielded 
closely related values. P95 values of the ROM reference-group were the highest, ROC values 
were slightly lower, and P5 values of the ROM patient-group were the lowest. A pervasive 
gender-specific pattern in reference values was observed, with higher reference values in 
women than in men in the ROM reference-group. 
 The mean PI-R score for our ROM reference-group (M=16.5; SD=13.3) was lower 
than the mean PI-R scores reported previously, ranging from 21.6 [21] to 37.7 [20]. The mean 
PSWQ score for the ROM reference-group (M=39.5; SD=13.2) was comparable to the mean 
PSWQ scores reported by other researchers, ranging from 34.9 to 49.5 [23-28,56], suggesting 
that our reference-group showed normal levels of pathological worry. The mean WDQ score 
for the ROM reference-group (M=43.7; SD=13.6) was slightly higher compared to the mean 
WDQ scores reported in the literature, where it ranged from 24.8 to 38.1 [26-28,30]. This 
could be explained by only a few participants in our reference-group that showed a high 
level of non-pathological worry, within the positively skewed distribution. For the ROM 
reference-group the mean SIAS score (M=12.5; SD=9.3) was slightly lower than the mean 
SIAS scores reported in other studies, ranging from 14.3 to 19.9 [22,31,32]. The mean SPS 
score for the ROM reference-group (M=6.0; SD=6.6) was slightly lower than the mean SPS 
scores reported in literature, ranging from 6.3 to 14.4 [22,31,32]. For the ROM reference-
group the mean IES-R score (M=8.0; SD=12.0) was much lower than the mean IES-R score 
reported by Creamer et al. (M=40.0; SD=23.1) [33]. In sum, the mean scores for our ROM 
reference-group tended to be lower than the mean scores reported by other researchers, 
suggesting that our reference-group was relatively healthy. It should however be taken into 
account that the highly skewed distributions precluded a valid comparison of mean values. 
For the ROM reference-group the mean scores for the PI-R, the PSWQ, and the IES-R were 
well below the clinical thresholds as used by other researchers [21,23,33]. This indicated 
no or only mild anxiety, similar to the previous results. The conducted sensitivity analyses 
showed slightly lower cut-off values for the reference-group with individuals with a current 
psychiatric diagnosis excluded. However, these individuals were chosen to be included, 
in order to prevent producing too strict cut-off values. This would lead to fewer patients 
considered recovered when P95 cut-off scores are used. The high internal consistencies of 
the PI-R, PAI, PSWQ, WDQ, SIAS, SPS, and IES-R are in accordance with previous studies 
[25,26,32,36,39,44]. 
 There were some notable differences among the previously published and the 
present reference values. Health perceptions and health problem expressions vary between 
cultures [57]. Furthermore, there are differences in study design (e.g., mode of questionnaire 
administration) [58-60], socio-economic status [58,61], physical functionality [61], health
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status varying with area of residence [59], or clinical severity [58,61]. Furthermore, 
different language versions of the same questionnaire have to measure the same underlying 
construct where all aspects of this construct (e.g., domain, operational mode, semantics, and 
psychometric properties) should be similar [60,62]. Two versions of the same questionnaire 
can be equally sensitive to a given change in functional status yet assign different scores to 
a given level of distress [61]. Therefore, our reference values should be used with caution 
in different settings. Further research should evaluate cross-country variability of reference 
values.
 It is noteworthy that a consistent pattern was observed in the 75th and 95th percentile 
scores of the ROM reference-group, the ROC cut-off values, and the 5th percentile scores 
of the patient-group. That is, they overlapped considerably, with P95 of the ROM reference-
group being slightly highest, followed by the ROC cut-off values. The 5th percentile scores 
of the ROM patient-group had similar values compared to the 75th percentile scores of the 
ROM reference-group. These values were lower than the 95th percentile scores and ROC 
cut-off values. This pattern is very similar to the pattern we observed for ROM generic 
questionnaires [48]. In contrast, for the ROM mood questionnaires the 5th percentile of the 
ROM patient-group had similar values compared to the 95th percentile of the ROM reference-
group [63]. This suggests that there is relatively more subsyndromal anxiety as compared to 
subsyndromal depression in the ROM reference-group. Mild anxiety may be considered a 
normal human experience. The ROC cut-off values were rather consistent with the cut-off 
values derived by other researchers for the PSWQ (55.5 versus 52.3 [23] and for the IES-R 
(27.5 versus 33 [33]. 
 Furthermore, on average, men from the ROM reference-group scored lower on all 
eight anxiety scales than did the women from the ROM reference-group. Respectively, for 
men and women, cut-off (P95) values were 10 and 12 for the BSA, 38 and 44 for the PI-R, 
27 and 39 for the PAI Anticipated Panic, 27 and 52 for the PAI Perceived Consequences, 
71 and 62 for the PAI Perceived Self-efficacy, 61 and 70 for the PSWQ, 61 and 77 for the 
WDQ, 27 and 34 for the SIAS, 14 and 22 for the SPS, and 29 and 38 for IES-R. It may be 
too early to recommend gender-specific reference values because more research is needed in 
reference populations. Nevertheless, it was striking that reference values from a non-anxious 
population showed a clinically important gender effect. Most previous studies did not stratify 
for gender, but those which did [25,26,31,32,43] reported higher means for women than for 
men, similar to our results.
 The results of our study have several clinical implications. The excellent performance 
of the questionnaires suggests that our reference values are appropriate for various objectives: 
1) decisions about treatment termination and referral back to primary care (using the P95 of 
the ROM reference-group); 2) identification of people who may benefit from referral by 
primary care to specialized mental health care (using the P5 of the ROM Patient-group), 
and even 3) diagnostics (using the ROC cut-off values). Regarding diagnostics, these cut-
off values might aid in screening for various anxiety disorders, although clinical judgment 
    Chapter 5134
and validated diagnostic tools remain the gold standard (e.g., MINI [49,50], Composite 
International Diagnostic Interview [CIDI; [64]], the Structured Clinical Interview for DSM-
III-R [SCID, [65]]). Moreover, cut-off values may be used to classify anxiety. When making 
decisions about treatment termination or referral to primary care, specificity has to be high 
[66]. The 75th percentile scores of the ROM reference-group result in few false positives for 
‘health’. For referral from primary care to specialized mental health care, cut-off values with 
a high sensitivity are more appropriate, and for that purpose we recommend ROC-based 
cut-offs or 5th percentile scores from the ROM patient-group because they result in few false 
positives for ‘disease’.
 The present study has several strengths. The assessment procedures for both groups 
were standardized and of high quality (ascertained by training and supervision). Furthermore, 
the ROM reference-group was large, it was clearly defined, and it resembled the patient-
group in all relevant respects (age, gender, level of urbanization) other than those under 
investigation (i.e., level of psychopathology). The rather precise estimates arising out of the 
current study are probably attributable to the large sample size. Additionally, the reference-
group probably represents the general population quite well. GP registers were used to recruit 
the reference-group and in the Netherlands the GP registration rate is very high. The ROM 
patient-group was large as well. Finally, stratification of the ROM reference-group into more 
homogeneous gender-subgroups may have reduced variation among subgroups, leading to 
gender-specific reference values, which can be used in clinical practice. 
 A limitation of the present study includes the relatively high non-response rate in 
the ROM reference-group, which may have introduced potential selection bias. Additionally, 
the generalizability of this study is limited by the nature of our ROM reference-group in that 
it included Dutch-speaking people aged between 18 and 65 years. Reference values may not 
automatically be applicable to other ethnic groups, to children, and to the elderly. Finally, 
it is important to recognize that population-based reference values should not be applied 
rigidly. The choice of cut-off values remains arbitrary and dependent on one’s goal (e.g., for 
confirmation of a diagnosis, specificity should be high and the 95th percentile would be more 
appropriate than the 75th percentile of the ROM reference-group).  
 In conclusion, this large-scale population-based study provides reference values and 
reliability coefficients for the BSA, PI-R, PAI, PSWQ, WDQ, SIAS, SPS, and IES-R. These 
values increase the utility of these questionnaires, inasmuch as they can be employed as 
ROM questionnaires to facilitate the assessment of severity of anxiety disorder symptoms. 
To make responsible decisions about continuing, changing, or terminating therapy, any of 
these questionnaires can be offered to every patient with MAS disorders. Additionally, these 
reference values are suitable for indicating which patients have recovered enough to be 
referred back from specialized mental health care to primary care.
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Supplementary Table 5.4: Percentile scores and mean values in the ROM reference (n=630) 
and patient (n=1392) groups for the subscales and total score of the Panic Appraisal Inventory 
(PAI).
 Supplementary Table 5.5: Percentile scores and mean values in the ROM reference 
(n=651/649) and patient (n=893/887) groups for the subscales and total score of the Penn 
State Worry Questionnaire (PSWQ) and the Worry Domains Questionnaire (WDQ).
Supplementary Table 5.6: Percentile scores and mean values in the ROM reference (n=651) 
and patient (n=1231/1237) groups for the subscales and total score of the Social Interaction 
and Anxiety Scale (SIAS) and the Social Phobia Scale (SPS) and.
Supplementary Table 5.7: Percentile scores and mean values in the ROM reference 
(n=1272) and patient (n=390) groups for the subscales and total score of the Impact of Events 
Scale (IES-R).
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Supplementary Table 5.1: Sociodemographic and psychiatric characteristics of the ROM reference 
(n=1295) patient and (n=5066) groups.
*Data not available for 128 (2.4%) to 640 (11.8%) of patients
** Lower education: primary or vocational school;  Higher education: college or university
***Selection criterion
ROM reference group 
(n=1295)
ROM patient group (n=5066)
females males females males
Gender - n (%) 813 (62.8) 482 (37.2) 3260 (64.6) 1806 (35.7)
Age in years: mean (± SD) 39.7 (12.6) 41.2 (12.6) 35.8 (11.8) 37.8 (11.9)
Marital status¹ - n (%)
  Married/cohabitating 552 (67.9) 338 (70.1) 1455 (44.6) 751 (41.6)
 Divorced/separated/widow 59 (7.3) 19 (3.9) 401 (12.3) 138 (7.6)
  Single 202 (24.8) 125 (25.9) 1047 (32.1) 697 (38.6)
Housing situation¹ - n (%)
  Living alone 132 (16.2) 69 (14.3) 547 (16.8) 435 (24.1)
Living with partner 560 (68.9) 342 (71.0) 1492 (45.8) 767 (42.5)
  Living with family 121 (14.9) 71 (14.7) 864 (26.5) 384 (21.3)
Educational status1,3- n (%)
  Lower 189 (23.2) 106 (22.0) 1226 (37.6) 641 (35.5)
  Higher 624 (76.8) 376 (78.0) 1676 (51.4) 943 (52.2)
Employment status¹:- n (%)
  Employed part-time 428 (52.6) 81 (16.8) 854 (26.2) 179 (9.9)
  Employed full-time 222 (27.3) 332 (68.9) 402 (12.3) 584 (32.3)
  Unemployed/retired 140 (17.2) 57 (11.8) 909 (27.9) 389 (21.5)
  Work-related disability 23 (2.8) 12 (2.5) 738 (22.6) 434 (24.0)
Ethnic background¹: - n(%)
  Dutch 710 (87.3) 440 (91.3) 2259 (69.3) 1246 (69.0)
  Other ethnicity 103 (12.7) 42 (8.7) 642 (19.7) 340 (18.8)
MINI diagnoses: - n (%)
  Currently None 723 (88.9) 451 (93.6) 0*** 0***
  Anxiety disorder (single) 42 (5.2) 12 (2.5) 1446 (44.4) 800 (44.3)
  Anxiety disorder 
(comorbidity)
15 (1.8) 3 (0.6) 1814 (55.6) 1006 (55.7)
 Other psychiatric disorder 
(without anxiety)
32 (3.9) 16 (3.3) 0*** 0***
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ABSTRACT
Background: 
The Body Image Concern Inventory (BICI), the Whitely Index (WI), and the Checklist 
Individual Strength (CIS-20R) are three questionnaires often incorporated in Routine 
Outcome Monitoring (ROM). Respectively, they assess symptom severity in patients with 
body dysmorphic disorder (BDD), hypochondriasis, and chronic fatigue syndrome (CFS). We 
aimed to generate reference values for a healthy population (ROM reference-group) and for a 
population of patients fulfilling diagnostic criteria for at least one of BDD, hypochondriasis, 
and CFS (ROM patient-group).
Methods: In the ROM reference-group we included 648 subjects recruited through 
general practitioners. These subjects were matched for age and sex with 823 psychiatric 
outpatients in the ROM patient-group. To define limits (i.e., cut-off-values) for one-sided 
reference intervals (5th percentile [P5] for ROM patient-group and 95th percentile [P95] for 
ROM reference-group) the outermost 5% of observations were used. Receiver Operating 
Characteristics (ROC) analyses were used to yield additional cut-off-values.
Results: Cut-off-values (P95 ROM reference-group) were 55 for the BICI, 6 for the WI, 
and 92 for the CIS-20R. These values differed for men and women, being mostly higher 
for women. P5 ROM patient-group assessments and ROC analyses yielded slightly lower 
reference values. The discriminative power of all three somatoform questionnaires was very 
high.
Conclusions: For the BICI, WI, and CIS-20R a comprehensive set of reference values 
was obtained. The reference values  may facilitate responsible clinical decision-making 
with respect to adjusting or terminating therapy, and with respect to referring patients from 
specialized mental health care to primary care and vice versa.
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INTRODUCTION
Somatoform disorders are a group of psychiatric disorders in which the patient experiences 
physical symptoms that are inconsistent with, or cannot be fully explained by, any underlying 
general medical or neurological condition. The Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR) includes the following specific somatoform disorders: Somatization 
Disorder, Undifferentiated Somatoform Disorder, Conversion Disorder, Pain Disorder, 
Hypochondriasis, and Body Dysmorphic Disorder (BDD) [1]. Patients with these disorders 
tend to frequently consult general practitioners (GPs) or medical specialists rather than mental 
healthcare specialists [2]. In the Netherlands, however, such patients do find their way to 
specialized mental health care due to the availability of evidenced-based and patient-tailored 
treatment options. Relevant are the use of the maintenance model during intake and special 
outpatient clinics within the medical setting. Evidenced-based treatments are available for 
somatization disorder, some of the undifferentiated somatoform disorders (e.g., chronic 
fatigue syndrome (CFS) [3] and irritable bowel syndrome [4,5]), some of the pain disorders 
(e.g., low back pain [6] and fibromyalgia [7]), BDD [8,9], and hypochondriasis [10-13].
 Routine Outcome Monitoring (ROM) is a system of routine psychometric 
assessments at baseline (i.e., pre-treatment) and at regular intervals to monitor patients’ 
progress during treatment. DSM-IV-TR Axis I diagnoses are established using the Mini-
International Neuropsychiatric Interview-Plus (MINI-Plus) [14]. Together with generic 
questionnaires, which are completed by all patients, disorder-specific questionnaires are 
administered to patients who meet the MINI-Plus criteria for a particular disorder [15,16]. 
These disorder-specific questionnaires assess the severity of symptoms, in order to facilitate 
the evaluation of treatment effect and clinical decisions about treatment termination. When 
symptom severity is equivalent to levels found in the general population, second-line 
treatment can be terminated and referral back to primary care may be indicated. 
 ROM instruments used to assess symptom severity for a specific disorder need to 
have good psychometric properties. Preferably, they are also widely used both in research 
and clinical settings. The availability of the questionnaires in the public domain is also 
required, given that they are offered to large numbers of patients on numerous occasions. 
Questionnaires, which fulfill these criteria, are available for the assessment of BDD, 
hypochondriasis, and CFS. Respectively, the questionnaires are the Body Image Concern 
Inventory (BICI) [17], the Whitely Index (WI) [18], and the Checklist Individual Strength 
(CIS-20R) [19]. 
 Reliable ratings from reference populations are required if the ROM results are used 
for clinical decisions about continuing, altering or terminating treatment [20]. In the present 
study reference values were established for the BICI, the WI, and the CIS-20R. This set of 
questionnaires is particularly relevant because it is not easy to ascertain the severity of BDD, 
CFS and hypochondriasis, and BDD is not easily diagnosed. Some descriptive statistics 
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(means and standard deviations [SDs]) have been published for healthy controls (see Table 
6.1) [17-19,21-23], but we are not aware of studies reporting clinically useful reference 
values for these scales when administered in the general population. Additionally, we studied 
a possible gender effect in the reference values.
METHODS
Participants
The reference values were based on two study samples, namely: 1) the ROM reference-group, 
a sample from the general population; and 2) the ROM patient-group, a sample of psychiatric 
outpatients diagnosed with BDD (n=130), hypochondriasis (n=226), or CFS (n=481). The 
ROM patient-group included participants (n=14) with two or more somatoform disorders.
 The ROM reference-group is the reference group included in the ‘Leiden Routine 
Outcome Monitoring Study’ [16]. Participants in the ‘Leiden Routine Outcome Monitoring 
Study’ were randomly selected from the registration systems of eight GPs in the Leiden 
region, with the aim of recruiting a representative general population sample1. Sufficient 
mastery of the Dutch language and the ability to complete computerized and written 
questionnaires were required. The response rate was 37.1%, as described previously [16,25]. 
In all, 1295 participants were included in the ‘Leiden Routine Outcome Monitoring Study’ 
[16,16,25,26]. Because of time and financial constraints, 50% of these participants (n=648) 
were administered the somatoform questionnaires [16]. This group was aged 18 to 65 years 
(M=40.0 years; SD=12.6) and 62.5% were females. Given that the aim of this study was to 
generate reference values that can be used to guide decision-making about the continuation 
or termination of therapy, we excluded those who received treatment for psychiatric disorders 
and/or were dependent on alcohol or drugs during the six months prior to assessment. The 
reference-group was matched for gender and age to the ROM patient-group, to ensure it was 
demographically comparable.
 The ROM patient-group of the ‘Leiden Routine Outcome Monitoring Study’ 
consisted of a baseline sample of 7840 psychiatric outpatients. This constituted approximately 
80% of the total number of referred patients with a tentative diagnosis of mood-, anxiety- and/
or somatoform disorder [27]. Inclusion criteria were the diagnosis of at least one somatoform 
disorder, according to the MINI-Plus, and an age between 18 and 65 years. A sub-sample 
of 823 patients fulfilled the criteria (mean age=38.6, SD=11.7), of whom 70.5% were 
females. Depending on their MINI-Plus diagnosis, patients completed the BICI (n=130), the 
WI (n=226), or the CIS-20R (n=481). They were treated in the Leiden University Medical 
Center (LUMC) Department of Psychiatry or the Rivierduinen mental health care centres. At 
baseline, scores represented the severity of symptoms prior to the first treatment session.
1In the Netherlands, 99,9% of the general population is registered with a GP [24].
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Procedures 
Procedures for the web-based ROM program of the LUMC Department of Psychiatry and 
mental health care centre Rivierduinen are described in detail elsewhere [15]. In short, the 
baseline ROM assessments comprised a standardized diagnostic interview (Dutch version of 
the Mini-International Neuropsychiatric Interview Plus, version 5.00-R: MINI-Plus) [14,28], 
the collection of sociodemographic data, and the administration of generic and disorder-
specific instruments for mood, anxiety, and somatoform disorders. The MINI-Plus was 
used to establish the presence of Axis I symptoms according to the DSM-IV-TR. Disorder-
specific self-rating questionnaires were selected on the basis of the MINI-Plus. Participants 
in the reference-group were assessed in a similar way to those in the patient-group, except 
that those in the ROM reference-group completed all three questionnaires whereas the 
participants of the ROM patient-group only completed those questionnaires relevant to their 
diagnosed disorder(s). The assessments were performed by specially trained and regularly 
(i.e., monthly) supervised research nurses in the outpatient clinics. 
 The general study protocol associated with ROM, in which ROM is administered 
as part of the routine treatment process for patients, was approved by the Medical Ethical 
Committee of the LUMC. This comprehensive protocol (titled “Psychiatric Academic 
Registration Leiden Database”) safeguards the anonymity of patients and reference-group 
participants and ensures proper handling of the ROM data. If patients object to the use of 
their outcome data for scientific purposes, the data are removed. Participants of the ROM 
reference-group signed informed consent for the purpose of this study.
 
Questionnaires 
 Body Image Concern Inventory (BICI)
The BICI measures concerns about appearance [17]. The 19 self-report items are answered 
on a 5-point Likert scale (1=’never’, 5=’always’) and the total score ranges between 19 and 
95. Two factors have been identified. Factor 1 (12 items) relates to dissatisfaction and shame 
regarding one’s appearance. Factor 2 (7 items) relates to interference with functioning due to 
appearance concerns. Because the two factors are highly correlated, Littleton and colleagues 
[17] suggested using a single total score. A cut-off-value of 72 has been recommended, such 
that scores above 72 are regarded as clinical concerning. The time frame for the reported 
symptoms is the past week. The BICI can be used to assess symptom severity. Previous 
studies have not yielded percentile scores. Means and standard deviations (SDs) for healthy 
control groups were previously determined, ranging from 42.8 (SD=15.0) to 50.4 (SD=14.2) 
[17,21,22]. For a BDD patient-group a mean of 80.1 (SD=9.0) was reported [17]. Reliability, 
validity, and internal consistency (Cronbach’s alpha’s [Cα] range from 0.91-0.94) of the 
English-language version are good [17,21,22], as is the Cα (0.93) for the Dutch version [29].
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 Whitely Index (WI)
The WI is a self-report questionnaire that assesses the severity of symptoms of 
hypochondriasis [18]. Scores for the 14 dichotomous items are summed to yield a total score 
(range 0-14). The WI is unifactorial [30]. The time frame for the symptoms is the past week. 
Previous studies have not assessed percentile scores but they have reported means and SDs 
for healthy control groups, which ranged from 1.7 (SD=2.4) to 3.0 (SD=2.5) [18,23]. For 
hypochondriacal patients the mean scores ranged from 7.6 (SD=3.0) to 8.9 (SD=5.2) [18,23]. 
Internal consistency ranged from 0.76-0.80), stability, concurrent and discriminative validity 
are adequate [30].
 Checklist Individual Strength (CIS-20R)
The CIS-20R was designed to measure the severity of symptoms typical of CFS [19]. Each 
item is scored on a 7-point Likert scale (1 = ‘yes, that is true’; 7 = ‘no, that is not true’). The 
total score is the sum of all items (range 20-140). The four subscales are Subjective Fatigue 
(8 items), Concentration (5 items), Motivation (4 items), and Physical Activity (3 items). 
The time frame for the reported symptoms is the past two weeks. The recommended clinical 
cut-off-value for the CIS-20R is 35 [19]. No percentile scores have been reported yet. Means 
and SDs for healthy controls and CVA-patient related controls were 41.5 (SD=19.8) and 
50.9 (SD=26.6), respectively [19]. Internal consistencies for the CIS-20R total scale and 
subscales are very good (0.90 for the total scale; from 0.83 to 0.92 for the subscales) [19,31] 
and  psychometric properties (i.e., reliability and validity) are excellent [19].
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Table 6.1: Somatoform questionnaires used in Routine Outcome Monitoring
BICI denotes Body Image Concern Inventory; CIS-20R denotes Checklist Individual Strength; WI denotes 
Whitely Index.
* Patients diagnosed with Body Dysmorphic Disorder (BDD)
+ Patients diagnosed with Hypochondriasis
‡ Patients diagnosed with Chronic Fatigue Syndrome (CFS)
Table 6.1 presents the sample sizes, disorder domains, subscales, ratings, and score ranges for 
each questionnaire, together with the reference values reported in previous studies.
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Statistical analyses
Descriptive statistics were derived for the sociodemographic variables and the psychiatric 
variables, including means and SDs for the continuous variables, and percentages for the 
categorical variables.
 The internal consistency of the questionnaires was determined using Cronbach’s 
alpha (with >0.70 indicating adequate internal consistency).
The 5th, 25th, 50th, 75th, and 95th percentiles were calculated. They were calculated for the 
entire ROM reference-group and for the sub-set of the ROM patient-group that completed 
the BICI, WI, or CIS-20R. Furthermore, percentiles were calculated separately for men 
and women. To facilitate comparability with the international literature, we also calculated 
means and SDs, although these reference values are less useful in skewed reference-group 
distributions [34]. Receiver Operating Characteristics (ROC) analyses were used to derive 
a cut-off-value for each instrument, indicating a neutral discrimination threshold between 
‘healthy’ and ‘diseased’. Sensitivity and specificity were chosen to be equal. In this way, 
an acceptable compromise was reached between as few false positives as possible, and as 
few false negatives as possible. The discriminatory power of the questionnaire total scales 
and subscales was assessed using the associated areas under the ROC curve (AUCs), where 
AUC values above 0.75 were considered clinically useful, with 0.85 showing moderate 
discriminatory power, and 0.95 showing very high power [35]. To assess the effects on 
the reference values of individuals in the ROM reference-group with a current psychiatric 
diagnosis, we performed a sensitivity analysis in the group while excluding participants with 
any psychiatric diagnosis.
 When reference values are calculated and interpreted, attention needs to be paid 
to sensitivity and specificity, the definition of health, and required sample sizes. Firstly, in 
the assessment of cut-off-values, sensitivity (i.e., the proportion of actual positives which 
are correctly identified as such) and specificity (i.e., the proportion of negatives which 
are correctly identified) play a key role. The 95th percentile (P95) of the reference-group is 
recommended as a cut-off-value when considering referral back from secondary to primary 
care. The specificity to assess health is relatively high. The 5th percentile (P5) of the patient-
group is recommended as a cut-off-value when considering referral from primary to secondary 
care. In this case, the sensitivity to assess disease is relatively high. The 5th percentile (P5) 
of the ROM reference-group is generally lower than the 95th percentile (P95) of the patient-
group. Secondly, it is preferable that reference values [36] are established in healthy (normal) 
populations [34] with normality defined statistically rather than as a medical (ab)normality. 
This statistical definition of normality is based on the distribution of scores from the general 
population (including all individuals) [37]. Finally, (sub)sample sizes of at least 120 are 
needed to reduce the amount of uncertainty and error caused by potential outliers [38,39]. 
For all analyses, SPSS version 20.0 was used (SPSS Inc, Chicago, Illinois).
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RESULTS
Sociodemographic and psychiatric characteristics 
The sociodemographic and psychiatric characteristics of the ROM reference-group and 
patient-group are shown in Table 6.2. Characteristics per gender are given in Supplementary 
Table 6.1.
 The ROM reference-group and patient-group were rather well matched for age 
(M=40.0 years [SD=12.6] and M= 38.6 years [SD=11.8], respectively) and gender distribution 
(62.5% females and 70.5% females, respectively). Participants from the ROM reference-
group were more often married than those from the ROM patient-group (70.5% versus 
47.6%) and less often living alone (13.4% versus 16.8%), had higher levels of education 
(78.7% higher education versus 50.9%), had less work-related disability and unemployment 
(17.9% versus 52.2%), and were less often from non-Dutch ethnic origin (defined as oneself 
or both parents not being born in the Netherlands). In the ROM reference-group 5.0% had at 
least one somatoform disorder according to the MINI-Plus, compared to 100% of the subjects 
from the ROM patient-group (inclusion criterion). In the ROM reference-group 0.5% fulfilled 
criteria for BDD, 0.6% for Hypochondriasis, and 2.0% for Undifferentiated Somatoform 
Disorder. In the patient-group 15.8% fulfilled criteria for BDD, 27.5% for Hypochondriasis, 
58.5% for Undifferentiated Somatoform Disorder (of whom 21.9% CFS), and 1.0% for 
Somatization Disorder. Comorbid BDD and CFS was seen in 0.7% of the patients, 2.9% had 
hypochondriasis and CFS, and no patients had BDD and hypochondriasis or three diagnoses. 
In the ROM patient-group, a high proportion of subjects (53.6%) had a co-morbid mood or 
anxiety disorder.
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Table 6.2: Sociodemographic and psychiatric characteristics of the ROM reference (n=648) and patient 
(n=823) groups.
                                                         ROM reference group       ROM patient group
                                                        (n= 1295)                            (n=4627)
Gender: - n (%)
   Male 243 (37.5) 243 (29.5)
   Female 405 (62.5) 580 (70.5)
Age  in years: - mean (± SD) 40.0 (12.6) 38.6 (11.7)
   Male 40.8 (12.6) 38.0 (12.2)
   Female 39.6 (12.6) 38.9 (11.5)
Marital status¹: - n (%)
   Married/cohabitating 457 (70.5) 392 (47.6)
   Divorced/seperated/widow 34 (5.2) 96 (11.7)
   No data available 119 (14.5)
Housing situation¹: - n (%)
   Living alone 87 (13.4) 138 (16.8)
   Living with partner 462 (71.3) 403 (49.0)
   Living with family 99 (15.3) 163 (19.8)
   No data available 119 (14.5)
Educational status1,3: - n (%)
   Lower 138 (21.3) 285 (34.6)
   Higher 510 (78.7) 419 (50.9)
   No data available 119 (14.5)
Employment status¹: - n (%)
   Employed part-time 256 (39.5) 157 (19.1)
   Employed full-time 276 (42.6) 117 (14.2)
   Unemployed/retired 101 (15.6) 200 (24.3)
   Work-related disability 15 (2.3) 230 (27.9)
   No data available 14 (1.7)
Ethnic background¹: - n (%)
   Dutch 569 (87.8) 590 (71.6)
   Other ethnicity 79 (12.2) 114 (13.9)
   No data available 119 (14.5)
MINI diagnoses: - n (%)
   Currently None 590 (91.0) 02
   Somatoform disorder (single) 25 (3.9) 382 (46.4)
   Somatoform disorder (comorbidity) 7 (1.1) 441 (53.6)
   Other than somatoform disorder 26 (4.0) 02
¹ Data not available for 14 (1.7%) to 119 (14.5%) of patients
² Selection criterion
³ Lower education: primary or vocational school; Higher education: college or university
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Reference values and internal consistencies
Table 6.3 presents the internal consistencies (Cronbach’s alpha Cα) and results of the ROC 
analyses of the BICI, WI, and CIS-20R (sub-) scales for both the ROM reference-group and 
the patient-group. Table 6.4 presents the percentile scores and mean scores. Results of gender 
analyses are presented in Supplementary Tables 6.2 through 6.4.
 For the ROM reference-group, the distributions of total scores and subscale scores 
were strongly positively skewed (Figure 6.1). Apparent health was also demonstrated by the 
substantial percentage of participants rating the lowest possible scores. 
Table 6.3: Internal consistency and cut-off-values in the ROM reference (n=648) and patient (n=823) 
groups for Routine Outcome Monitoring somatoform disorder questionnaires.
BICI denotes Body Image Concern Inventory; CIS-20R denotes Checklist Individual Strength; WI 
denotes Whitely Index.
 *The optimal cut-off derived by the ROC analysis is defined by equal sensitivity and 
specificity
 Body Image Concern Inventory (BICI)
The internal consistency of the BICI was excellent (Cα=0.96).
For the ROM reference-group, the P95 cut-off-value was 55 for the BICI: this is the 
recommended cut-off-value for the referral of patients in specialized mental health care back 
to primary care. The P5 value for the ROM patient-group was 39, which is the recommended 
cut-off-value when  primary care patients should be referred to specialized mental health 
care. Stratified analyses according to gender indicated that, on average, healthy women 
reported more symptoms than men in relation to the BICI. reference values were also higher 
for women relative to men. ROC analyses yielded a BICI cut-off-value of 49.5. The AUC 
value indicated very high discriminatory power for the BICI. The discriminative power of the
Nr of items Cron-
bach’s 
Alpha










BICI 19 0.96 645 130 49.5 0.96 0.90 / 0.90
WI 14 0.90 644 226 5.5 0.98 0.95 / 0.93
CIS-20R 643 481
   Checking 8 0.97 42.5 0.96 0.92 / 0.92
   Rumination 5 0.93 17.5 0.89 0.83 / 0.83
   Precision 4 0.84 10.5 0.85 0.79 / 0.76
   Total 3 0.90 9.5 0.89 0.81 / 0.82
20 0.97 81.5 0.97 0.92 / 0.92
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BICI is depicted in Figure 1.
 Whitely Index (WI)
The internal consistency of the WI was excellent (Cα=0.90).
For the ROM reference-group, the WI total score showed a P95 value of 6, which is the 
recommended cut-off-value for referral back to primary care of patients in specialized mental 
health care. The P5 value for the ROM patient-group was 5. Again, the P95 and mean values 
were higher among healthy women than among healthy men. ROC analyses yielded a WI 
cut-off-value of 5.5. The AUC value indicated very high discriminatory power for the WI. 
The discriminative power of the WI is depicted in Figure 6.1.
 Checklist Individual Strength (CIS-20R)
The CIS-20R showed excellent internal consistency (Cα= 0.97).
For the CIS-20R total score, the P95 cut-off-value for the ROM reference-group was 92. 
The cut-off-values for the subscales were as follows: 46 for Subjective Fatigue, 26 for 
Concentration, 20 for Motivation, and 15 for Activity. The P5 value for the ROM patient-
group was 74 for the total score. The P5 values for the subscales were 38 for Subjective 
Fatigue, 6 for Concentration, 4 for Motivation, and 3 for Activity. Once again, stratified 
analyses according to gender indicated that, on average, healthy women reported more 
symptoms than did healthy men. However, for the CIS-20R subscale Activity, no gender 
difference was found. ROC analyses yielded a CIS-20R cut-off-value of 81.5. AUC values 
indicated very high discriminatory power for the CIS-20R total scale and moderate to very 
high discriminatory power for the subscales. The discriminative power of the CIS-20R total 
score is depicted in Figure 6.1.
 
 In a sensitivity analysis, all 58 (9%) participants with any MINI-diagnosis were 
excluded from the ROM reference-group. Among the remaining 590 participants we found 
that the median of the changes of the mean scores of the three somatoform questionnaires 
decreased by 5% (interquartile range -4 to -5%). The median of the changes of the P95 
scores decreased by 7% (interquartile range -4 to -8%). Thus, the inclusion of (non-healthy) 
participants with symptoms led to slightly higher reference values relative to reference values 
for a ‘supernormal’ (i.e., overly healthy) reference-group. 
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Figure 6.1: Distribution of the scores of the Body Image Concern Inventory (BICI), the Checklist 
Individual Strength (CIS-20R), and the Whitely Index (WI). Three types of cut-off-values are depicted: 
the 75th percentile score (P75), the 95th percentile score (P95) and the Receiver Operating Characteristics 
(ROC) cut-off-value defined by equal sensitivity and specificity.
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DISCUSSION AND CONCLUSION
The aim of this study was to determine reference values for the BICI, WI, and CIS-20R based 
on data from a large sample of ‘healthy’ participants (defined as not being in specialized 
mental health care treatment for a psychiatric disorder) and a large ‘psychiatrically ill’ 
population. Two clinically relevant types of cut-off-values were generated: the 95th percentile 
of the ROM reference-group and the 5th percentile of the ROM patient-group. We also derived 
an additional set of percentile scores and ROC-based cut-off-values for both the ROM 
reference-group and the patient-group. A gender-specific pattern in reference values was 
observed for the total scores of all three questionnaires, but not for the CIS-20R subscales. 
We therefore consider gender-specific reference values to be of clinical relevance for these 
somatoform questionnaires. 
 The prevalence rate of any somatoform disorder in the ROM reference-group (5.0%) 
was comparable to the 4-week prevalence rate (7.5%) in the German general population [40]. 
As could be expected, the point prevalence rate of BDD in the ROM reference-group (0.5%) 
was slightly lower than the previously reported 1-year prevalence rates ranging from 0.7 to 
2.4 [41-44]. Similarly, the point prevalence rate of hypochondriasis in the ROM reference-
group (0.6%) was slightly lower than a previously reported 1-year prevalence rate (4.5%) 
[41]. The prevalence rate for undifferentiated somatoform disorder in our reference-group 
was 2.0%, compared with 13.0% in the Dutch treatment-seeking population of De Waal [45]. 
Our GP population was not necessarily a consulting (i.e., treatment seeking) population. 
Rather, it was selected from the GP-registration system. The fact that people tend to visit 
their GP when they have complaints, and that many of these complaints can be classified 
as undifferentiated somatoform disorder, might explain the large difference in prevalence 
rate in both studies. Furthermore, it is indeed possible that the MINI-Plus under diagnosed 
somatoform and other disorders.
 The internal consistency of the BICI (0.96) is in accordance with previous studies 
[17,21,22,29]. The cut-off-values reported in this study (50, P95 reference-group; 49.5, ROC 
based cut-off-value; 39, P5 patient-group) are substantially lower than the BICI cut-off-value 
of 72 reported by Littleton and colleagues [17]. This may be explained by Littleton’s use of 
a sample of college students (80% females), where body image concerns appear to be more 
common [46]. Moreover, they were younger than our reference-group and patient-group and 
younger people have more body image concerns than older people [47]. The mean BICI 
score for our ROM reference-group (34) was similar to the mean BICI scores reported by 
Littleton and colleagues (32 to 43) [21], and lower than the means reported in other studies, 
ranging from 43 [22] to 50 [17]. This suggests that our reference-group was relatively 
healthy. However, consideration should be given to the fact that the comparison of mean 
values of variables with skewed distributions may reflect the strong impact of a few outliers. 
The internal consistency (α=0.90) of the WI is in accordance with a previous study [23]. The 
different types of cut-off-values reported in the current study (6, P95 reference-group; 5.5, 
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ROC based cut-off-value; 5, P5 patient-group) were very similar. To our knowledge, no cut-
off-values have previously been reported. The mean WI score of 2.2 for the ROM reference-
group was comparable to the mean WI scores reported by Pilowsky (i.e., 1.7 for normal 
controls) [18]. The mean WI score of 9.8 for our patient-group (10) was very similar to the 
mean of 8.0 reported by Speckens and colleagues [23] and the mean of 8.5 as reported by 
Pilowsky [18].
 The internal consistency (α=0.97) of the CIS-20R is in accordance with previous 
studies [19,31]. Vercoulen and colleagues [19] reported decile scores. The P50 value for our 
ROM reference-group of 38 is very close to Vercoulen’s P50 values of 35 for healthy controls 
and 42 for controls who are related to somatic (CVA) patients. The mean CIS-20R total score 
was 46 for the ROM reference-group. The mean Subjective Fatigue score was 20, well below 
the cut-off of 35 for this subscale [19]. By contrast, the somatoform patient-group had a mean 
total score of 112 and a mean Subjective Fatigue score of 52. This latter score is well above 
the cut-off of 35, indicating psychopathology, as was expected.
 Gender-effects were analyzed. For the BICI percentile scores were lower for men 
than for women: e.g., cut-off (P95) values were 45 for men and 57 for women. Luca and 
colleagues (2011;[22]) found a similar gender effect in their healthy Italian sample [22]. WI 
data showed that for the ROM reference-group, P95 cut-off-values were 5 for men and 7 for 
women. However, most reference values were equal or close to equal for men and women, 
both in the reference-group and the patient-group. Pilowski and colleagues (1967;[18]) did 
not test gender-effects in their healthy sample, but they also reported slightly less symptoms 
for male non-psychiatric cancer patients compared to their female counterparts [18]. A Dutch 
study reported no gender differences [30]. Regarding the CIS-20R, ROM reference-group P95 
cut-off-values for the total score were 89 for men and 97 for women. However, no general 
gender effect was observed for the subscales. In the ROM reference-group, men reported 
slightly lower Subjective Fatigue than women, but there was no significant gender-effect for 
the Concentration, Motivation, and Activation subscales. The developers of the questionnaire 
found no significant gender-effect [19]. So, at this moment there is not enough evidence to 
recommend gender specific reference values for the BICI, the WI, nor the CIS-20R.
 The excellent (illness-health) differentiating performance of the BICI, WI, and 
CIS-20R implies that the reference values can be used by clinicians in specialized mental 
health care to test whether their patient has recovered. Also, the reference values can be used 
by clinicians in primary care to assess whether referral to specialized mental health care is 
warranted. Regarding the first point about making decisions about treatment termination, 
specificity for the assessment of health has to be high. (This contrasts with the normal concept 
of specificity, which is generally used when ascertaining disorders or dysfunction.) If a 
treated patient in specialized mental health care displays symptom severity that is equivalent 
to levels found in the general population, termination of treatment is warranted and referral 
back to primary care is indicated. The remaining (subsyndromal) symptoms generally do not 
require specialized treatment anymore. 
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require specialized treatment anymore. The clinical threshold would be the 95th percentile 
score (P95) of the reference population (i.e., this results in few false positives). Regarding 
the second point, referral from primary care to specialized mental health care requires high 
sensitivity for ascertaining somatoform disorders. The GP has to decide whether the symptoms 
are so severe that they are equivalent to levels found in the psychiatrically ill population. So, 
the 5th percentile score (P5) of the patient population would be the clinical threshold. Severity 
measures for the BDD, hypochondriasis, and CFS are particularly relevant because these 
disorders are common but are often unrecognized [48-50]. 
 The present study has several merits. Firstly, the ROM reference-group consisted 
of individuals without any psychopathological symptoms as well as individuals with 
psychopathology symptoms who were not receiving treatment in specialized mental health 
care. In this way, a non-realistic ‘supernormal’ (i.e., too healthy) reference-group [38] was 
avoided. This criterion is relevant when the reference values are used to make decisions 
about the continuation or termination of treatment. It is not necessary that the patient is 
symptom free; treatment can also be terminated if symptoms have reached a level for which 
no more specialized care is needed. Secondly, the size of the ROM reference-group sample 
was large (more than 600 cases). Moreover, the reference-group was clearly defined and 
it resembled the patient-group in relevant respects (age, gender, level of urbanization). 
Therefore, our reference values had rather good precision. Thirdly, the ROM reference-group 
likely represents the general population quite well, because of the very high GP registration 
rate in the Netherlands. Finally, the assessment procedures for both groups were standardized 
and of high quality (achieved by training and supervision).
 The results should be interpreted in the light of some limitations. Firstly, of the 
persons (non-consulting GP patients) approached, 63.2% did not want to participate in the 
study [16]. This large non-response might be due to the extensiveness of the interview. The 
total time involved was 3 hours which were unpaid. The non-response rate implies potential 
selection bias, which may have resulted in slightly different (higher or lower) percentile and 
cut-off-values. Secondly, the patient samples completing the BICI and WI were relatively 
small in size compared to the reference-group, but they were nevertheless larger than 120. 
Thirdly, given that our ROM reference-group was aged between 18 and 65 years, Dutch, and 
taken from a sample of Leiden area GP’s, reference values may not necessarily be applicable 
to children, the elderly, or other ethnic or cultural groups. Fourthly, some demographic data 
were not collected for about 15% of the ROM patient-group. Finally, only a selection of 
questionnaires was studied, and thus not every somatoform disorder was investigated. 
 In conclusion, this large-scale population-based study provides reference values for 
the BICI, WI, and CIS-20R. This helps improve their usability as ROM questionnaires to 
differentiate between clinically relevant conditions and normal conditions. These reference 
values facilitate clinical decisions regarding the continuation, adjustment, or termination 
of treatment. Additionally, the values allow for the identification of patients in specialized 
mental health care that have recovered enough in order to be referred back to primary care. 
Finally, the reference values allow also for the identification of primary care patients that may 
benefit from specialized mental health care.  
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ABSTRACT
Self-report measures of psychological distress or psychopathology are widely used and can 
be easily implemented as psychiatric screening tools. Positive psychological constructs such 
as vitality/optimism and work functioning have scarcely been incorporated. We aimed to 
develop and validate a psychological distress instrument, including measures of vitality and 
work functioning. A patient sample with suspected depressive, anxiety, and somatoform 
disorders (N=242) and a reference sample of the general population (N=516) filled in the 48-
item Symptom Questionnaire (SQ-48) plus a battery of observer-rated and self-report scales 
(MINI Plus, MADR, BAS, INH, BSI), using a web-based ROM program. The resulting 
SQ-48 is multidimensional and includes the following nine subscales: Depression (MOOD, 
six items), Anxiety (ANXI, six items), Somatization (SOMA, seven items), Agoraphobia 
(AGOR, four items), Aggression (AGGR, four items), Cognitive problems (COGN, five 
items), Social Phobia (SOPH, five items), Work functioning (WORK, five items), and Vitality 
(VITA, six items). The results showed good internal consistency as well as good convergent 
and divergent validity. The SQ-48 is meant to be available in the public domain for Routine 
Outcome Monitoring (ROM) and can be used as a screening/monitoring tool in clinical 
settings (psychiatric and non-psychiatric), as a benchmark tool, or for research purposes. 
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INTRODUCTION
The measurement of self-reported psychological distress is prominently represented in 
both the psychological and psychiatric literature. Historically, assessment of the general 
psychological status of individuals by means of self-report dates back to the First World War, 
and the development of the so called Personal Data Sheet by Woodworth [1]. Woodworth’s 
scale provided a means for each man to “interview himself” and created a historical benchmark 
for a new modality of psychological measurement [2]. Nowadays, self-report measures of 
psychological distress or psychopathology are widely used as psychiatric screening tool in 
clinical settings and epidemiological studies.
 Many validated self-report questionnaires for measuring psychological distress or 
psychopathology have been developed [3-6]. For instance, Symptom Checklist-90 [7] and 
its short-form Brief Symptom Inventory [2,8]; General Health Questionnaire [9]; 50-Item 
Brief Symptom Rating Scale [10]; Talbieh Brief Distress Inventory [11]; Mood and Anxiety 
Symptoms Questionnaire [12,13] and its short-form MASQ-D30 [14].
Studies concerning the above-mentioned instruments often used multiple related concepts 
interchangeably: concepts such as psychological distress, emotional distress, affective 
distress, mental distress, global distress, symptom distress, psychiatric distress, general 
psychopathology. Notably, however, these instruments have been useful for assessing the 
aggregate level of nonspecific psychological distress, and not for diagnosing particular 
psychiatric disorders [3,5,15]. Elevated scores on the scales are an indicator of possible 
psychopathology and could assist the clinician to predict the probability of individuals 
meeting criteria for disorder [3,16,17].
 More specifically, “psychological distress” can be described as a reaction of an 
individual to external and internal stresses, characterized by a mixture of psychological 
symptoms, such as sadness, anxiety, confused thinking, hopelessness, helplessness, dread, and 
poor self-esteem [6]. In addition, some instruments, such as the BSI, include somatic distress. 
Psychological distress was originally considered as a uni-dimensional construct. However, 
more recent research suggested a multidimensional structure of psychological distress. For 
instance, Schwannauer and Chetwynd [18] found a three-factor model of depression, anxiety, 
and general psychological distress. 
 The assessment of psychological distress is important both in health care and mental 
health care, because of its relevance for compliance, quality of life, prediction of treatment 
outcome, and planning of treatment [6,19-21]. Research has shown that pervasive distress 
may affect the course of illness, symptom expression, as well as levels of social relationships 
and adaptation [6,22-24]. 
relationships and adaptation [6,22-24]. 
 More recently, there is a growing awareness that, in addition to distress-based 
measures, attention must also be paid to more positive constructs such as vitality/optimism
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[25,26] and work functioning [27,28]. The importance of both constructs has already been 
demonstrated. For instance, Burdick et al. [27] showed that poor work functioning was 
significantly related to subsyndromal depression and course of illness. Emotional vitality, 
on the other hand, seems to be a critical positive psychological factor (related to but separate 
from optimism) that may promote psychological health as well as physical health [25,29-31]. 
In addition, (lack of) vitality/optimism has been shown to be an important defining feature of 
depression, with distinct implications for prognosis [32].
 To date, there is no psychological distress instrument available that also measures 
vitality and work functioning. Another shortcoming is that most self-report instruments are 
usually not free of charge, which particularly in Routine Outcome Monitoring (ROM) with 
repeated assessment is a costly matter. In line with these shortcomings, the purpose of this 
study was to develop and validate a brief psychological distress instrument (SQ - 48), which 
also includes measures of vitality and work functioning (or study). In addition, the SQ-48 is 
developed as a public domain questionnaire, freely available to clinicians and researchers. 
This practical advantage is in line with growing efforts in other scientific areas to develop 
instruments that are free of charge [33]. 
 The SQ-48 is meant as a screening tool to improve diagnostic recognition in clinical 
and nonclinical settings. Therefore, the present study used both clinical and nonclinical 
samples: a patient sample with suspected depressive, anxiety, and somatoform disorders, 
and a reference sample of the general population. In this way, the SQ-48 could be useful 
as a monitoring tool in the context of ROM [4,33,34], for benchmark purposes (Hermann 
et al., 2006; Minami et al., 2008; Cleary et al., 2010), or as a research tool in for instance 
epidemiological studies.
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METHODS
The present study was conducted with patients and non-patients, and consisted of two phases: 
(1) instrument development of the SQ-48 and (2) its psychometric evaluation.
Participants and procedures
The total sample among which the SQ-48 was developed and evaluated consisted of 
participants from two large studies: a Routine Outcome Monitoring (ROM) sample of 
psychiatric outpatients and a ROM reference sample of the general population.  
The Medical Research Ethics Committee at the Leiden University Medical Centre (LUMC) 
approved the general study protocol and documents presented to participants in both phases. 
A comprehensive protocol safeguards anonymity of ROM-participants and ensures proper 
handling of the data. This protocol (Psychiatric Academic Registration Leiden database) is 
available on request for participants, and informed consent is not required for patients. Non-
patients provided written and informed consent.
 For details about the web-based ROM programme of the LUMC, Department 
of Psychiatry, we refer to some relevant publications [26,34-36]; see also www.lumc.nl/
psychiatry/ROM-instruments).
The ROM patient-group 
A total of 242 psychiatric outpatients was included (61.2% females; mean age=38.8 years; 
SD=14.0), referred with suspected (not necessarily diagnosed) mood, anxiety or somatoform 
disorders to the LUMC Department of Psychiatry or to Rivierduinen specialized mental 
healthcare centres. Data were collected during a 2-3 h ROM baseline assessment in the LUMC 
or at the home of the participant. The assessment consisted of a face-to-face psychiatric 
interview by a trained psychiatric research nurse and the administration of observer-rated and 
self-report questionnaires, including the SQ-48. 
The ROM reference-group
A total of 516 participants (67.2% females; mean age=38.8 years; SD=12.8) was included in 
the reference-group, as part of the ‘Leiden Routine Outcome Monitoring Study’ [36,37]. These 
participants were randomly selected from the registration systems of general practitioners 
(GPs) in the Leiden region, in order to recruit a representative general population sample 
(all Dutchmen are registered with a GP). Because the group was aimed to be used as a 
healthy reference-group, participants that received treatment for psychiatric problems and/
or dependence on alcohol or drugs within six months prior to the assessment were excluded. 
The inclusion for the ROM reference-group was stratified for gender (62.6% women), 
age (mean 40.2 years; SD 12.5) and urbanization-level (62.3% urban), to make the group 
demographically comparable to the ROM patient-group. The participants in the reference-
group completed the same assessments as the patient-group.
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Instruments
Development of the SQ-48
The SQ-48 was developed to include separate subscales concerning several psychopathological 
domains matching diagnostic categories in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR; [38].  Three main goals were set to achieve during the SQ-48 item-
writing and item-selection procedure. First, the items should be easy and unequivocal to 
understand for everyone, irrespective of level-of-education. Second, the instrument should 
include measures of functioning which can judge the actual impact of psychiatric problems 
on daily life. Third, the instrument should cover (lack of) vitality/optimism.
The initial item development followed commonly accepted methods for the creation of 
patient-reported instruments [39-44]. The questionnaire was drafted by a multidisciplinary 
team of psychologists and psychiatrics through a comprehensive review of existing screening 
tools, relevant literature, as well as psychiatric diagnostic criteria for mood, anxiety, and 
somatoform disorders on the basis of the DSM-IV. 
 Existing screening tools reviewed in this context were for instance: MASQ (-D30); 
Dimensional Assessment of Personality Pathology-Short Form [45]; BSI; Short-Form 36 
[46]; Outcome Questionnaire 45 [47,48]; Fear Questionnaire [48]; Aggression Questionnaire 
[49]; Mental Vitality Scale [50]; Work Home and Leisure Activities Scale [51]; MIRECC 
Version of the Global Assessment of Functioning Scale [52]; Physical Symptom Checklist 
[53]; Life Orientation Test-revised concerning optimism [54].
 The SQ-48 development was based on consensus within the aforementioned 
multidisciplinary team. It was decided to create a questionnaire covering nine domains or 
categories: depression, anxiety, somatization, cognitive problems, social phobia, agoraphobia, 
aggression, work (or study) functioning, and vitality/optimism. Except work functioning and 
vitality, these general domains cover the most common psychopathological symptoms. So, 
items were arranged in subscales according to this organization and chosen from a large 
pool of items. Each item was evaluated to determine whether it was formulated in the 
simplest way and whether it was unambiguous in its meaning. If there was any disagreement 
about this within the team, the item was not included. Additional care was taken to prevent 
redundancy within subscales and to prevent overlap between subscales, to increase the 
potential discriminant ability of the subscales. The experimental version of the questionnaire 
was pre-tested in a reduced sample (n=30) of participants in the ROM programme. The aim 
of the pre-test was to evaluate the practicality and acceptability by collecting comments of 
participants, clinicians, investigators, in order to better formulate the items. 
 The final version of the questionnaire included 48 items based on re-evaluation. Re-
evaluation consisted of an Exploratory Factor Analysis with oblique Promax-rotation in both 
non-reduced samples, to check for items with ambiguous factor loads (loads on more than 
one factor). On the whole, the following seven items were removed because the factor loads 
indicated poor fit: “I felt confused” (factor load 0.18); “I had the feeling as if something
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terrible was going to happen” (factor load 0.21); “I could not relax in the company of others” 
(factor load 0.03); “I have threatened people I know” (factor load 0.38); “I was incited by 
people” (factor load 0.24); “I couldn’t enjoy my free time” (factor load 0.01); “In the morning 
I was full of energy” (factor load 0.61). 
The final version of the SQ-48
The nine subscales of the SQ-48 corresponded with the abovementioned domains of interest. 
Five subscales covered aspects of psychopathology: Depression (“MOOD” subscale: items 
3, 7, 13, 19, 38, 40), Anxiety, (“ANXI” subscale: items 24, 28, 33, 41, 46, 48), Somatization 
(“SOMA” subscale: items 1, 5, 11, 17, 22, 26, 31), and Agoraphobia (“AGOR” subscale: 
items 4, 8, 14, 25). In addition, four subscales were constructed to assess specific aspects 
of behaviour and/or functioning: Aggression (“AGGR” subscale: items 10, 16, 21, 43), 
Cognitive problems (“COGN” subscale: items 2, 6, 39, 44, 47), Social Phobia (“SOPH” 
subscale: items 23, 27, 32, 36, 45), Work (“WORK” subscale: items 9, 15, 20, 30, 35), and 
Vitality/Optimism (“VITA” subscale: items 12, 18, 29, 34, 37, 42). Each item is rated by the 
respondent on a 5-points Likert-scale (0: ‘Never’, 1: ‘Rarely’, 2 ‘Sometimes’, 3: ‘Often’, 4: 
‘Very often’). Mean administration time was 5.4 minutes (S.D.=1.4).  
 Respondents received the following instruction in the SQ-48: “Try to answer the 
following statements honestly and accurately. Please indicate what applies best to you. There 
are no ‘right’ or ‘wrong’ answers. Give the answer that best expresses how often you have 
felt that way in the last week, including today. The answer which comes to your mind first, is 
often the best answer. Note: If you did not work or study or have not been able to do so, then 
you can skip questions 9, 15, 20, 30 and 35”.
The scoring of the SQ-48 items is as follows. For the score of all subscales, the scores of the 
relevant items must be added. The 48 items are scored 0-4. 
 For the purpose of this article, the Dutch SQ-48 was translated into English, 
according to guidelines for translation and cultural adaptation of questionnaires [55-57]. 
Both English and Dutch SQ-48 are available as Supplementary material associated with this 
article, and can be found in the online version.
Other measures
In both groups, the same battery of other measures was administered. The presence of DSM-
IV diagnoses was determined by a trained psychiatric research nurse by means of the Mini-
International Neuropsychiatric Interview (version: MINI Plus; [58]. General psychopathology 
was assessed with two generic measures. The first was an observational instrument, the 
CPRS-SF (Comprehensive Psychopathological Rating Scale-Short Form) consisting of: 
the Montgomery–Ǻsberg Depression Rating Scale (MADRS; [59], the Brief Anxiety Scale 
(BAS; [60], and a scale assessing psychomotor inhibition (INH; [61,62]. The second generic 
instrument, the BSI, is a self-report instrument that assesses psychopathological symptoms 
in several domains such as depressive -, anxiety-, somatic symptoms, and hostility [2,63].
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Statistical analyses
Analyses were performed in both the patient and reference samples and in the combined 
datasets. In both samples, data were prepared: missing values were substituted by the mean 
item-response per subject per subscale. Subjects who had more than three missing values for 
the total sum score (or more than one per subscale) were excluded.
 To evaluate the construct validity, Confirmatory Factor Analysis (CFA) was 
used on the non-reduced samples (N=516 patient sample, N=242 reference sample). The 
appropriateness of a 9-factor model (the SQ-48 subscale structure) was evaluated and 
compared with a 1-factor model. In the input model, all items were set to load freely on their 
hypothesized factor, except for one item per factor, which had its loading set to 1 in order to 
fix the scale of the model. Because the items were categorical and non-normally distributed, 
fit-estimations were based on robust maximum likelihood [64], using polychoric correlation 
matrices [65]. Fit-indices instead of a traditional χ2-test were used to assess fit, because the 
χ2-test is oversensitive to misfit when testing complex models [66]. The used fit-indices 
were the Comparative Fit Index (CFI) and the Root Mean Square Error of Approximation 
(RMSEA). A CFI of at least 0.90 indicates adequate fit, and an RMSEA that is smaller than 
0.08 indicates acceptable fit. The CFA was conducted with EQS 6.1 [65].
 To investigate internal consistency, Cronbach’s alphas were calculated for the 
subscales and the total scale. To investigate the extent of differentiation between the subscales, 
Spearman’s (ρ) correlation coefficients were computed for intercorrelations of the SQ-48 
subscales. To evaluate convergent/divergent validity, correlations (Spearman’s ρ) between 
the subscale scores and other instruments (see paragraph 2.2.3) were calculated. ROC 
(Receiver Operating Characteristic) analysis provided a cut-off score indicating an optimal 
discrimination threshold between “healthy” and “diseased”. Sensitivity and specificity were 
chosen to be equal, taking into account the trade-off between the two. AUC’s (Area Under 
Curves) were calculated to indicate the predictive capacities of the instrument subscales. 
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RESULTS
Sociodemographic and clinical characteristics of the samples 
The sociodemographic characteristics of the two research groups are shown in Table 7.1.
Table 7.1: Sociodemographic and clinical characteristics of the samples
 Both groups were similar with regards to most sociodemographic variables. As 
expected – because of the sampling procedure – the mean age and gender distribution were 
comparable between the reference- and patient-groups. Educational status was also roughly 
similar; the reference-group had 75.6% higher education compared to 69.8% of the patient-
group education. However, the groups also differed on some aspects. In the patient-group, 
participants were less often married and more often unemployment or with work-related 






Female gender (%) 347 (67.2%) 149 (61.6%) 0.13
Age (yr), mean (SD) 38.8 (12.7) 37.9 (12.9) 0.38
Marital status¹: - n (%)
   Married/cohabitating 355 (68.4%) 115 (47.5%) <0.001
   Divorced/seperated/widow 23 (4.5%) 29 (12.0%)
   Single 140 (27.1%) 98 (40.5)
Housing situation¹: - n (%)
   Living alone 79 (15.3%) 77 (31.8%) 0.02
   Living with partner 357 (69.2%) 115 (47.5%)
   Living with family 80 (15.5%) 50 (20.7%)
Educational status, n (%)
   Lower 126 (24.4%) 73 (30.1%) 0.07
   Higher 390 (75.6%) 149 (69.8%)
Employment status, n (%)
   Employed part-time 218 (42.2%) 54 (22.3%) <0.001
   Employed full-time 199 (38.6%) 53 (21.9%)
   Unemployed/retired 84 (16.3%) 76 (31.4%)
   Work-related disability 15 (2.9%) 59 (24.4%)
Ethnic background, n (%)
   Dutch 467 (90.5%) 198 (81.8%) 0.07
   Other ethnicity 49 (9.5%) 44 (18.2%)
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Table 7.2: Clinical characteristics according to group.
BSI denotes the short-form Brief Symptom Inventory, BAS denotes Brief Anxiety Scale, INH denotes 
the scale assessing psychomotor inhibition, and MADRS denotes Montgomery-Ǻsberg Depression 
Rating Scale. SQ-48 subscales: MOOD denotes Depression, ANXI denotes Anxiety, SOMA denotes 
Somatization, AGOR denotes Agoraphobia, AGGR denotes Aggression, COGN denotes Cognitive 
problems, SOPH denotes Social Phobia, WORK denotes Work functioning, and VITA denotes Vitality.
Because of adjustments made to the final version of instructions to the WORK subscale, insufficient data 









Psychiatric scales, mean (SD)
   MADRS 0-6 3.0 (4.0) 18.5 (9.1) <0.001
   INH 0-6 0.62 (1.5) 3.4 (3.0) <0.001
   BSI 0-4 0.2 (0.3) 1.2 (0.7) <0.001
   BAS 0-6 4.4 (4.2) 13.9 (6.2) <0.001
SQ-48 scores, mean (SD)
   MOOD 0-24 2.1 (2.5) 11.3 (6.3) <0.001
   ANXI 0-24 3.8 (3.9) 12.1 (5.8) <0.001
   SOMA 0-28 1.7 (3.1) 6.3 (6.2) <0.001
   AGOR 0-16 0.4 (1.1) 2.8 (3.6) <0.001
   AGGR 0-16 1.2 (1.7) 3.7 (3.4) <0.001
   COGN 0-20 4.1 (3.4) 11.3 (4.6) <0.001
   SOPH 0-20 2.4 (3.0) 8.1 (5.1) <0.001
   WORK – – – <0.001
   VITA 0-24 15.8 (4.6) 9.2 (4.9) <0.001
MINI-Diagnoses, n (%)
   Depressive disorder 1 (0.2%) 64 (26.4%) <0.001
   Anxiety disorders 35 (6.8%) 31 (12.8%) <0.001
   Comorbid depression &           
Anxiety
6 (1.2%) 66 (27.3%) <0.001
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 The clinical characteristics of the two groups are shown in Table 7.2. 
As expected, the scores on all psychopathology ratings were much higher in the patient-
group than in the reference-group. Specifically, the mean total SQ-48 score in the patient-
group (73.0) was twice as high compared to the reference-group (36.6). The majority of the 
patient-group met criteria for depression and anxiety disorder (27.3%) versus a neglectable 
few in the reference-group (1.2 %).
Confirmatory Factor Analyses
CFA was conducted to test the fit of a 9-factor structure to the SQ-48 data. The hypothesized 
model fitted well with the data in both the reference-group (CFI=0.96; RMSEA=0.05) and the 
patient-group (CFI=0.97; RMSEA=0.06). In addition, the fit of a simple 1-factor model was 
worse in both samples (reference group: CFI=0.88; RMSEA=0.08; patient group: CFI=0.88; 
RMSEA=0.13). 
Scale intercorrelations
The Spearman rho’s intercorrelations of the SQ-48 subscales are shown in Table 7.3.
The correlations ranged from 0.38 to 0.81, with the highest correlations between MOOD 
and ANXI (ρ=0.81), MOOD and COGN (ρ=0.78), COGN and ANXI (ρ=0.76), and between 
ANXI and SOPH (ρ=0.73). The lowest correlations were found between VITA and AGGR 
(ρ=0.38), and between AGOR and AGGR (ρ=0.39).
Table 7.3: Correlations between the subscales of the SQ-48 in all 758 subjects.
Data are Spearman’s (rho) correlation coefficients. All P-values <0.001.
SQ-48 subscales: MOOD denotes Depression, ANXI denotes Anxiety, SOMA denotes Somatization, 
AGOR denotes Agoraphobia, AGGR denotes Aggression, COGN denotes Cognitive problems, SOPH 
denotes Social Phobia, WORK denotes Work functioning, and VITA denotes Vitality.
Because of adjustments made to the final version of instructions to the WORK subscale, insufficient 
data were available as yet.
MOOD ANXI SOMA COGN SOPH AGOR AGGR
ANXI 0.81
SOMA 0.52 0.59
COGN 0.78 0.76 0.55
SOPH 0.69 0.73 0.47 0.72
AGOR 0.51 0.57 0.50 0.49 0.56
AGGR 0.60 0.60 0.44 0.56 0.54 0.39
VITA –0.66 –0.57 –0.43 –0.60 –0.54 –0.45 –0.38
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Internal consistency
The internal consistency coefficients of the SQ-48 subscales were as follows. In general, the 
Cronbach’s alpha coefficients ranged from 0.78 to 0.98 across the different SQ-48 subscales: 
0.97 (Total); 0.93 (MOOD); 0.92 (ANXI); 0.89 (SOMA); 0.89 (COGN); 0.91 (SOPH), 0.84 
(AGOR); 0.78 (AGGR); 0.90 (VITA); 0.78 (WORK). So, none of the subscales had alphas 
below the critical cut-off of 0.70, indicating overall adequate to high internal consistency.
Convergent/divergent validity
Correlations between the SQ-48 subscales and other instruments are shown in Table 7.4. 
Table 7.4: Correlations between the subscales of the SQ-48 in all 758 subjects.
Data are Spearman’s (rho) correlations coefficients are presented. All P-values <0.05.
BSI denotes the short-form Brief Symptom Inventory, BAS denotes Brief Anxiety Scale, INH denotes the 
scale assessing psychomotor inhibition, and MADRS denotes Montgomery-Ǻsberg Depression Rating 
Scale. MOOD denotes Depression, ANXI denotes Anxiety, SOMA denotes Somatization, AGOR denotes 
Agoraphobia, AGGR denotes Aggression, COGN denotes Cognitive problems, SOPH denotes Social 
Phobia, VITA denotes Vitality. Because of adjustments made to the final version of instructions to the 
WORK subscale, insufficient data were available as yet.
In line with its coverage of depression-related symptomatology, the MADRS was most 
strongly correlated with the MOOD subscale (ρ=0.77), the ANXI and COGN subscales 
(ρ=0.73), and the VITA subscale (ρ=0.64). In line with its anxiety-related symptomatology, 
the BAS was most strongly correlated with the ANXI subscale (0.72), the MOOD subscale 
(ρ=0.69) and the COGN subscale (ρ=0.64). The INH scale was most strongly correlated with 
the MOOD subscale (ρ=0.61) and VITA subscale (ρ=0.56), in line with its presumed role in 
both depression and its counterpart vitality. The BSI was moderately to strongly correlated 
with all subscales, indicating that all subscales are associated with overall psychopathology 
severity. 
Scale MADRS INH BAS BSI
MOOD 0.77 0.61 0.69 0.82
ANXI 0.73 0.52 0.72 0.84
SOMA 0.51 0.35 0.53 0.59
AGOR 0.47 0.42 0.50 0.58
AGGR 0.47 0.32 0.50 0.60
COGN 0.73 0.54 0.64 0.82
SOPH 0.60 0.49 0.57 0.77
VITA –0.64 –0.56 –0.59 –0.66
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Reference values
Finally, percentiles and mean values on the SQ-48 subscales in the ROM reference (n=516) 
- and patient (n=242) groups are shown in Table 7.5.
 Table 7.5 shows the following P95 cut-off values for the subscales, i.e., MOOD-
8.0; ANXI-11.2; SOMA-8.0; AGOR-2.0; AGGR-5.0; COGN-11.0; SOPH-9.0; and 
VITA-15.0. These cut-off points are more conservative (with higher specificity but lower 
sensitivity for MAS disorders) than ROC cut-off points (AUC). Table 5 also shows the cut-
off values with almost equal (optimal) sensitivity and specificity values, i.e., MOOD-4.0 
(0.91); ANXI-6.5 (0.88); SOMA-1.5 (0.74); AGOR-0.5 (0.75); AGGR-1.5 (0.74); COGN-
7.5 (0.89); SOPH-3.5 (0.83); and VITA-10.5 (0.87). Because of adjustments made to the 
final version of instructions to the WORK subscale, insufficient data were available as yet. 
These adjustments were related to the fact that many patients no longer worked or could 
no longer work. As a result, there were also no sufficient data available regarding the total 
scale of the SQ-48.
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DISCUSSION 
The primary purpose of this study was to construct a psychometrically sound self-report 
measure for psychopathology (depression, anxiety, somatization, agoraphobia, aggression, 
cognitive problems, social phobia), which also measures vitality and work functioning. The 
main advantages of the present study were the use of two samples of both patients and non-
patients, as well as the broad composition of a naturalistic outpatient population with mood, 
anxiety, and somatoform disorders. 
  The resulting SQ-48 is a multidimensional scale with good internal consistency 
and validity. Our results also indicated that – as intended – the two samples represent 
quite different populations, which makes them suitable to test the generalizability of the 
SQ-48 psychometric properties across different population strata. Also, the large range of 
correlations in both groups indicated that there is sufficient differentiation across the nine 
subscales. 
 Outcome assessment is essential in order to determine treatment effectiveness. 
Preferably, outcome assessment should be implemented as part of an outcomes evaluation 
programme [67].With the rapidly growing dissemination of computer-based assessment 
and feedback tools, the monitoring of psychotherapeutic processes and patients’ outcome 
is becoming feasible in routine clinical practice [33,68]. ROM, in the sense of continuous 
monitoring of patient progress, requires valid measures, which are sensitive to change but 
also allow inexpensive repeated assessment [4,33]. In this context, self-report questionnaires 
are a cost-effective option, because they are inexpensive in terms of professional time needed 
for administration.
 The clinical relevance of self-report measures has been demonstrated [6]. A major 
problem, however, is the fact that the licence policy of many self-report questionnaires is 
often restrictive. As a result, computerized assessments may not be possible due to copyright 
regulations. In addition, there can be serious economic obstacles to frequent assessments for 
the patient [33]. The SQ-48 is partly developed to overcome these problems, and can be used 
as a public domain questionnaire in both mental health care and general health care. As an 
example of the latter, Lee et al. [69] described the use of routine distress screening of newly 
admitted patients to an acute haematology and oncology ward. 
 Most scales of the SQ-48 measure psychopathology or psychological distress. 
Psychological distress also incorporates other nonspecific psychological manifestations, 
has stronger relations with common psychosocial factors, and tends to be milder and more 
transient than for instance depression [70]. A growing number of studies place specific 
emphasis on the need to expand the focus from only negative mental health (symptom- 
or distress-based outcome measures) to also positive mental health [67,71]. Examples of 
positive mental health outcome measures are work functioning, vitality, dispositional 
optimism. For this reason, the SQ-48 also assesses work functioning and vitality. Our results 
showed low correlations between work functioning and vitality, indicating a clear subscale 
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differentiation. For clinicians it may be helpful to focus on both reducing psychopathology 
and promoting positive emotions, skills, and engagement with life [29]. Further research in 
this area is worthwhile.
 The endorsing reliability and validity evidence as produced by this study justifies 
further research on the psychometric properties and utility of the SQ-48. In particular, future 
research can be pursued in the following five directions (see also [72]. First, cross-validation 
of the factor analytic solution in an independent sample would enhance confidence in the nine 
factor structure which was found. Second, it would be informative to compare the results of 
the SQ-48 to other relevant instruments like for instance the OQ-45, MASQ(-D30). A related 
research area concerns the possible association between psychological distress measured by 
the SQ-48 on the one hand and quality of life on the other hand [73]. Third, it would be 
useful to study the temporal stability of the SQ-48 in a community sample by means of test-
retest reliability at for instance one-month interval. Fourth, additional research could explore 
possible intergroup differences in levels of psychological distress as measured by the SQ-48. 
More specifically, research could focus on possible differences in psychological distress as 
a result of for example gender and age [5,74]. Fifth, further research could also determine 
whether the SQ-48 is useful in predicting treatment outcome.
 In summary, the SQ-48 provides a broad and comprehensive survey of psychological 
distress as well as vitality and work functioning. It has satisfactory psychometric properties 
and therefore can be used in clinical, research and service settings. Further testing of the 
utility and validity of the SQ-48 (Dutch and English version) is planned by our department 
of Psychiatry, including assessment of its use in other cultural settings, psychiatric inpatients, 
and other diagnostic categories such as personality disorders. Further research is also planned 
to determine whether the SQ-48 is suitable for measuring changes in symptoms during the 
course of treatment. Finally, additional data will be collected regarding the subscale WORK 
and the SQ-48 total scale.
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Supplementary Material 
 






Probeer de volgende stellingen eerlijk en accuraat te beantwoorden. Geef aan wat op u van 
toepassing is. Er zijn geen ‘goede’ of ‘foute’ antwoorden. U geeft het antwoord dat het beste 
uitdrukt hoe vaak u zich de afgelopen week, met vandaag erbij, zo hebt gevoeld. Wat het 
eerste in u opkomt, is vaak het beste . 
 
NB: Indien u niet werkt of studeert, of indien u dat de afgelopen week niet hebt kunnen doen, 
dan kunt u de volgende vragen overslaan: 9, 15, 20, 30 en 35. 
 
 

































1. Ik was kortademig zonder dat ik mij inspande 0   1   2    3   4 
2. Ik voelde mij vertraagd of langzaam 0   1   2    3   4 
3. Ik was ontevreden. 0   1   2    3   4 
4. Ik werd angstig in een menigte van mensen 0   1   2    3   4 
5. Ik had hartkloppingen. 0   1   2    3   4 
6. Ik had moeite met het nemen van beslissingen. 0   1   2    3   4 
7. Ik kon nergens van genieten. 0   1   2    3   4 
8. Ik durfde open ruimtes, zoals een plein, niet over te steken. 0   1   2    3   4 
9. Ik voelde stress op mijn werk of studie. 0   1   2    3   4 
10. Ik had onenigheid met anderen. 0   1   2    3   4 
11. Ik voelde pijn of druk op de borst. 0   1   2    3   4 
12. Ik zag naar dingen uit. 0   1   2    3   4 
13. Ik dacht aan mijn dood of zelfmoord. 0   1   2    3   4 
14. Ik durfde niet alleen met het openbaar vervoer te reizen. 0   1   2    3   4 
15. Mijn werk of studie gaf me geen voldoening. 0   1   2    3   4 
16. Ik was opvliegend zonder aanleiding. 0   1   2    3   4 
17. Ik voelde mij duizelig of licht in het hoofd. 0   1   2    3   4 
18. Ik had zin om dingen te doen. 0   1   2    3   4 
19. Ik had geen zin in het leven. 0   1   2    3   4 
20. Ik had het gevoel dat ik teveel werkte of studeerde. 0   1   2    3   4 
21. Ik had moeite om mijn woede te beheersen. 0   1   2    3   4 
22. Ik voelde tintelingen, bijvoorbeeld in mijn handen. 0   1   2    3   4 
23. Ik kon moeilijk voor mijn mening uitkomen. 0   1   2    3   4 
24. Ik was bang of angstig. 0   1   2    3   4 
25. Ik durfde niet alleen naar een drukke winkel te gaan.. 0   1   2    3   4 
26. Ik trilde of beefde. 0   1   2    3   4 
27. Ik was bang om afgewezen te worden in een groep. 0   1   2    3   4 
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28. Ik was schrikachtig. 0   1   2    3   4 
29. Ik was optimistisch over mijn toekomst. 0   1   2    3   4 
30. Ik werkte of studeerde minder hard dan voorheen. 0   1   2    3   4 
31. Ik voelde mij rillerig. 0   1   2    3   4 
32. Ik voelde mij de mindere van anderen. 0   1   2    3   4 
33. Ik was zenuwachtig en nerveus. 0   1   2    3   4 
34. Ik had plannen of stelde mezelf doelen. 0   1   2    3   4 
35. Ik had het gevoel dat het niet goed ging met mijn werk/studie. 0   1   2    3   4 
36. Ik voelde mij ongemakkelijk als anderen naar mij keken. 0   1   2    3   4 
37. Ik had interesse in dingen. 0   1   2    3   4 
38. Ik voelde mij hopeloos. 0   1   2    3   4 
39. Ik was vergeetachtig. 0   1   2    3   4 
40. Ik voelde mij somber of depressief. 0   1   2    3   4 
41. Ik voelde mij onrustig. 0   1   2    3   4 
42. Ik voelde me energiek en levenslustig. 0   1   2    3   4 
43. Ik wilde mensen het liefst slaan als dat werd uitgelokt. 0   1   2    3   4 
44. Ik had moeite om op gang te komen. 0   1   2    3   4 
45. Ik voelde mij onzeker in gezelschap. 0   1   2    3   4 
46. Ik voelde mij gespannen. 0   1   2    3   4 
47. Ik kon mij niet goed concentreren. 0   1   2    3   4 
48. Ik piekerde. 0   1   2    3   4 
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Name of the Patient: 
Today’s Date: 
Number: 
Date of Birth: 
 
Instruction: 
Try to answer the following propositions fairly and accurately. There are no ‘right’ or ‘wrong’ answers. 
Give the answer that best expresses the number of times you have felt the following ways last week, 
including today. The answer which comes to your mind first is often the best answer. 
 
Note: If you did not work or study or have not been able to do so, then you can skip the questions 9, 15, 







































1. I was short of breath with minimal excursion. 0   1   2    3   4 
2. I felt weak or slow. 0   1   2    3   4 
3. I was irritable and dissatisfied. 0   1   2    3   4 
4. I felt anxious while I was in a crowd (of people). 0   1   2    3   4 
5. I felt palpitations. 0   1   2    3   4 
6. I had trouble making decisions. 0   1   2    3   4 
7. I could not enjoy anything at all. 0   1   2    3   4 
8. I did not dare to cross open spaces, such as a public square. 0   1   2    3   4 
9. I felt stressed at my work or study. 0   1   2    3   4 
10. I argued with others. 0   1   2    3   4 
11. I felt chest pain (or pressure).  0   1   2    3   4 
12. I looked forward to things. 0   1   2    3   4 
13. I considered my death or suicide. 0   1   2    3   4 
14. I did not dare to travel on my own using public transport. 0   1   2    3   4 
15. I was dissatisfied with my work or study. 0   1   2    3   4 
16. I was hot-tempered without good reason. 0   1   2    3   4 
17. I felt dizzy or lightheaded. 0   1   2    3   4 
18. I felt like doing things. 0   1   2    3   4 
19. I did not want to live anymore. 0   1   2    3   4 
20. I had the feeling that I have been working or studying very hard. 0   1   2    3   4 
21. I had trouble with controlling my anger. 0   1   2    3   4 
22. I felt a tingling, for example in my hands. 0   1   2    3   4 
23. I could hardly express myself. 0   1   2    3   4 
24. I was afraid or anxious. 0   1   2    3   4 
25. I did not dare to go alone to a crowded shop. 0   1   2    3   4 
26. I was shaking or trembling. 0   1   2    3   4 
27. I was afraid of rejection by others. 0   1   2    3   4 
28. I was scared. 0   1   2    3   4 
29. I was optimistic about my future. 0   1   2    3   4 
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30. I worked or studied less intensely than before. 0   1   2    3   4 
31. I felt shaky or I had shivers. 0   1   2    3   4 
32. I felt low and less than others. 0   1   2    3   4 
33. I felt jittery and nervous. 0   1   2    3   4 
34. I looked forward to my plans and goals for the future. 0   1   2    3   4 
35.  I had the feeling that I did not do well with my work or study. 0   1   2    3   4 
36.  I felt uncomfortable when other people looked at me. 0   1   2    3   4 
37. I took interest in things. 0   1   2    3   4 
38. I felt hopeless. 0   1   2    3   4 
39. I was forgetful. 0   1   2    3   4 
40. I felt down or depressed. 0   1   2    3   4 
41. I felt restless. 0   1   2    3   4 
42. I felt energetic and high-spirited. 0   1   2    3   4 
43. I wanted to hit people if I was provoked. 0   1   2    3   4 
44. I struggled to get the day started. 0   1   2    3   4 
45. I felt insecure in the company of others. 0   1   2    3   4 
46. I felt tense. 0   1   2    3   4 
47. I could not concentrate well. 0   1   2    3   4 
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1. SUMMARY OF RESULTS
1.1 Aims of our study
The primary aim of the NormQuest study described in this thesis was to generate evidence-
based, reference values for 19 self-report and observational questionnaires. The focus was 
on questionnaires measuring mood, anxiety, and somatoform (MAS) disorders used in 
Routine Outcome Monitoring (ROM). The set of cut-off values of the ROM reference group 
(‘healthy’) can be used in specialized mental health care by therapists to support the decision 
whether a patient is sufficiently recovered to be considered as a member of the healthy 
population, and no longer as a member of the patient population. These reference values 
are suitable as decision support for referral back to primary care physicians. Additionally, 
the set of the ROM patient group (‘clinically ill’) cut-off values can be used by primary 
care physicians as decision support for referral to the specialized mental health care. To 
allow determination of cut-off points for skewed distributions, percentile scores were used. 
In addition, we assessed the discriminative power of the questionnaire scores by means of 
Receiver Operating Characteristics (ROC) analyses. Finally, we calculated reference values 
in separate strata of gender and age.
 The secondary aim of the NormQuest study concerned the need for the development 
of public domain questionnaires. In the NormQuest study, the generic Symptom 
Questionnaire-48 (SQ-48), aimed at broad applicability in patients with MAS disorders, was 
developed. Also, for the SQ-48 reference values were calculated.
1.2 Summary of major findings
This is the first study of this size carried out in the Netherlands to yield reference values 
for questionnaires measuring MAS disorders. Chapter 2 described the objectives, design, 
and methodologies. Two groups were included. The first group, the ROM patient group, 
comprised specialized mental health care (i.e., secondary care) outpatients with one or more 
MAS-disorders. Patients were screened as part of their routine intake procedure. For the 
NormQuest study, a group of 5269 outpatients, aged 18-65 years, with complete data were 
selected. The second group, the ROM reference group, comprised primary care patients, 
registered with one of 8 participating general practitioners (GPs) but not necessarily seeking 
treatment. They can be considered to constitute a general population sample since in the 
Netherlands 99.9% of the general population is registered with a GP [1]. The ROM reference 
group comprised 1302 participants, aged 18-65 years. The ROM reference group matched the 
ROM patient group in terms of gender-, age distribution, and the level of urbanization. Data 
were collected during a baseline assessment comprising a standardized diagnostic interview, 
administration of rating scales, and completion of several self-report questionnaires by the 
ROM reference group. For the ROM patient group the baseline assessment was part of the 
intake procedure. The interviewers were extensively trained and supervised, thus maximizing 
the inter-rater reliability and validity of the assessment.
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In Chapters 3 to 7, we discussed the assessed reference values for the 19 questionnaires. All 
of the P95 ROM reference group and the P5 patient group cut-off values are summarized in 
Tables 8.1 and 8.2 of the Appendix of this chapter. 
 In Chapter 3, reference values for four generic questionnaires were calculated: the 
Brief Symptom Inventory (BSI), the Mood & Anxiety Symptom Questionnaire – 30-item 
short adaptation of the MASQ, Dutch translation (MASQ-D30), the Short Form Health 
Survey 36 (SF-36), and the Dimensional Assessment of Personality Pathology - Short Form 
(DAPP-SF). Data from 1294 ROM reference group participants were compared with data 
from 5269 psychiatric outpatients of the ROM patient group. The P95 ROM reference group 
and the P5 patient group cut-off values are summarized in Table 8.1. The data illustrate 
gender-specific results. There was a tendency for women in the ROM reference group to 
have somewhat higher cut-off scores on the BSI and MASQ-D30 than men in the ROM 
reference group, while the two genders had the opposite pattern of cut-off scores on the 
DAPP-SF. Men, especially young men, reported better health, reflected in higher scores on 
several subscales of the SF-36 than young women. The discriminative power of the BSI, 
MASQ-D30 and SF-36 was good, but it was poor for the DAPP-SF. All analyses of internal 
consistency were based on a combination of data from the ROM reference group and the 
ROM patient group. The internal consistency of the subscales ranged from adequate to 
excellent for all questionnaires.
 From Chapter 4 onward, we focused on the reference values for disorder-specific 
questionnaires. 
 Chapter 4 concerned major depression, using the Beck Depression Inventory-II (BDI-
II), the Inventory of Depressive Symptoms (Self-Report) (IDS-SR), and the Montgomery-
Äsberg Depression Rating Scale (MADRS). We compared data from 1295 ROM reference 
group participants with data from 4627 patients of the ROM patient group diagnosed with 
major depressive disorder (MDD) or dysthymic disorder. Cut-off values (P95 ROM reference 
group) were significantly higher for women compared to men. The discriminative power 
of the BDI-II, IDS-SR, and MADRS scores was very high. The internal consistency was 
excellent for all total scores. For the subscales, internal consistency was satisfactory, with the 
exception of the IDS-SR subscale Atypical Characteristics, which was poor.
 In Chapter 5, we discussed reference values for eight questionnaires measuring 
anxiety disorders: the Brief Scale for Anxiety (BSA), the PADUA Inventory Revised (PI-R), 
the Panic Appraisal Inventory (PAI) (with three subscales: the PAI Anticipated Panic, the 
PAI Perceived Consequences, and the PAI Perceived Self-Efficacy), the Penn State Worry 
Questionnaire (PSWQ), the Worry Domains Questionnaire (WDQ), the Social Interaction, 
the Anxiety Scale (SIAS), the Social Phobia Scale (SPS), and the Impact of Event Scale-
Revised (IES-R). These questionnaires cover most of the DSM-IV anxiety disorders. We 
included 1295 ROM reference group participants and 5066 psychiatric outpatients of the 
ROM patient group diagnosed with at least one specific anxiety disorder. Reference values 
were generally higher for women than for men. The discriminative power of all eight 
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were generally higher for women than for men. The discriminative power of all eight 
questionnaires measuring anxiety disorders was very high. The internal consistency was 
excellent for the total scores and subscales of all questionnaires, except for the BSA and for 
the WDQ subscale Work Incompetence: they had adequate internal consistencies. 
Chapter 6 included reference values for three disorder-specific questionnaires concerning 
some of the somatoform disorders: the Body Image Concern Inventory (BICI; for body 
dysmorphic disorder), the Whitely Index (WI; for hypochondriasis), and the Checklist 
Individual Strength (CIS20R; for chronic fatigue syndrome). Data were compared from 648 
ROM reference group participants and 823 ROM patient group outpatients diagnosed with at 
least one somatoform disorder. Compared to the sizes of the groups in the previous chapters, 
the ROM reference group and the ROM patient group were smaller. Somatoform disorders 
are less prevalent compared to mood- and anxiety disorders. For the BICI, the WI, and the 
CIS20R total score, the cut-off values differed for men and women, again being higher for 
women. The discriminative power of all 3 questionnaires was very high and the internal 
consistency was excellent.
 Chapter 7 described the development, validation and reference values of our newly 
developed public domain questionnaire, the 48-item Symptom Questionnaire (SQ-48). 
The SQ-48 was developed to be multidimensional, including the following nine subscales: 
Depression (MOOD, 6 items), Anxiety (ANXI, 6 items), Somatization (SOMA, 7 items), 
Agoraphobia (AGOR, 4 items), Aggression (AGGR, 4 items), Cognitive problems (COGN, 
5 items), Social Phobia (SOPH, 5 items), Work functioning (WORK, 5 items), and Vitality 
(VITA, 6 items). A part of the ROM reference group (n=516) and a part of the ROM patient 
group with suspected depressive, anxiety, and somatoform disorders (n= 242) completed the 
SQ-48 plus a set of observer-rated and self-report scales (MINI-Plus, MADR, BSA, BSI). 
The discriminative power of the questionnaire was good. The results showed good internal 
consistency as well as good convergent and divergent validity. The SQ-48 is meant to be 
available in the public domain for Routine Outcome Monitoring (ROM).
 In conclusion, for 19 generic and disorder-specific ROM questionnaires a 
comprehensive set of reference values was provided. These reference values may support 
responsible clinical decision-making with respect to initiating, adjusting, or terminating 
therapy, and with respect to referring patients from mental health care to primary care and 
vice versa. The main, clinically useful reference values are presented in Tables 8.1 and 8.2 of 
the Appendix.
2. GENERAL DISCUSSION
In this section, the findings of the NormQuest study will be discussed in a broader 
perspective. The first topic is the choice of percentile scores as reference values, where the 
distribution of data guided this choice. The reference group will be outlined, since it provides 
the characteristics needed for comparison and evaluation of the patient’s characteristics
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(i.e., severity of psychopathology). The next topic is the representativeness of the reference 
group and the generalizability of the results. Subsequently, we will elaborate on the 
implications of our findings for clinical practice, with practical recommendations for referral 
back to primary care and referral to specialized mental health care. The reference values in 
separate gender and age strata will be discussed, which followed a consistent pattern for 
all the questionnaires. We will comment on the discriminative powers of the questionnaire 
scores by means of ROC analyses. ROM questionnaires are appropriate for the assessment 
of symptom severity, but our findings suggest that they are also of some value for diagnostic 
purposes. Finally, the newly developed self-report questionnaire Symptom Questionnaire-48 
(SQ-48) will be discussed. We will finish with recommendations for future research.
2.1 Reference values
Reference values of assessment tools are important for different clinical purposes, which 
were summarized by Solberg [2] as early detection of disease, differential diagnosis, and 
monitoring response to therapy . Since the questionnaires in this study are measures of 
symptom severity, rather than diagnostic tools, Solberg’s last purpose is the most relevant 
for the use of our reference values. Other purposes of our reference values are: 1) screening 
of patients when they first seek treatment by the GP and supporting clinical decisions about 
possible referral to specialized mental health care; and 2) comparison of individual patients’ 
scores with scores from a similar group (e.g., same gender, same disorder) in order to assess 
the severity of symptoms. The clinical use of the relevant reference values is described in 
section 2.4.
 The concept of reference values of laboratory measures has been widely accepted 
in medicine, (e.g., glucose, total cholesterol, serum liver enzymes, and other biochemical 
analyses) [3-5]. Reference values are widely used in health care [4,6]. In psychiatry, however, 
reference values still need to be established and applied, to which aim the NormQuest study 
can contribute.
 To derive valid reference values, the reference group needs to have specific 
characteristics. The COTAN (Commissie Testaangelegenheden Nederland), documentation 
from the Dutch Institute of Psychologists (NIP), is a leading grading system for test quality in 
the Netherlands [7]. The COTAN grading system suggests three criteria that are relevant in the 
context of reference groups. Firstly, the size and representativeness of the groups is evaluated. 
A group size of N ≥ 400 is considered good, a group size of 300 ≤ N < 400 is considered 
adequate, and a group size of N < 300 is considered insufficient. We aimed for group sizes 
(including gender stratification) of at least N ≥ 300 and succeeded for all generic, mood, 
and anxiety questionnaires. Thus, according to COTAN criteria, our group sizes for these 
questionnaires ranged from adequate to good. For the somatoform questionnaires the group 
sizes were smaller and therefore did, not meet the COTAN criteria. The representativeness of 
the ROM reference group is discussed in section 2.3. The second COTAN criterion evaluates 
psychometric measures (e.g., score distribution, means, and standard deviations). We have 
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met that criterion by providing percentile scores (in view of the skewed distributions), in 
addition to means and standard deviations, which we considered less appropriate because of 
the skewed data distributions. Thirdly, data on possible differences between subgroups need 
to be analyzed properly, according to the COTAN criteria. We used gender stratified sampling 
for the assessment of reference values for all questionnaires and age stratified sampling for 
the generic questionnaires and the questionnaires measuring major depression. Therefore we 
can conclude that our analyses fairly met the COTAN criteria.
Figure 8.1. Prevalence-dependent cut-off values. Top: low prevalence of the psychiatric disorder: a fixed 
reference value x results in many false positives. Bottom: high prevalence of the psychiatric disorder in a 
high-risk population: the same fixed reference value x now results in many false negatives.
Prevalence rates will influence test characteristics of reference values. When the prevalence 
of the disease is low (i.e., in the general population), the P95 cut-off point discriminating 
clinically ill from healthy will lead to many false positives (see Figure 8.1, top). However, 
when the prevalence of the disease is high (as it is in a patient population), the same P95 
cut-off point discriminating clinically ill from healthy will lead to many false negatives (see 
Figure 8.1, bottom). Therefore, clinicians should always use the test results in conjunction 
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2.2 Reference group
A reference group consists of a sample of persons who are representative of the population for 
whom the test is intended. Reference values facilitate the comparison of the individual score 
to the distribution of scores in a population. The two populations considered in this study 
are specialized mental health (secondary) care patients (ROM patient group) and ‘healthy’ 
members of the general population (ROM reference group) [3,8].
Since our aim was the comparison of these two populations, we chose to ensure similar 
sociodemographic characteristics. We matched the ROM reference group with the ROM 
patient group in terms of gender- and age distribution, as well as level of urbanization. With 
our large ROM reference group of about 1300 persons, the subgroups stratified for gender 
and age were larger than the required minimum size of 120 that is considered to provide 
adequate power to yield reference values [9].
 Individuals with current psychopathology were not excluded from the ROM 
reference group, as long as they were not treated in specialized mental health (secondary) 
care. As noted by Gräsbeck [10] “Absolute health does not exist. Some degree of pathology 
is present in every individual like entropy in a chemical system”. Where reference values 
are derived from measurements of a so-called healthy population, the ’level of health’ of the 
population should be specified, based upon the criteria for inclusion or exclusion of persons 
from the ’healthy’ population. In this study we chose to not exclude any person, provided 
that in the past six months they received no treatment for psychiatric problems in specialized 
mental health (secondary) care. We support the argument made by Kendall et al., [11] that 
excluding participants with elevated levels of the target psychopathology from the reference 
group might lead to creating a non-representative, ’supernormal’ sample. Comparing the 
patient group with such a supernormal group would represent an overly stringent criterion 
with unreasonable narrow reference intervals [12]. The statistical definition of normality is 
in line with Kendall’s argument. This definition is based on the distribution of scores in the 
general population (including all individuals) [13] where disease is defined as a ’quantitative 
deviation from the normal’ [14]. The statistical definition is opposed to the medical definition. 
This medical definition equates normality with health and thus with the absence of pathology, 
which is difficult to quantify [15]. By including all possible participants in the ROM reference 
group, this group also includes those who may currently be experiencing elevated levels of 
psychopathology, but are not being treated in specialized mental health (secondary) care.
 Reference values are usually based on the middle 95% of the reference population, 
with the most outlying 5% defined as abnormal. Most often, these outlying observations are 
split evenly between the ends of the score distributions in the reference group, 2.5% at each 
end of the distribution. For the ROM questionnaires, only high values are of clinical concern. 
Therefore, we defined 5% of outlying observations at the high end of the distribution of the 
ROM reference group scores as abnormal (and 5% at the low end of the distribution for the 
‘inverted’ subscales of the SF-36). This is in line with the practice in laboratory medicine 
[16]. With a similar argument, the 5% of outlying observations of the ROM patient group at 
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 the low end of the distribution were by definition considered as clinically deviant from the 
patient population. 
 According to the MINI-Plus data, about 10% of the ROM reference group reported 
enough psychiatric symptoms to warrant (at least) one DSM-IV diagnosis. We noted a 
reduction in the P95 ROM reference group values when we excluded these 10% non-healthy 
subjects from the ROM reference group: for the four generic questionnaires (not for the 
SQ-48) the decrease was 5% of the P95 value [17]; for the three questionnaires measuring 
major depression the decrease was 15% [18]; for the eight questionnaires measuring anxiety 
disorders the decrease was 9% [19]; and for the three questionnaires measuring somatoform 
disorders the decrease was 7% [20].
2.3 Representativeness and generalizability 
When deriving reference values, we aimed for generalizability and representativeness. The 
NormQuest sample was representative for the gender and age distributions of the ROM 
patient group. Random sampling among persons registered with the participating GPs was 
used as a strategy for ensuring representativeness. Indeed, in the Netherlands 99.9% of the 
general population is registered with a GP [1]. There was large variability for many of the 
demographic variables in the ROM reference group. To yield reference values this variability 
is recommended, as the reference values need to be applied to a wider population and external 
validity is required.
 Representativeness is related to response rate. The response rate of the present 
NormQuest study was 37.1%. We used several methods to enhance the possible response 
rate. These efforts included offering participant-friendly interview conditions, such as 
choice of venue (at the homes of the participants , at the general practice, or at the academic 
center LUMC) and time (in the morning, afternoon, or evening), and a personal phone call 
for further information after an invitation by mail. We have compared the gender and age 
distributions between the non-respondents and participants. The response rate for women 
was slightly lower than the response rate for men, implying possible (greater) selective 
sampling in women. Slightly more persons aged 36-55 years responded compared to those 
aged 18-35 years. This suggests a slight under-representation of younger participants. Some 
other populations (i.e., younger fulltime employed men, or persons with (subthreshold) 
psychopathology) may also have been underrepresented. A possible mechanism of this 
selective sampling was the contacting of subjects by phone: few mobile phone numbers 
were registered in the GP information system, thus possibly missing many young subjects. 
Prevalence rates of mood- and anxiety disorders in 18-24 year olds and prevalence rates of 
mood disorders in 25-34 year olds are higher than prevalence rates in the older age groups 
[21]. So, this may have led to a slight underestimation of our reference values. A further 
possible mechanism of selective sampling was the exclusion of subjects by the GPs. They 
unlisted subjects who were not able to cope with the effort of the NormQuest interview. Some 
of those subjects possibly had elevated levels of psychopathology. Again this might have 
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resulted in a slight under-estimation of our reference values. However, it is also possible that 
participants, compared to persons who actively refused to participate, are likely to be more 
interested in their mental health, to be more eager to take actions that improve their health 
and to have a more favorable clinical course of symptoms [22]. It is unknown whether this 
has resulted in an overestimation or underestimation of our reference values. Furthermore, 
it might be relevant that self-report questionnaires are subject to response bias. Previous 
research suggested that there may be systematic gender differences in self-report bias, with 
men tending to minimize their depressive symptoms more than women [23]. Therefore, 
we may have underestimated the prevalence of depression in men, resulting in an under-
estimation of reference values for men. In sum, despite our efforts, the ROM reference group 
may not have been fully representative of the general population. The possible total effect on 
the calculated reference values is hard to quantify.
 Generalizability of the reference values was another aim in this study. As noted 
before, the NormQuest sample was representative for the gender and age distributions of 
the ROM patient group. Therefore, its reference values can be validly used as a comparison 
against this patient group. However, several reference values calculated in this study differ 
from reference values in previous studies. In general, our reference values are slightly higher. 
Why do reference data differ so much over (internationally) different populations? Are the 
differences culture and language related, or are they design-related? Firstly, the perception 
of health and the ways health problems are expressed vary from culture to culture [24]. A 
conceptual distinction exists between disease and illness. Disease relates to malfunctioning 
or maladaptation of biologic and psychophysiologic processes; illness represents personal, 
interpersonal, and cultural reactions to disease or discomfort [24]. Semantics may vary 
between cultures and they may vary between international versions of a questionnaire 
[25,26]. Self-report questionnaires in particular may reflect the experience of illness and 
may therefore be culture sensitive. Secondly, design-related differences can emerge when 
the comparisons are made between ‘cheese and chalk’ (i.e., differences in terms of patient 
population [25,27,28], mode of questionnaire administration [25,28,29], socio-economic 
status [27,29], or clinical severity [27,29]). Especially levels of physical and psychological 
functioning have to be well-defined. Two versions of the same questionnaire can be equally 
sensitive to a given change in functional status, yet assign different scores to a given level 
of distress [27]. Furthermore, using a questionnaire in different national regions may lead 
to differences: health status may vary by area of residence [28]. Our reference values are 
regional ones (province of South-Holland). Generalizability to the national level might be 
not entirely obvious. Further research could legitimize this generalizability. These reference 
values are appropriate for outpatients referred for MAS disorders. Some caution is appropriate 
with other patient populations, e.g., inpatients, psychotic or Severe-Mental-Illness-patients, 
or patients with personality disorders as main diagnosis.
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2.4 Clinical use of the reference values
This study yielded reference values, including cut-off values. Reference values allow the 
determination of the position of the patient in the distribution of the total population as a 
measure of symptom severity. Reference values can help to indicate when the patient is 
sufficiently recovered to make a next step in the treatment. In particular, reference values 
can help to assess whether therapy has moved someone outside the range of the patient 
population and within the range of the reference population. Clinicians in specialized mental 
health care can use certain cut-off values to support their decisions concerning the end of 
treatment and possible referral back to primary care. Vice versa, general practitioners (GPs; 
primary care) can use a different set of cut-off values to support their decision about referral 
to specialized mental health (secondary) care. Thus, the choice of cut-off values depends on 
the purpose for which the cut-off values will be used.
 Sensitivity and specificity vary with different cut-off values. Figure 8.2 depicts the 
proportions of the ROM reference group and of the ROM patient group that scored higher 
than a certain cut-off value and lower than this cut-off value. 
 When referral from secondary care to primary care is at order, ‘health’ is the condition 
that is to be detected. A cut-off value with high sensitivity for symptomatic health is advised. 
The proportion of the ROM reference group scoring lower than the cut-off value (d/M0) will 
be maximal; the proportion of real patients scoring lower than the cut-off value (b/M1) will 
be maximal as well. As we discussed previously, high sensitivity to health is associated with 
low sensitivity to establish disease: a/M1 is minimal. Vice versa, when referral from primary 
care to secondary care is at order, ‘disease’ is the condition that is to be detected. A cut-off 
value with high sensitivity for disease is advised. The proportion of real patients scoring 
higher than the cut-off value (a/M1) will be maximal; the proportion of the ROM reference 
group scoring higher than the cut-off value (c/M0) is then maximal as well. High sensitivity 
to disease is associated with low sensitivity to symptomatic health: d/M0 is minimal.
Figure 8.2: The choice of the reference value will determine the sensitivity or specificity of the test, with a trade-off 
between the two. Sensitivity or specificity also depends on whether health or disease is being assessed. Depicted 
are proportions of the ROM reference group and of the ROM patient group that scored higher than a certain cut-off 
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Decisions concerning the end of treatment and possible 
referral back to primary care
This paragraph is meant for specialized mental health (secondary) care clinicians in order to 
support their decisions concerning the end of treatment and possible referral back to primary 
care.
Figure 8.3: Cut-off values relevant for referral back to primary care. Patients depart from treatment 
when they no longer belong to the patient population, but belong to the reference population instead, 
below the cut-off value P95 ROM reference group.
It can be argued that patients enter treatment when they are part of a patient (clinically ill) 
population and they depart from treatment when they no longer belong to that population, 
but belong to the reference (‘healthy’) population. Referral back to primary care might 
be indicated when the patient in specialized mental health care has become similar to 
the reference population (i.e., belongs to the 95% normality range of the ROM reference 
group). In order to support decisions regarding back referral, a cut-off point can be used. The 
clinically relevant cut-off point is the point that the patient has to cross at the time of the post-
treatment assessment in order to be classified as changed to a clinically significant degree of 
functionality or health. As can be seen in Figure 8.3, the cut-off value, marking the top 5% 
of the ROM reference group, is equivalent to the 95th percentile score: P95 ROM reference 
group. This cut-off value is highly sensitive to symptomatic health. It can be considered as 
a reliable indicator of symptomatic health, since it rarely misses health among those who 
are actually healthy. However, high sensitivity to health is associated with low sensitivity to 
establish disease. The cost of low sensitivity to disease or many false negative results might 
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 Referral back to primary care might be indicated even when the patient in 
specialized mental health care still has some residual symptoms. Indeed, a substantial part 
of primary care patients are not without symptoms. Furthermore, referral back to primary 
care might be indicated for patients with recurrent depression for treatment of any residual 
anxiety symptoms. [30].
 In Table 8.1 of the Appendix the cut-off values, i.e., the P95 ROM reference group 
values, are summarized for the 19 ROM questionnaires. Four sets of questionnaires are 
available: 1) generic questionnaires; 2) questionnaires measuring mood disorders; 3) 
questionnaires measuring anxiety disorders; and 4) questionnaires measuring somatoform 
disorders. When comparing the P95 ROM reference group cut-off values with the few cut-
off values that were previously published, our values were generally higher. Thus, when 
our P95 ROM reference group cut-off values are used a patient will be eligible for referral 
back to primary care having more residual symptoms than would be the case if previously 
published cut-off values were used. Previously published cut-off values were established 
in groups of recovering patients [31-33] and in control groups with no life-time personal 
history of psychopathology [13,34]. For the groups of recovering patients in these studies 
[31-33], the cut-off value was defined as the point of remission, with the total absence of 
significant signs or symptoms [31-33]. It seems to imply circularity to establish a reference 
group based on the amount of symptoms. This procedure may have resulted in lower cut-
off values compared to our cut-off values, based on patients with some residual symptoms. 
For the control groups with no life-time personal history the medical definition of normality 
was used [13,34] thus creating a control group comprising ‘supernormal’ participants (see 
section 2.2). Again, this resulted in lower cut-off values compared to our cut-off values, 
which were based on a reference group with 10% non-healthy subjects (see section 2.2). 
In yet another control group study, the derived cut-off value provided a high sensitivity 
(and a lower specificity) [35]. Our P95 ROM reference group cut-off values were related to 
low sensitivity to disease (and high specificity; see section 2.4.1) and therefore they were 
higher than the previously published values.
 Practicing therapists may have specialized mental health (secondary) care 
patients with continuous high severity scores, despite therapy, for whom treatment is no 
longer effective. These patients may not have been identified as being ready to be referred 
back to primary care with conventionally used decision supports, but may be considered 
ready by our decision supports. On the other hand, therapists do not want to increase the 
primary care patient population with redundant symptoms, leading to unnecessary risks 
of recurrence. The P95 ROM reference group cut-off values may indicate and aid a proper 
decision.
Decisions concerning possible referral to specialized 
mental health (secondary) care
This paragraph is aimed at general practitioners (GPs; primary care) in order to support 
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decisions about referral of patients to specialized mental health (secondary) care.
Figure 8.4: Cut-off value relevant for referral to specialized mental health care. Patients enter secondary 
treatment when they are no longer part of the reference population, but belong to the patient population 
instead, above the cut-off value P5 ROM patient group.
Referral to specialized mental health (secondary) care may be indicated when the patient 
is more similar to the patient population than to the reference population. In this case the 
clinically relevant cut-off point is the point that the patient has to cross at the time of the 
assessment in order to be classified as similar to a clinically significant degree of psychiatric 
illness. As can be seen in Figure 8.4, the cut-off value, marking the bottom 5% of the ROM 
patient group, is equivalent to the 5th percentile score: the P5 ROM patient. This cut-off value 
represents high sensitivity for psychopathology. 
 In Table 8.2 of the Appendix the cut-off values, the P5 ROM patient group values, 
are summarized for the 19 ROM questionnaires. Four sets of questionnaires are available: 
1) generic questionnaires; 2) questionnaires measuring mood disorders; 3) questionnaires 
measuring anxiety disorders; and 4) questionnaires measuring somatoform disorders. The 
use of reference values is feasible when ROM is available to GPs. Currently, ROM is used by 
some primary care psychologists [36] but not yet on a large scale by GPs [37].
 When using the P5 ROM patient group for referral to specialized mental health care, 
some issues have to be considered. The P5 cut-off value is highly sensitive to disease. It can 
be considered as a reliable decision support when its result is negative, since true positives 
(psychopathology) are rarely missed among those who are actually positive – i.e., most sick 
people are recognized as being ill. However, high sensitivity is related to low specificity in a 
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of subjects with the mistaken prospect of facing a disease that they do not have. Furthermore, 
it may lead to additional tests and possibly to treatments that are not necessary or even 
detrimental [30,38].
 Referral to specialized mental health care can be difficult because of the vague 
nature of complaints [39]. E.g., persons who are depressed may visit a GP where their 
disorder remains undetected and untreated [40]. The cause could be that GPs tend to be more 
responsive to the overall level of distress than to whether patients meet formal criteria for 
depression [41]. Another obstacle to referral to specialized mental health care could be patient 
attitudinal barriers to the expected extended treatment [42]. The questionnaires described in 
this study plus the provided reference values are tools to support clinical decisions about 
referral to specialized mental health care or counseling in primary care.
Reflection and recommendations on the use of ROM 
reference values
Reference values have to be used with care. Although it was not a topic of this thesis, the 
course Reference values have to be used with care. Although it was not a topic of this 
thesis, the course of questionnaire scores may be a more sensitive indication of the level 
of responsiveness. Comparison with percentile scores can assist the interpretation of these 
scores. Cut-off values can be used to support clinical decisions about referral and, at intake, 
decisions about diagnosis and treatment. Reference values in the present thesis were based 
on one-time cross-sectional data, whereas the clinician bases his decisions on repeated ROM 
sessions with his patient and on observed clinical changes. These time-series ROM data 
likely provide a wealth of information that can assist in better clinical decision making. 
 The reference values were based on cross-sectional data of subjects without any or 
with normal (non-treated) symptoms. The limit of ‘normality’ was determined according to 
the statistical distribution of the 95th percentile. However, this is an arbitrary assumption and 
there is no hard evidence that these recommended and statistically derived reference values 
predict morbidity, relapse, or recurrence [43,44]. Furthermore, cross-sectional data do not 
provide information about the duration of any of the symptoms [45]. Reference values are 
relevant factors in decisions about diagnosis and treatment and should therefore be related 
to prognosis [44]. However, in this study we have not evaluated the prognostic value of our 
proposed reference values. Mental health studies and physical health studies are not on a 
par, yet. In somatic medicine it is common practice to study effectiveness and efficacy of 
reference values [46,47].
2.5  Gender - and age effects
In our analyses, as described in chapters 3 to 7, we observed gender differences in reference 
values in the ROM reference group with women reporting more severe symptoms on 
observational and self-report scales for general psychopathology (i.e., BSI, MASQ-D30, 
and SF-36), depression (i.e., BDI-II, IDS-SR, and MADRS), anxiety (i.e., BSA, PI-R, PAI, 
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PSWQ, WDQ, SIAS, SPS, and IES-R), and body dysmorphic disorder (i.e., BICI) than 
men. No gender differences were found for the personality questionnaire DAPP-SF, the 
hypochondriasis questionnaire WI, and the chronic fatigue questionnaire (CIS-20R). These 
findings were not unexpected, since gender differences are commonly described in literature 
for well-defined patient groups [48-52] and for subjects from the general population [21,53]. 
Women are twice as likely to report depression or anxiety as men [21,53,54]. Gender may be 
related to a number of environmental causes and other aspects of psychopathology such as 
the stressors and exposures that influence the onset of disease, how symptoms are expressed 
[48,50,52,55-59], whether patients seek care [48,49,52,60,61], and how they are treated in 
the mental health care system [62].
 The process of being mentally ill and subsequently seeking help has gender-specific 
aspects. The issue is what exactly is different between men and women. Are symptoms 
different or are their standards of acceptable psychological discomfort different? Is their 
sensitivity to different symptoms different or is their way to present symptoms different? 
Do women have (or take) more opportunity to report psychological symptoms to mental 
health care providers? Or are the differences caused by the questionnaires and criteria used in 
mental health care? [63].
 The ROM reference group, a population based, non-treatment-seeking sample, may 
not completely reflect treatment-seeking patient samples in most of the above mentioned 
gender studies. Yet, this ROM reference group showed a similar gender effect in the reference 
values for most generic questionnaires, and questionnaires measuring major depression, 
anxiety-, and somatoform disorders. We have previously described that participants of 
the ROM reference group were not necessarily free of psychopathology. Therefore, the 
gender difference in this group might have been influenced by a relatively larger number 
of female than male subjects with psychopathology. Indeed, the percentage of participants 
with psychopathology was higher in women than in men (11.1% versus 6.6%). However, 
excluding these participants still yielded comparable gender differences in the reference 
values. For most questionnaires measuring generic symptoms, major depression, and 
somatoform disorders the gender differences decreased slightly. For some questionnaires 
measuring anxiety disorders the gender differences were unaffected or increased slightly 
(data not shown).
 The gender effect in the reference values for most questionnaires measuring major 
depression, anxiety-, and somatoform disorders was similar in the ROM patient group: 
women reported slightly more symptoms than men. For generic questionnaires, no clear 
gender effect was found. Our data tentatively suggest that gender-specific reference values 
might increase precision in the assessment of the clinical state of psychiatric outpatients. 
However, the use of gender-specific reference values for questionnaires measuring generic 
symptoms, mood, anxiety, and somatoform disorders is open to debate. The consequence 
of using gender-specific reference values is illustrated in Figure 8.5. If the cut-off value P95  
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ROM reference group is assumed to be lower for men, it would imply that women, treated 
in specialized mental health care, might be referred back to primary care with more residual 
symptoms compared to men.
 Also, the effect of age on the reference values was studied, as described in chapters 
3 and 4. For the generic questionnaires BSI, MASQ-D30, and DAPP-SF we showed that 
advancing age was not clearly associated with more symptoms of psychopathology. Only the 
results of the SF-36 showed a small negative correlation between age and health. This could 
be expected on the basis of declining physical health in the elderly. For the self-report BDI-II 
and IDS-SR, higher age was associated with a higher severity of MDD symptoms in women 
and men from the ROM reference group, which was not the case for the observer-rated 
MADRS. Since a clear general age effect was lacking, we decided not to pursue the analyses 
of age effects in detail.
Figure 8.5. Hypothetical distribution of the scores of a questionnaire measuring psychopathology within 
the ROM reference group and within the ROM patient group. Scores are gender-specific: for women and 
men separately.
2.6 Discriminatory power of the questionnaires
The ROM questionnaires that are used to assess the level of (dys-) functionality in the 
ROM reference group and the ROM patient group are primarily designed for assessment 
of severity of MAS disorders. An additional aim of the NormQuest study was to test if 
these questionnaires can support the diagnostic process. By means of Receiver Operating 
Characteristics (ROC) and subsequent Area Under the Curve (AUC) analyses we investigated 
the discriminative power, which is indicative for the diagnostic capability of the 19 ROM 
questionnaires. For the generic questionnaires BSI, SF-36, and MASQ-D30, which assess 
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very satisfactory, given the fact that they are applicable for patients with more than one 
condition and irrespective of specific disorders. For all 14 disorder-specific (i.e., 3 major 
depression related, 8 anxiety related, and 3 somatoform disorder related) questionnaires the 
discriminative power was excellent. Only for the DAPP-SF subscales the discriminative 
power was poor. The DAPP-SF measures Axis-II personality traits that are thought to 
be stable and less affected by current psychopathology and treatment. So, although the 
questionnaires in this study were not designed for diagnostics but for severity assessment, 
the good discriminatory performance of the scales suggests that these questionnaires (except 
the DAPP-SF) can aid the diagnostics process.
 Although the discriminatory power of the disorder-specific questionnaires are very 
good, these questionnaires cannot replace the MINI-Plus used for diagnosis. Most are self-
report questionnaires and focus on particular symptoms relevant to a single disorder and are 
more sensitive to changes in outcome due to treatment as they assess the intensity of the 
symptoms that the patient suffers from [64,65]. The MINI-Plus, however, focuses on general 
psychopathology, distress, or general functioning and is a structured diagnostic interview, 
incorporating clinical judgment. It allows statements about the therapy effect regardless of 
the diagnosis and it is applicable for patients with more than one condition [66].
2.7 The SQ-48
To allow broad implementation, ROM questionnaires should ideally be free of copyright. 
Regrettably, some publishers claim copyrights for some ROM questionnaires. Therefore, 
the need has arisen to develop and validate freely available alternatives. As a first initiative, 
we developed and validated a 48-item psychological distress questionnaire, the Symptom 
Questionnaire (SQ-48; [67]), including measures of vitality and work functioning. This self-
report questionnaire is intended as a tool for screening in clinical settings (psychiatric and 
non-psychiatric), monitoring during treatment in the context of ROM, and benchmarking. 
Reference values were derived and psychometric characteristics (e.g., internal consistency, 
convergent validity, and divergent validity) were validated. For the Depression subscale the 
discriminative power was good; for the subscales Anxiety, Cognitive complaints, Social 
phobia, and Vitality/optimism the discriminative power was moderate, for the subscales 
Aggression, Agoraphobia, and Somatic complaints the discriminative power was not 
clinically useful. By developing and validating the SQ-48 we have paved the way for further 
research that is aimed at the sensitivity to change due to treatment.
2.8 Recommendations for future research
The NormQuest study presented in this thesis can be seen as the overture to the establishment 
of reference values for all ROM questionnaires, used for the assessment of MAS disorders. 
Several additions and adjustments may further improve the quality and implementation of 
these reference values.
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• External validity of the reference values for certain subgroups can be improved. 
Replication of this study with children, the elderly, and ethnic minorities is needed. 
Furthermore, the presented reference values are not necessarily generalizable to other 
language versions of the questionnaires or to other countries and cultures [68-70]. So, 
international and cross-country studies are recommended to develop internationally valid 
outcome measures, including reference values.
• The definition of 95% of a population as being normal, and 5% as being abnormal, 
is common practice but an arbitrary choice. Future research has to evaluate how well this 
definition and subsequent cut-off is in sink with the objective to provide an adequate tool to 
support clinical decisions on referral back to primary care.
• The size of the ROM reference group and of the ROM patient group that completed 
the questionnaires measuring somatoform disorders was suboptimal. Replication of the study 
with larger samples would enhance the validity and precision of the reference values.
• It might be possible to improve the specificity of a questionnaire without 
compromising a high sensitivity by sequencing questionnaires. By requiring a sequence 
of positive test results before taking further diagnostic action or starting treatment, the 
specificity of the questionnaire might be improved [30]. This would apply to patients with 
mild to moderately severe symptoms. Furthermore, either the sensitivity or the specificity of 
a questionnaire might be improved by using it in combination with a second questionnaire. 
Requiring a positive result from two questionnaires increases the specificity but decreases 
the sensitivity. Conversely, if a positive result on either questionnaire is taken to indicate the 
presence of the disease the sensitivity will become higher but the specificity will become 
lower [30]. In this study we focused on individual questionnaires. The effect of specific 
combinations of questionnaires on sensitivity and specificity could be further studied.
• Reference values are widely applied and recognized in laboratory medicine [4], 
but not in mental health care yet. The clinical application of test scores would have to be 
further evaluated. Subsequently, following laboratory medicine routine, a comprehensive 
approach should ideally be developed to implement the reference values of this study nation-
wide. This would include an information development plan, summaries of reference values 
and clinical guidelines (i.e., elaboration of the guidelines in section 2.6.), and national 
reporting. Stakeholders (e.g.,psychiatrists, GPs, mental health nurses, managers, and 
insurance companies) would have to be engaged and motivated. Because ROM is getting 
implemented in several organizations, this seems feasible. Studies on implementation and 
factors influencing implementation are needed but lacking, as far as we know.
• It is imperative to have an optimal (not maximal) set of questionnaires in ROM. The 
set of 19 questionnaires we provided reference values for may not constitute this optimum. 
Further research will have to decide whether questionnaires have to be added, removed or 
replaced. Newly added questionnaires will need rigorously assessed reference values similar 
to the ones we provided.
• Future research could evaluate whether the extension of ROM with extra 
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questionnaires regarding (additional) somatoform disorders and subsequent derivation of 
reference values would increase the utility of ROM.
• With the introduction of the DSM-V (APA, 2011), revisions for some diagnostic 
categories may warrant adaptations of some questionnaires. These adaptations and any newly 
developed questionnaires will require (new) reference values.
3. GENERAL CONCLUSIONS
We have gathered reference data in a larger group of population based controls and in a larger 
number of MAS outpatients than in any other Dutch or international study. Reference values, 
including cut-off scores, were calculated for 19 questionnaires. 
 When collecting reference data, it is important to match the ROM reference group to 
the ROM patient group in terms of gender- and age distribution, as well as level of urbanization. 
To minimalize selective sampling the response rate has to be optimalized (e.g., by offering 
the possibility of home-based completion of questionnaires, a larger monetary incentive, 
personalized invitational letters, stamped return envelopes, contacting participants before 
sending questionnaires, sending non-respondents a second invitational letter). Furthermore, 
clinical interpretations of symptoms and complaints have to be reliable. Therefore, and to 
minimalize inter-rater variability between interviewers, interviewers should be trained and 
supervised.
 The provided reference values can be used to support decisions of referral to or 
from specialized mental health care. When a therapist considers treatment termination and 
subsequent referral back to primary care, the P95 ROM reference group can be used to support 
the decision. When a GP regards referral to specialized mental health care a feasible option, 
the P5 ROM patient group can support his decision. 
 Reference data have to be used with care. Percentile scores are clear but strict; the 
practical use of these reference values should not be that strict. Purely statistical approaches 
are unsatisfactory. Additional information regarding comorbidity, personal functioning, and 
motivation for treatment is needed. A treatment strategy is most likely to succeed when it 
combines effective therapy and a strong therapeutic relationship, with ROM and its reference 
values.
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 8
Summary, general discussion, and conclusions 229
Table 1: Cut-off values for specialized mental health (secondary) care supporting decisions 
concerning referral back to primary care - P95 ROM reference group 
Questionnaire Domain Cut-off 
Symptom Questionnaire 48 items (SQ-48) Generic  
        Aggression (AGGR)  5.0 
        Agoraphobia (AGOR)  2.0 
        Anxiety (ANXI)  11.2 
        Cognitive complaints (COGN)  11.0 
        Depression (MOOD)  8.0 
        Somatic complaints (SOMA)  8.0 
        Social phobia (SOPH)  9.0 
        Vitality/optimism (VITA)  15.0 
Brief Symptom Inventory (BSI) Generic 0.68 
Mood & Anxiety Symptom Questionnaire 30-item (MASQ-D30) Generic 
depression/anxiety 
 
       General distress (GD)    depression 23 
       Anhedonic depression (AD)    anxiety 29 
       Anxious arousal (AA)  17 
Short Form 36 (SF36)* Generic  
       Physical Functioning    health status 65 
       Role-Physical    well-being 5 
       Bodily Pain  54 
       Social Functioning  63 
       Mental Health  56 
       Role-Emotional  33 
       Vitality  40 
       General Health  45 
Dimensional Assessment of Personality Pathology–short form (DAPP-SF) Generic  
       Submissiveness    personality 3.50 
       Cognitive Distortion  2.33 
       Identity Problems  2.70 
       Affective Lability  3.50 
       Stimulus Seeking  3.38 
       Compulsivity  4.00 
       Restricted Expression  3.63 
       Callousness  2.60 
       Oppositionality  3.20 
       Intimacy Problems  3.38 
       Rejection  3.75 
       Anxiousness  3.50 
       Conduct Problems  2.13 
       Suspiciousness  2.15 
       Social Avoidance  3.33 
       Narcissism  3.50 
       Insecure Attachment  3.33 
       Self-Harm  1.50 
Beck Depression Inventory-II (BDI-II) MDD 13 
Inventory of Depressive Symptomatology - Self-Report (IDS-SR) MDD 20 
Montgomery Åsberg Depression Rating Scale (MADRS) MDD 11 
Brief Scale for Anxiety (BSA) Anxiety Disorder 11 
PADUA Inventory Revised (PI-R) OCD 43 
Panic Appraisal Inventory (PAI) Panic Disorder 37 
        Anticipated panic  47 
        Perceived consequences of Panic (Total):   
        Perceived self-efficacy in coping with panic  65 
Penn State Worry Questionnaire (PSWQ) Worry (pathological) 66 
Worry Domains Questionnaire (WDQ) Worry 74 
Social Interaction and Anxiety Scale (SIAS) Social Anxiety 32 
Social Phobia Scale (SPS) Social Anxiety 19 
Impact of Event Scale – Revised (IES-R)¹ Total PTSD 36 
Body Image Concern Inventory (BICI) BDD 55 
Whitely Index (WI) Hypochondriasis 6 
CIS20R Chronic Fatigue 92 
ROM, routine outcome monitoring; MDD denotes major depressive disorder; OCD denotes obsessive compulsive 
disorder; PTSD denotes posttraumatic stress disorder; BDD denotes body dysmorphic disorder. 
*: P5 ROM reference group and P95 ROM patient group, as high scores indicate better functioning. 
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Table 2: Cut-off values for primary care supporting decisions concerning referral to specialized 
mental health (secondary) care - P5 ROM patient group 
Questionnaire Domain Cut-off 
Symptom Questionnaire 48 items (SQ-48) Generic  
        Aggression (AGGR)  0.0 
        Agoraphobia (AGOR)  0.0 
        Anxiety (ANXI)  2.0 
        Cognitive complaints (COGN)  3.0 
        Depression (MOOD)  1.0 
        Somatic complaints (SOMA)  0.0 
        Social phobia (SOPH)  0.0 
        Vitality/optimism (VITA)  6.0 
Brief Symptom Inventory (BSI) Generic 0.34 
Mood & Anxiety Symptom Questionnaire 30-item (MASQ-D30) Generic 
depression/anxiety 
 
       General distress (GD)    depression 17 
       Anhedonic depression (AD)    anxiety 17 
       Anxious arousal (AA)  18 
Short Form 36 (SF36)* Generic  
       Physical Functioning    health status 100 
       Role-Physical    well-being 100 
       Bodily Pain  100 
       Social Functioning  88 
       Mental Health  76 
       Role-Emotional  100 
       Vitality  65 
       General Health  90 
Dimensional Assessment of Personality Pathology–short form (DAPP-SF) Generic  
       Submissiveness    personality 1.25 
       Cognitive Distortion  1.00 
       Identity Problems  1.33 
       Affective Lability  1.63 
       Stimulus Seeking  1.00 
       Compulsivity  1.38 
       Restricted Expression  1.75 
       Callousness  1.00 
       Oppositionality  1.40 
       Intimacy Problems  1.13 
       Rejection  1.13 
       Anxiousness  1.67 
       Conduct Problems  1.00 
       Suspiciousness  1.00 
       Social Avoidance  1.17 
       Narcissism  1.10 
       Insecure Attachment  1.00 
       Self-Harm  1.00 
Beck Depression Inventory-II (BDI-II) MDD 14 
Inventory of Depressive Symptomatology - Self-Report (IDS-SR) MDD 18 
Montgomery Åsberg Depression Rating Scale (MADRS) MDD 11 
Brief Scale for Anxiety (BSA) Anxiety Disorder 6 
PADUA Inventory Revised (PI-R) OCD 20 
Panic Appraisal Inventory (PAI) Panic Disorder  
        Anticipated panic  14 
        Perceived consequences of Panic (Total):  10 
        Perceived self-efficacy in coping with panic  29 
Penn State Worry Questionnaire (PSWQ) Worry (pathological) 48 
Worry Domains Questionnaire (WDQ) Worry 44 
Social Interaction and Anxiety Scale (SIAS) Social Anxiety 18 
Social Phobia Scale (SPS) Social Anxiety 11 
Impact of Event Scale – Revised (IES-R)¹ Total PTSD 19 
Body Image Concern Inventory (BICI) BDD 39 
Whitely Index (WI) Hypochondriasis 5 
CIS20R Chronic Fatigue 74 
ROM, routine outcome monitoring; MDD denotes major depressive disorder; OCD denotes obsessive compulsive 
disorder; PTSD denotes posttraumatic stress disorder; BDD denotes body dysmorphic disorder. 
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In het kort
NormQuest is een studie die ten doel had referentiewaarden (normscores) voor de in Routine 
Outcome Monitoring (ROM) gebruikte vragenlijsten in een huisartspopulatie vast te stellen. 
Die referentiewaarden waren voor de meeste ROM vragenlijsten niet bekend, maar ze zijn 
wel van belang voor een juiste interpretatie van de scores bij patiënten met stemmings-, 
angst- en somatoforme (SAS-) stoornissen in de tweede en de derde lijn. In NormQuest 
stelden we deze referentiewaarden vast bij een grote steekproef van ca. 1300 patiënten uit 
huisartspraktijken voor negentien vragenlijsten die in ROM-SAS gebruikt worden.
Inleiding
In de geestelijke gezondheidszorg is het gebruikelijk dat de resultaten van een behandeling 
geëvalueerd worden door de behandelaar en de patiënt. ROM is een methode om die resultaten 
meer objectief vast te stellen door regelmatig de aard, de ernst en het beloop van klachten 
van patiënten te meten. Feedback over de behandelresultaten is gunstig gebleken voor de 
behandeling: deze werkt naast informerend vooral ook beïnvloedend en motiverend voor de 
patiënt. Een behandelaar kan met deze feedback nagaan of de behandeling aanslaat. ROM 
blijkt een gunstig effect te hebben op de communicatie tussen patiënt en behandelaar. Deze 
feedback wordt mogelijk gemaakt door ROM-scores te vergelijken met referentiewaarden. 
Behalve voor het meten van de werkzaamheid van de behandeling kunnen referentiewaarden 
gebruikt worden ter ondersteuning van besluiten over voortzetting, wijziging of beëindiging 
van de behandeling.
Een 64-jarige vrouw werd opgenomen met ernstige depressieve en angstklachten. Haar 
problemen waren 7 jaar geleden nogal abrupt begonnen na echtelijke problemen die 
resulteerden in een echtscheiding. In haar medische verleden was er sprake van agorafobie 
en orthostatische hypotensie (plotselinge bloeddrukdalingen met duizeligheid of flauwvallen 
als gevolg). Meerdere malen werd ze behandeld voor angst en depressie met psychotherapie 
en verschillende antidepressiva, soms klinisch, soms poliklinisch. Vanwege ernstige depressie 
met psychotische kenmerken en resistentie tegen behandeling met antidepressiva werd ze 
opgenomen in de psychiatrische universiteitskliniek (PUK) van het Leids Universitair Medisch 
Centrum (LUMC). Ze werd gedurende enige tijd behandeld met elektroconvulsietherapie 
(ECT) en haar depressie verminderde. Tijdens de behandeling werd de ernst van de depressie 
wekelijks beoordeeld door haar psychiater. Ook werden er wekelijks ROM-scores bepaald 
door een onafhankelijk onderzoeksverpleegkundige.
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 De ROM-scores in het bovenstaande geval behoeven interpretatie. Is de patiënt 
verbeterd of hersteld (in remissie), verslechterd, of niet veranderd? Een belangrijke vraag 
voor de therapeut is: wanneer is de patiënt voldoende hersteld om de volgende stap in de 
behandeling te maken? Een aanpak die een dergelijke beslissing kan ondersteunen is het 
vergelijken van de ROM-scores met die van een normale of referentiepopulatie. Wanneer 
ROM-scores onder een bepaalde cut-off-waarde komen, is de patiënt qua ernst van de 
depressieve symptomen niet meer te onderscheiden van de normale referentiepopulatie. 
De behandeling zou dan kunnen verschuiven naar het voorkomen van een terugval en de 
patiënt zou terugverwezen kunnen worden naar de eigen huisarts. Evidence based cut-off-
waarden voor ROM-vragenlijsten kunnen klinische beslissingen ondersteunen. Deze cut-
off-waarden kunnen worden afgeleid uit de verdeling van scores van de gezonde bevolking 
en van patiëntenpopulaties. Cut-off-waarden en aanvullende scoreverdelingen worden hier 
aangeduid als referentiewaarden.
Doel van deze NormQuest-studie
Voor diverse ROM-vragenlijsten zijn er nog geen referentiewaarden beschikbaar. Om deze 
referentiewaarden te ontwikkelen, werd in 2008 de NormQuest-studie geïnitieerd door 
de afdeling Psychiatrie van het LUMC en de Zuid-Hollandse instelling voor geestelijke 
gezondheidszorg Rivierduinen. Dit proefschrift presenteert referentiewaarden voor 19 
ROM-vragenlijsten (18 bestaande en 1 nieuw ontwikkelde) die kunnen worden gebruikt om 
klinische beslissingen te ondersteunen bij de behandeling en verwijzing van patiënten met 
SAS-stoornissen. Referentiewaarden bestaan uit afkap (cut-off-) waarden die het verschil 
markeren tussen de patiëntenpopulatie (‘psychisch ziek’) en de referentiepopulatie (‘gezond’).
 Verder wordt het onderscheidend vermogen van de vragenlijsten besproken aan 
de hand van Receiver Operating Characteristics (ROC-) analyses. Ook wordt het effect 
van geslacht en leeftijd op referentiewaarden gepresenteerd. Het secundaire doel van de 
NormQuest-studie betreft de noodzaak van de ontwikkeling van publiek domein vragenlijsten. 
De generieke Symptom Questionnaire-48 (SQ-48) is ontwikkeld en referentiewaarden 
worden gepresenteerd.
ROM-vragenlijsten
Voor het meten van de klachten binnen ROM is een reeks van objectieve, standaard 
vragenlijsten (zowel voor zelfrapportage als observaties) een essentieel onderdeel. ROM-
vragenlijsten moeten klinisch relevant, gevoelig voor verandering en minimaal belastend 
voor patiënten, personeel en organisatie zijn. Derhalve dient de keuze van vragenlijsten 
gebaseerd te zijn op validiteit, betrouwbaarheid en op beschikbaarheid in het publieke 
domein. Vragenlijsten voor ROM zijn generiek of specifiek. Generieke vragenlijsten worden 
gebruikt voor het meten van algemene psychopathologie, angst of algemeen functioneren. 
Omdat ze in principe geschikt zijn voor alle patiënten met psychische problemen, maken 
ze uitspraken mogelijk over het behandeleffect, onafhankelijk van de diagnose. Verder zijn 
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ze geschikt voor patiënten met meer dan een aandoening. Bovendien vergemakkelijken 
ze vergelijkingen tussen verschillende patiëntengroepen. Ziekte-specifieke vragenlijsten 
zijn gericht op specifieke symptomen van een enkele psychiatrische aandoening of groep 
stoornissen en worden alleen aangeboden aan patiënten die voldoen aan de criteria voor die 
bepaalde stoornis. Zij zijn gevoeliger voor veranderingen door de behandeling, aangezien ze 
de intensiteit van de symptomen waarvoor behandeld wordt meten. Voor bijna alle ROM-
vragenlijsten geldt dat een hogere score op een vragenlijst méér psychopathologie betekent.
Omdat ROM-vragenlijsten bij veel patiënten afgenomen worden, vaak ook meerdere 
keren, is het belangrijk dat er geen of minimale kosten verbonden zijn aan het gebruik van 
de vragenlijsten. Een belangrijk criterium voor selectie van onze vragenlijsten is daarom 
geweest dat deze beschikbaar waren in het publieke domein.
Stemmings-, Angst- en Somatoforme (SAS-) stoornissen
De meerderheid van de patiënten van het LUMC en een aanzienlijk aantal patiënten van 
Rivierduinen worden behandeld voor SAS-stoornissen. Schattingen van de life-time 
prevalentie in Nederland bedragen ruim 19% voor de groep stemmings- en angststoornissen. 
Minder duidelijk is de prevalentie van somatoforme stoornissen, maar schattingen van de 
prevalentie zijn ook relatief hoog (± 16%). SAS-aandoeningen komen vaak voor als comorbide 
stoornissen: depressie gaat vaak gepaard met angst en patiënten met een angststoornis 
zijn ook vaak somber gestemd. Ook kunnen bijvoorbeeld persoonlijkheidsstoornissen en 
middelenmisbruik naast SAS-stoornissen voorkomen.
 SAS-aandoeningen zijn de meest frequent waargenomen psychische stoornissen in 
de eerste lijn (bij de huisarts). De ziektelast is zeer groot, met de depressieve stoornis als de 
meest belangrijke bijdrage aan de wereldwijde ziektelast. 
Referentiewaarden
Referentiewaarden worden gebruikt voor variabelen die kwantitatief worden beoordeeld, 
zoals lichaamstemperatuur of ernst van de depressie. Referentiewaarden worden bepaald 
in een referentiepopulatie. De selectie van de referentiepopulatie en de definitie van de 
referentiewaarden zijn van de referentiepopulatie en de definitie van de referentiewaarden zijn 
belangrijk. De referentiepopulatie moet bestaan uit individuen met een goed gedefinieerde 
gezondheidstoestand. Gezondheid kan worden gedefinieerd op verschillende manieren: 
medisch en statistisch. De medische benadering beschouwt gezondheid als afwezigheid 
van pathologie, in absolute termen, of op zijn minst van een bepaald type van pathologie. 
Zo worden mensen met die aandoening uitgesloten van de referentiepopulatie. Wanneer 
volgens deze medische benadering referentiewaarden voor bijvoorbeeld depressie bepaald 
worden, zullen depressieve patiënten uitgesloten worden van de referentiepopulatie. De 
statistische benadering is gebaseerd op de verdeling van de scores van een variabele in een 
totale referentiepopulatie, inclusief personen die toevallig hoog scoren op die variabele. In 
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de statistische benadering worden scores in de centrale 95% meestal beschouwd als gezond; 
extreem hoge of lage scores worden als afwijkend gezien. Voor veel ROM-variabelen, 
zoals de ernst van een depressie, is alleen een extreem hoge score afwijkend. (Een hogere 
score op een vragenlijst betekent immers méér psychopathologie. Heel lage scores hebben 
daarom geen speciale betekenis.) In dergelijke gevallen wordt ‘afwijkend’ beperkt tot de 
top 5% van de verdeling. Personen met verhoogde niveaus van psychopathologie worden 
niet uitgesloten van de referentiegroep, want anders zou een te gezonde (‘supernormale’) 
steekproef gecreëerd worden. De resulterende referentiewaarden zouden overdreven streng 
zijn. Van de psychiatrisch zieke populatie echter, kan de onderste 5% van de scores worden 
beschouwd als ‘afwijkend’: hun symptomen zijn subsyndromal geworden – er zijn nog wel 
klachten, maar men is niet meer ernstig ziek. In deze studie werd de statistische benadering 
gevolgd.
 We berekenden percentiel scores als referentiewaarden. In een scheve verdeling, 
zoals we die (terecht, naar later bleek) verwachtten voor de ROM-referentiegroep, zijn deze 
meer zinvol dan de vaak gebruikte gemiddeldes en standaarddeviaties. Om vergelijking 
met de internationale literatuur mogelijk te maken, hebben we echter gemiddeldes en 
standaarddeviaties wel bepaald. 
Samenvatting van de belangrijkste bevindingen
Dit is de eerste in Nederland uitgevoerde studie van deze omvang die als doel heeft 
referentiewaarden te genereren voor SAS-vragenlijsten. Hoofdstuk 2 beschrijft de 
doelstellingen, het design en de methodieken van deze studie. Twee groepen werden 
geïncludeerd. De eerste groep, de ROM-patiëntengroep, bestond uit 5.269 patiënten die voor 
een of meer SAS-stoornissen behandeld werden op de polikliniek van het LUMC of bij de 
Zuid-Hollandse instelling voor geestelijke gezondheidszorg Rivierduinen. De patiënten, in 
de leeftijd van 18-65 jaar, werden gescreend als onderdeel van de routine intakeprocedure. 
De tweede groep, de ROM-referentiegroep, bestond uit 1302 huisartspatiënten, ook tussen 
18 en 65, geregistreerd bij een van de acht deelnemende huisartsen, maar niet per se 
onder behandeling. Deze personen kunnen worden beschouwd als een steekproef van de 
algemene bevolking, aangezien in Nederland 99,9% van de bevolking staat ingeschreven 
bij een huisarts. De ROM-referentiegroep en de ROM-patiëntengroep waren vergelijkbaar 
in termen van geslacht, leeftijdsopbouw en het wonen in een stad of een dorp. Gegevens die 
werden verzameld bestonden uit een gestandaardiseerd diagnostisch interview (MINI-Plus 
5.0.0) en uit enkele beoordelingsschalen (BAS, MADRS). Daarnaast werden door de patiënt 
of deelnemer een aantal zelfrapportage vragenlijsten ingevuld. De interviewers werden 
uitgebreid getraind en begeleid, waardoor de interbeoordelaars-betrouwbaarheid en validiteit 
van de metingen geoptimaliseerd werden.
 In de hoofdstukken 3 tot en met 6 worden de gevonden referentiewaarden voor de 
18 (reeds bestaande) vragenlijsten besproken. De belangrijkste referentiewaarden betreffen 
het 95ste percentiel van de huisartspatiënten (P95 ROM-referentiegroep) en het 5de percentiel 
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van de psychiatrische patiënten (P5 ROM-patiëntengroep). Deze zijn weergegeven in Tabel 
I en Tabel II van de Appendix. Deze referentiewaarden kunnen een verantwoordelijke, 
klinische besluitvorming met betrekking tot het initiëren, aanpassen of beëindigen van de 
behandeling ondersteunen. Daarnaast kunnen ze beslissingen ondersteunen met betrekking tot 
het doorverwijzen van patiënten uit de GGZ (gespecialiseerde geestelijke gezondheidszorg) 
terug naar de huisarts en andersom van de huisartspraktijk naar de GGZ.
De 18 vragenlijsten omvatten de volgende 4 clusters: 
1) Vier generieke vragenlijsten: Brief Symptom Inventory (BSI), Mood & Angst Symptom 
Questionnaire 30-item (MASQ-D30), Short Form 36 (SF36) en Dimensional Assessment of 
Personality Pathology–short form (DAPP-SF)
2) Drie vragenlijsten die depressie meten: Beck Depressie Inventory-II (BDI-II), Inventory 
of Depressive Symptomatology - Self-Report (IDS-SR) en Montgomery Åsberg Depressie 
Rating Scale (MADRS);
3) Acht vragenlijsten die angst meten: Brief Scale for Angst (BSA), PADUA Inventory 
Revised (PI-R), Panic Appraisal Inventory (PAI), Penn State Worry Questionnaire (PSWQ), 
Worry Domains Questionnaire (WDQ), Social Interaction and Angst Scale (SIAS), Social 
Phobia Scale (SPS), and Impact of Event Scale – Revised (IES-R);
4) Drie vragenlijsten die somatoforme stoornissen meten: Body Image Concern Inventory 
(BICI), Whitely Index (WI) en Checklist Individual Strength (CIS20R).
Het eerste en tweede cluster vragenlijsten werden aangeboden aan alle ROM-referentiegroep 
deelnemers. Vervolgens beantwoordde 50% van deze groep het cluster met de vragenlijsten 
die angst meten, de andere 50% vulde de vragenlijsten in die somatoforme stoornissen 
meten. Alle ROM-patiënten werd het cluster generieke vragenlijsten aangeboden, ongeacht 
hun stoornis. De stoornisspecifieke clusters werden alleen aangeboden aan die patiënten die 
met de betreffende stoornis(sen) gediagnosticeerd werden.
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De gegevens illustreren sekse-specifieke resultaten. Er was een tendens voor vrouwen in 
de ROM-referentiegroep om hoger te scoren (en dus meer klachten te rapporteren) op alle 
vragenlijsten, behalve op de DAPP-SF. Het onderscheidend vermogen van de generieke 
vragenlijsten was goed met uitzondering van dezelfde DAPP-SF, die daar niet voor ontworpen 
is. De stoornisspecifieke vragenlijsten lieten een zeer goed onderscheidend vermogen zien. 
De interne consistentie varieerde van voldoende tot uitstekend voor alle totaalscores.
 Hoofdstuk 7 beschrijft de ontwikkeling en validatie van onze nieuw ontwikkelde 
publieke domein vragenlijst, de 48-item Symptom Questionnaire (SQ-48). De SQ-48 werd 
ontwikkeld als generieke, multidimensionale vragenlijst. Het onderscheidend vermogen 
van de vragenlijst blijkt goed te zijn. De resultaten tonen een goede interne consistentie 
en goede convergente en divergente validiteit. Uiteraard werden ook voor deze SQ-48 
referentiewaarden bepaald. De belangrijkste zijn weergegeven in de eerder genoemde Tabel 
I en Tabel II van de Appendix.
Klinisch gebruik van de referentiewaarden
Referentiewaarden kunnen aangeven of een patiënt voldoende hersteld is zodat de volgende 
stap in de behandeling gezet kan worden. Clinici in de GGZ kunnen bepaalde cut-off-
waarden gebruiken om hun beslissingen te ondersteunen met betrekking tot beëindiging 
van de behandeling en mogelijke terugverwijzing naar de huisarts. Andersom kunnen 
huisartsen een (andere) set van cut-off-waarden gebruiken die hun beslissing met betrekking 
tot doorverwijzing naar de GGZ ondersteunen. Zo is de keuze van de cut-off-waarden 
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Beslissingen betreffende het beëindigen van de GGZ behandeling 
en het mogelijk terugverwijzen naar de huisarts
Men zou kunnen stellen dat patiënten in behandeling gaan wanneer ze deel zijn gaan 
uitmaken van een patiënten-(klinisch zieke) populatie. Andersom kan beëindiging van de 
behandeling en terugverwijzing worden overwogen wanneer de patiënt niet langer deel 
uitmaakt van die zieke populatie, maar gaat behoren tot de referentie-(‘gezonde’) populatie 
qua klachtenpatroon. Daarom is ‘gezondheid’ de conditie die moet worden opgespoord. Dit 
is het geval wanneer de patiënt behoort tot de range van 95% ‘normalen’ van de ROM-
referentiegroep, want we definiëren 5% van de uiterste waarnemingen aan de hoge kant van 
de verdeling van de ROM-referentiegroep scores als afwijkend. De cut-off-waarde die de 
top 5% van de ROM-referentiegroep markeert, is gelijk aan de 95ste percentiel score: de P95 
ROM-referentiegroep (zie Figuur 9.1). Deze cut-off-waarde kan worden beschouwd als een 
betrouwbare indicator voor de symptomatische gezondheid, omdat die zelden gezondheid 
mist bij diegenen die daadwerkelijk psychiatrisch gezien gezond zijn. Echter, hoge 
sensitiviteit voor gezondheid is gekoppeld aan lage sensitiviteit voor ziekte. Het nadeel van 
de lage sensitiviteit voor ziekte (met veel fout-negatieve resultaten) kan valse geruststelling 
over de afwezigheid van ziekte zijn. In Tabel 9.1 zijn de P95 ROM-referentiegroep cut-off-
waarden van de 18 bestaande ROM-vragenlijsten en van de SQ-48 weergegeven.
Figuur 9.1: De cut-off-waarde die relevant is voor terugverwijzing naar de huisarts. GGZ-behandeling 
van een patiënt kan beëindigd worden wanneer de patiënt niet langer tot de patiëntenpopulatie behoort 
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Terugverwijzing naar de huisarts kan geïndiceerd zijn zelfs wanneer de patiënt nog enige 
restsymptomen heeft. Dit strookt met het feit dat een aanzienlijk deel van de huisartspatiënten 
wel enige klachten of symptomen heeft. Daarnaast kan terugverwijzing naar de huisarts 
worden geïndiceerd voor patiënten met terugkerende depressies voor de behandeling van 
eventuele resterende stemmingsklachten.
 In Tabel 9.1 van de Appendix zijn de belangrijkste cut-off-waarden, de P95 ROM-
referentiegroepwaarden, weergegeven voor de 18 reeds bestaande ROM- vragenlijsten plus 
de SQ-48. In vergelijking met eerder gepubliceerde cut-off-waarden zijn deze waarden 
over het algemeen hoger. Dit betekent dat een patiënt eerder in aanmerking zal komen voor 
terugverwijzing naar de huisarts en met meer restverschijnselen dan voorheen.
 Er zijn patiënten die ondanks behandeling continu hoge ernstscores blijven houden. 
Het kan zijn dat voor hen de behandeling niet (langer) effectief is. Eerder gepubliceerde 
cut-off-waarden zouden suggereren dat deze patiënten nog niet klaar zijn om te worden 
terugverwezen naar de huisarts, terwijl onze cut-off-waarden een dergelijke beslissing wel 
zouden steunen. Aan de andere kant wil men niet dat de huisartspatiëntenpopulatie vergroot 
wordt met patiënten met veel restsymptomen en het daarbij horende verhoogde risico op 
terugval. De ROM-referentiegroep cut-off-waarden kunnen het maken van een goede 
afweging ondersteunen.
Beslissingen betreffende eventuele doorverwijzing vanuit 
de huisarts naar de GGZ 
Doorverwijzing naar de GGZ kan aan de orde zijn wanneer de huisartspatiënt meer 
vergelijkbaar is met de patiëntenpopulatie dan met de referentiepopulatie. ‘Ziekte’ is dan de 
conditie die moet worden gedetecteerd. Dit is het geval wanneer de huisartspatiënt behoort 
tot de range van 95% ‘zieken’ van de ROM-patiëntengroep, want we definiëren 5% van de 
uiterste waarnemingen aan de lage kant van de verdeling van de ROM-patiëntengroepscores 
als afwijkend, ofwel gezond. De cut-off-waarde die de laagste 5% van de ROM-patiëntengroep 
markeert, is gelijk aan de 5de percentielscore: de P5 ROM-patiëntengroep (zie Figuur 9.2). 
Deze cut-off-waarde vertegenwoordigt hoge sensitiviteit voor psychopathologie. In Tabel 9.2 
zijn de P5 ROM-patiëntengroep cut-off-waarden van de 18 bestaande ROM vragenlijsten en 
van de SQ-48 weergegeven.
 Bij gebruik van de P5 ROM-patiëntengroepwaarden voor verwijzing naar de GGZ 
moet een aantal zaken in overweging worden genomen. De P5 cut-off-waarde is zeer gevoelig 
voor de ziekte. Het kan worden beschouwd als een betrouwbare ondersteuning van de 
besluitvorming als het resultaat negatief is, omdat echte positieven (met psychopathologie) 
zelden worden gemist onder degenen die een positieve testuitslag hebben (d.w.z. dat de 
meeste zieke mensen ook als zodanig herkend worden). Echter, een hoge sensitiviteit is steeds 
gerelateerd aan een lage specificiteit. Lage specificiteit (d.w.z. veel fout positieve resultaten) 
houdt in dat relatief veel personen verdacht worden van een diagnose terwijl zij de ziekte niet 
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hebben. Bovendien kan het leiden tot extra tests en eventuele behandelingen die niet nodig of 
zelfs schadelijk kunnen zijn. of zelfs schadelijk kunnen zijn.
Figuur 9.2: De cut-off-waarde die relevant is voor verwijzing naar de GGZ. Patiënten kunnen daar 
behandeld worden wanneer ze niet langer deel uitmaken van de referentiepopulatie maar van de 
patiëntenpopulatie: dit is boven de cut-off-waarde P5 ROM-patiëntengroep.
 De afweging of doorverwijzing naar de GGZ nodig is, kan moeilijk zijn vanwege 
de vaak relatief subjectieve aard van psychiatrische klachten. Bij depressieve klachten 
kan de stoornis onopgemerkt en onbehandeld blijven. De oorzaak zou kunnen zijn dat 
huisartsen geneigd zijn meer in te spelen op het algemene niveau van onwelzijn dan de 
formele criteria voor depressie te testen. Een ander obstakel voor doorverwijzing naar de 
GGZ zouden bezwaren van de patiënt tegen de verwachte langdurige behandeling kunnen 
zijn. De referentiewaarden van de -studie kunnen klinische beslissingen ondersteunen m.b.t. 
een eventuele doorverwijzing naar de GGZ.
Algemene discussie
In onze analyses zagen we sekseverschillen in referentiewaarden in de ROM-referentiegroep: 
in vergelijking met mannen rapporteerden vrouwen ernstigere symptomen, zoals gemeten 
met de meeste observationele en zelfrapportageschalen voor algemene psychopathologie, 
depressie, angst en de stoornis in de lichaamsbeleving. Er werden geen sekseverschillen 
gevonden voor de persoonlijkheidsvragenlijst, de hypochondrievragenlijst en de 
chronischevermoeidheidsvragenlijst. Deze bevindingen waren niet onverwacht, aangezien 
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patiëntengroepen als voor de algemene bevolking. Vrouwen rapporteren twee keer zoveel 
depressieve of angstklachten als mannen. Geslacht kan worden gerelateerd aan een aantal 
omgevingsfactoren en andere aspecten van psychopathologie zoals stressoren en de mate 
van blootstelling hieraan. Deze beïnvloeden  een eventueel begin van de ziekte, hoe 
symptomen worden uitgedrukt, of patiënten hulp zoeken en hoe ze worden behandeld in 
de geestelijke gezondheidszorg. De vraag is wat er precies verschillend is tussen mannen 
en vrouwen. Zijn het de symptomen zelf, de gevoeligheid voor symptomen, de manier van 
presenteren, of de maatstaven voor wat nog acceptabel is m.b.t. psychische klachten? Krijgen 
(of nemen) vrouwen meer de gelegenheid om psychische klachten te bespreken bij de GGZ? 
De literatuur lijkt erop te wijzen dat het traditionele masculiene genderrol stereotype de 
belangrijkste factor is. Of zijn de verschillen veroorzaakt door de vragenlijsten en de criteria 
die worden gehanteerd in de geestelijke gezondheidszorg? Het gebruik van sekse-specifieke 
referentiewaarden voor generieke  en SAS-vragenlijsten is echter open voor discussie. Als 
wordt aangenomen dat de cut-off-waarde P95 ROM-referentiegroep lager voor mannen zou 
zijn, zou het impliceren dat vrouwen, behandeld in de GGZ, eerder zouden kunnen worden 
terugverwezen naar de eerste lijn. Ze hebben dan gemiddeld meer restverschijnselen dan 
mannen.
 Ook het effect van leeftijd op de referentiewaarden werd bestudeerd. Aangezien 
een duidelijk algemene leeftijdseffect ontbrak, hebben we besloten dit niet verder in detail te 
beschrijven. 
 De ROM-vragenlijsten zijn primair bedoeld voor de ernstmeting van de SAS-
aandoeningen. Een bijkomend doel van de NormQuest-studie was om te testen of deze 
vragenlijsten het diagnostische proces kunnen ondersteunen. Het onderscheidend vermogen, 
indicatief voor de diagnostische mogelijkheden van vragenlijsten, bleek voor de meeste 
generieke vragenlijsten (behalve de DAPP-SF) goed te zijn en voor alle 14-stoornis-specifieke 
vragenlijsten was het uitstekend. Dus, hoewel de vragenlijsten in deze studie niet ontworpen 
zijn voor hun diagnostische waarde maar voor ernstmeting, suggereren de goede prestaties 
toch dat deze vragenlijsten (behalve DAPP-SF) het diagnostische proces wel kunnen 
ondersteunen. Deze vragenlijsten kunnen echter de MINI-Plus als diagnoseinstrument niet 
vervangen. De MINI-Plus richt zich op algemene psychopathologie, distress of algemeen 
functioneren. Het klinisch oordeel blijft natuurlijk een essentieel onderdeel vormen van deze 
observatielijst voor het stellen van de klinische hoofddiagnose. De MINI-Plus kan bovendien 
gebruikt worden bij patiënten met meer dan één aandoening.
 Onze bevindingen zijn gedaan bij volwassenen tussen de 18 en 65 jaar oud. 
Toekomstig onderzoek zal daarom referentiewaarden voor kinderen en ouderen moeten 
bepalen. Daarnaast zou verder onderzocht kunnen worden of de arbitraire grens van 95% 
van een populatie als ‘normaal’ te definiëren (en 5% als ‘abnormaal’) gerechtvaardigd is. 
Referentiewaarden zijn al veel gebruikt in een groot deel van de medische wereld, maar 
minder in de geestelijke gezondheidszorg. Verder onderzoek naar de implementatie van 
ROM en de geleverde referentiewaarden zijn noodzakelijk.




Tabel 9.1: Cut-off-waarden voor de GGZ die beslissingen t.a.v. terugverwijzing naar de huisarts kunnen ondersteunen - P95 
ROM-referentiegroep. 
Vragenlijst Domein Cut-off 
Symptom Questionnare 48 items (SQ-48) Generiek  
        Aggressie (AGGR)  5.0 
        Agorafobie (AGOR)  2.0 
        Angst (ANXI)  11.2 
        Cognitieve klachten (COGN)  11.0 
        Depressie (MOOD)  8.0 
        Somatische klachten (SOMA)  8.0 
        Sociale fobie (SOPH)  9.0 
        Vitaliteit/optimisme (VITA)  15.0 
Brief Symptom Inventory (BSI) Generiek 0.68 
Mood & Anxiety Symptom Questionnaire 30-item (MASQ-D30) Generiek depressie/angst   
       Non-specifieke symptomen (NA)    depressie 23 
       Anhedonie (PA)    angst 29 
       Fysiologische hyperarousal (SA)  17 
Short Form 36 (SF36 of RAND36)*  Generiek  
       Fysiek Functioneren  Kwaliteit van leven 65 
       Beperkingen functioneren tgv lichamelijke klachten  13 
       Pijnklachten  54 
       Sociaal Functioneren  63 
       Geestelijke gezondheid  56 
       Beperkingen functioneren tgv emotionele klachten  33 
       Vitaliteit  40 
       Algemene gezondheidsbeleving  45 
Dimensional Assessment of Personality Pathology–short form (DAPP-SF) Generiek   
       Volgzaam (bedeesdheid) Persoonlijkheid       3.50 
       Cognitieve vertekening        2.33 
       Identiteitsproblemen  2.70 
       Affectieve labiliteit/onstabiliteit  3.50 
       Behoefte aan prikkels  3.38 
       Dwangmatigheid  4.00 
       Gesloten  3.63 
       Gebrekkige empathie  2.60 
       Passief-agressief  3.20 
       Niet gesteld op intimiteit  3.38 
       Dominantie  3.75 
       Bezorgdheid/angstig  3.50 
       Gedragsproblemen  2.13 
       Gebrek aan vertrouwen in de medemens  2.15 
       Sociale ontwijking  3.33 
       Narcisme  3.50 
       Onveilige hechting  3.33 
       Zelfbeschadiging  1.50 
Beck Depression Inventory-II (BDI-II)  Depressie 13 
Inventory of Depressive Symptomatology - Self-Report (IDS-SR) Depressie  20 
Montgomery Åsberg Depression Rating Scale (MADRS) Depressie  11 
Brief Anxiety Scale (BAS) Angststoornis 11 
PADUA Inventory Revised (PI-R) OCS 43 
Paniek Opinie Lijst (POL) Paniekstoornis 37 
        Paniekverwachting  47 
        Catastrofale gevolgen van paniek (Total):   
        Maten van zelfvertrouwen in omgaan met paniek   65 
Penn State Worry Questionnaire (PSWQ) Piekeren (patholog.) 66 
Worry Domains Questionnaire (WDQ) Piekeren (normaal) 74 
Social Interaction and Anxiety Scale (SIAS) Sociale angst 32 
Social Phobia Scale (SPS) Sociale angst 19 
Impact of Event Scale – Revised (IES-R)¹ Total PTSS 36 
Body Image Concern Inventory (BICI) Lichaamsbeleving 55 
Whitely Index (WI) Hypochondrie 6 
Checklist Individuele Spankracht (CIS20R) Chron. vermoeidheid 92 
ROM - routine outcome monitoring; OCS - obsessief compulsieve stoornis; PTSS - posttraumatische stress stoornis. 
*: P5 ROM referentiegroep en P95 ROM patiëntengroep, aangezien hogere scores een beter functioneren aangeven 
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Table 9.2: Cut-off-waarden voor huisartsen die beslissingen t.a.v. verwijzing naar de GGZ kunnen 
ondersteunen - P5 ROM-patiëntengroep 
Vragenlijst Domein Cut-off 
Symptom Questionnare 48 items (SQ-48) Generiek  
        Aggressie (AGGR)  0.0 
        Agorafobie (AGOR)  0.0 
        Angst (ANXI)  2.0 
        Cognitieve klachten (COGN)  3.0 
        Depressie (MOOD)  1.0 
        Somatische klachten (SOMA)  0.0 
        Sociale fobie (SOPH)  0.0 
        Vitaliteit/optimisme (VITA)  6.0 
Brief Symptom Inventory (BSI) Generiek 0.34 
Mood & Anxiety Symptom Questionnaire 30-item (MASQ-D30) Generiek 
depressie/angst 
 
       Non-specifieke symptomen (NA)    depressie 17 
       Anhedonie (PA)    angst 17 
       Fysiologische hyperarousal (SA)  18 
Short Form 36 (SF36 of RAND36)*  Generiek  
       Fysiek Functioneren    Kwaliteit van leven 100 
       Beperkingen functioneren tgv lichamelijke klachten  100 
       Pijnklachten  100 
       Sociaal Functioneren  88 
       Geestelijke gezondheid  76 
       Beperkingen functioneren tgv emotionele klachten  100 
       Vitaliteit  65 
       Algemene gezondheidsbeleving  90 
Dimensional Assessment of Personality Pathology–short form (DAPP-SF) Generiek   
       Volgzaam (bedeesdheid)    persoonlijkheid 1.25 
       Cognitieve vertekening  1.00 
       Identiteitsproblemen  1.33 
       Affectieve labiliteit/onstabiliteit  1.63 
       Behoefte aan prikkels  1.00 
       Dwangmatigheid  1.38 
       Gesloten  1.75 
       Gebrekkige empathie  1.00 
       Passief-agressief  1.40 
       Niet gesteld op intimiteit  1.13 
       Dominantie  1.13 
       Bezorgdheid/angstig  1.67 
       Gedragsproblemen  1.00 
       Gebrek aan vertrouwen in de medemens  1.00 
       Sociale ontwijking  1.17 
       Narcisme  1.10 
       Onveilige hechting  1.00 
       Zelfbeschadiging  1.00 
Beck Depression Inventory-II (BDI-II)  Depressie 14 
Inventory of Depressive Symptomatology - Self-Report (IDS-SR) Depressie  18 
Montgomery Åsberg Depression Rating Scale (MADRS) Depressie  11 
Brief Anxiety Scale (BAS) Angststoornis 6 
PADUA Inventory Revised (PI-R) OCS 20 
Paniek Opinie Lijst (POL) Paniekstoornis  
        Paniekverwachting  14 
        Catastrofale gevolgen van paniek (Total):  10 
        Maten van zelfvertrouwen in omgaan met paniek   29 
Penn State Worry Questionnaire (PSWQ) Piekeren (patholog.) 48 
Worry Domains Questionnaire (WDQ) Piekeren (normaal) 44 
Social Interaction and Anxiety Scale (SIAS) Sociale angst 18 
Social Phobia Scale (SPS) Sociale angst 11 
Impact of Event Scale – Revised (IES-R)¹ Total PTSS 19 
Body Image Concern Inventory (BICI) Lichaamsbeleving 39 
Whitely Index (WI) Hypochondrie 5 
Checklist Individuele Spankracht (CIS20R) Chron. vermoeidheid 74 
ROM - routine outcome monitoring; OCS - obsessief compulsieve stoornis; PTSS - posttraumatische stress 
stoornis. 
*: P5 ROM referentiegroep en P95 ROM patiëntengroep, aangezien hogere scores een beter functioneren aangeven 
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LIST OF ABBREVIATIONS
AA   Anxious Arousal
AD   Anhedonic Depression
AD   Agoraphobia
AGO   Agoraphobia Scale
ANX   Anxiety
ASD   Acute stress disorder 
AUC   Area Under the ROC Curve
BDI-II   Beck Depression Inventory version II
BICI   Body Image Concern Inventory
BSA   Brief Scale for Anxiety
BSI   Brief Symptom Inventory
CFA   Confirmatory Factor Analysis
CFI   Comparative Fit Index
CFS   Chronic Fatigue Syndrome
CIDI   Composite International Diagnostic Interview
CIS20r   Checklist Individual Strength
COTAN   Commissie Testaangelegenheden Nederland
CPRS-SF  Comprehensive Psychopathological Rating Scale-Short Form
CVA   Cerebro vascular accident
Cα   Cronbach’s alpha
DAPP-BQ  Dimensional Assessment of Personality Pathology – Basic   
   Questionnaire
DAPP-sf  Dimensional Assessment of Personality Pathology - Short Form
DD   Dysthymic disorder
DEP   Depression
DSM-IV-TR   Diagnostic and Statistical Manual of Mental Disorders, fourth   
   edition, text revision
e.g.   Exempli gratia (meaning: for example)
ECT   Electroconvulsive Therapy
ERB   Ethical Review Board
GAD   Generalized anxiety disorder
GAF   Global Assessment of Functioning Scale
GD   General Distress
GP   General practitioner
HOS   Hostility
HPA   Hypothalamic-pituitary-adrenal 
i.e.   Id est (meaning: that is)
IDS-SR   Inventory of Depressive Symptoms (Self Report)
IES-R   Impact of Event Scale – Revised
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I-S   Interpersonal Sensitivity
LUMC   Leiden University Medical Center
M   Mean
MADRS  Montgomery-Äsberg Depression Rating Scale 
MAS   Mood, anxiety, and somatoform
MASQ-D30  Mood & Anxiety Symptom Questionnaire -30
MDD   Major depressive disorder 
MINI Plus 5.0.0. * Mini International Neuropsychiatric Interview Plus 5.0.0.
MOS   Rand Medical Outcome Study
NA   Negative Affect
NEMESIS  Netherlands Mental Health Survey and Incidence Study
O-C   Obsessive-Compulsive
OCD   Obsessive-compulsive disorder
PA   (lack of) Positive Affect
PADUA/PI-r  PADUA Inventory revised
PAI   Panic Appraisal Inventory
PAR   Paranoid Ideation
PHOB   Phobic Anxiety
PSWQ   Penn State Worry Questionnaire
PSY   Psychoticism
PTSD   Posttraumatic stress disorder
RD   Rivierduinen
RMSE   Root Mean Square Error of Approximation
ROC   Receiver Operating Characteristics
ROM   Routine Outcome Monitoring
SA   Somatic Arousal
SCID   Structured Clinical Interview for Diagnostic and Statistical   
   Manual
SD   Standard deviation
SD   Standard deviation
SF-36   Short Form Health Survey 36
SIAS   Social Interaction and Anxiety Scale
SOM   Somatization
SoPD   Social phobia
SpPD   Specific phobia 
SPS   Social Phobia Scale
SQ-48   Symptom Questionnaire -48 Items
vCPRS *  Abbreviated Comprehensive Psychopathological Rating Scale
WDQ   Worry Domains Questionnaire
WI   Whitely Index
WSQ   Web Screening Questionnaire for common mental disorders
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enorm gewaardeerd. Vivian, Alice en Lia, ook jullie secretariele hulp was heel fijn.
 Arianne en Leonie, mijn hele promotieperiode waren jullie beiden er, met jullie 
steun, inhoudelijke adviezen en gezelligheid. Het was heel fijn samenwerken met jullie 
tijdens de ‘hartgroepen’. Maar bovenal ben ik heel blij met jullie beider vriendschap. Onze 
gastronomische en nautische ervaringen hebben zeker bijgedragen aan de wetenschappelijke 
verdieping van onze discussies! En dan de collega’s van de kantoortuin en van ‘boven’: 
Nienke, Denise, Anke, Steven, Justine, Jessica, Moji, Marloes, Viki, Sumayah, Liora en 
Monique. Dank voor jullie goede gezelschap en jullie collegialiteit. 
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 Ik vond het geweldig dat ruim 1300 mensen, huisarts patienten die zelf niet onder 
behandeling waren voor psychische problemen, mee hebben willen doen aan dit onderzoek. 
Door 3 uur lang diverse vragen, mondeling en schriftelijk, te beantwoorden is dit onderzoek 
werkelijkheid geworden. Voor hun hulp bij het selecteren van deze deelnemers dank ik de 
huisartspraktijken: VEUR, Bootsma en Joustra (Leidschendam), Van Haastert en Roelen 
(Roelofarendsveen), De Lange (Leiden), Barnhoorn (Leiden), Schinkelshoek (Voorhout), 
Zaaijer, Zaaijer & Hensing (Leiden), Hammerstein & Meskers (Leiden) en Boenders 
(Leiden).
 
 NormQuest was NormQuest niet geworden zonder het NormQuest-team, mijn 
geweldige interviewers en bellers. Met de interviewers van het eerste uur ging ik naar de 
verschillende deelnemers thuis. Het was dikke pret met jullie: Lennie Geerlings, Anna 
Coppoolse, Bart Huisman, Roy de Kleijn en Nathalie Boot. Mirjam vd Hoorn, Marian Lucas 
en Marieke de Wit, fijn dat jullie op het LUMC zoveel mensen hebben gezien. Na een half 
jaar hebben we het team uitgebreid met een 2de lichting interviewers, al even enthousiast en 
geweldig: Lilo Gerdessen, Charlotte Flierboom, Anne Raterman, Elise van Holsteijn, Karlijn 
Noest, Lotte van Reuler, Margina Ruiter, Nicole Billingy, Cyntha Bogaart en Vera Atema. De 
avonden boven op C8, samen met Gea, jullie interviewers en de bellers Tessa Kooistra, Jordy 
Fransz, Lisette Bedijn, Charlotte Pronk, Nikki Elbers en Brenda Riegman waren oergezellig! 
En dat kwam mede door de gastvrijheid van de C8-afdeling. Dank aan Barbara Romson, 
Nadine Schonberger en het verplegend personeel. 
 Zonder dierbare vrienden zou promoveren niet half zo leuk zijn geweest. David 
Heyne, dank je wel voor het corrigeren van mijn Engelstalige artikelen. Maar vooral: dank 
je voor de stimulerende gesprekken en de gezellige etentjes. Annemarie Smith, ik heb 
genoten van onze discussies over onderzoek doen, over genderverschillen in gerapporteerde 
psychopathologie, over promoveren en over lekker eten. Marijke Heijloo, het was heel fijn 
om tijdens het hardlopen over alle promotieperikelen met je te praten. Top dat jij zo snel 
en zo goed mijn Nederlandse samenvatting hebt bekeken. Arnold van Emmerik, het had 
zomaar gekund dat jij hier als copromotor was genoemd, als ons PTSS-project anders was 
uitgepakt. Dank voor je vriendschap en dank voor goede eerste ervaringen op het gebied van 
promotieonderzoek opzetten. Promotieplezier heb ik van heel nabij meegemaakt bij mijn 
vriendinnen, de “meisjes van de ondergang” van FSW: Marieke Tolenaar, Rimke Haringsma, 
Ilke Jellema, Jacobien van Peer, Emma Massey, Maarten Fischer (als enig niet-meisje) en 
Anja Greeven. Het plezier werkte aanstekelijk!
 
En dan heel belangrijk: Alle vrienden en familie, die de afgelopen 5 jaar veel te weinig tijd/
aandacht van mij hebben gehad. Dank voor jullie geduld en begrip. Het wordt weer beter, dat 
beloof ik jullie!
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 Nienke en Jasper, ik ben heel erg blij dat jullie tijdens de verdediging naast mij staan 
als mijn paranimfen. Nienke, jouw niet aflatende steun en jouw bezorgdheid dat ik wel eens 
te veel hooi op mijn vork nam hebben me steeds weer laten voelen wat een lief mens jij bent. 
Jasper, jouw trots op wat ik deed en je relativerend vermogen, naast je humor, hebben me 
steeds weer veel goed gedaan.
 
 Mijn geweldige andere dochter, Jolien, en mijn drie evenzo geweldige ‘schoonkids’ 
Marco, Boudewijn en Marielle en natuurlijk mijn allerliefste kleinkinderen Isabel, James en 
Matthijs: jullie hebben deze 5 jaren voor veel energie en plezier gezorgd.
 Willem, mijn lief. Ruim 35 jaar geleden hebben we samen jouw promotietraject 
doorlopen. Het was een heftige periode waarin ik je op allerlei mogelijke manieren heb 
geprobeerd steunen. Die periode heeft tot veel goeds geleid. Nu, tijdens mijn promotietraject, 
was jij er steeds met praktische steun, met advies, met heerlijke maaltijden plus een kaarsje 
als ik moe thuis kwam, met humor en, vooral, met veel liefde. Op naar ons volgende project!
Yvonne, Gea en een aantal interviewers
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Met dank aan A. Schat voor de opmaak van dit overzicht.


